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11:00 - 12:30 Congress Hall
Scientific Session SS 1
Pancreas: technical advances in tumour 
imaging
SS 1.1 
Prediction of pancreatic neuroendocrine tumor grade 
with MR imaging features: added value of diffusion-
weighted imaging
M. Ronot1, E. Lotfalizadeh1, M. Wagner2, W. Allaham1, 
M.-P. Vullierme1, V. Vilgrain1; 1Clichy/FR, 2Paris/FR 
Purpose: To evaluate the value of MRI including diffusion-weighted imaging 
(DWI) for the grading of pancreatic neuroendocrine tumors (pNET).
Material and methods: Between 2006 and 2014, all patients with resected 
pNETs with preoperative MRI including DWI were included. Tumor grading was 
based on the 2010 WHO classification (G1-3). MRI features including size, T1w 
and T2w signal intensity, enhancement pattern, apparent (ADC) and true diffu-
sion (D) coefficients were reported.
Results: 108 pNETs (mean 40±33mm) were evaluated in 94 patients (48 wom-
en, 51%, mean 52±12yo). Fifty-five (51%), 42 (39%), and 11 (10%) tumors 
were G1, G2 and G3, respectively. Mean ADC and D values were significantly 
lower as grade increased (ADC: 2.13±0.70, 1.78±0.72, and 0.86±0.22 10-3 
mm²/s for G1, G2 and G3; D: 1.92±0.70, 1.75±0.74, and 0.82±0.19 10-3 mm²/s 
for G1, G2 and G3, all p<0.01). pNETs with hypo/iso-signal intensity on arterial 
(p<0.001), portal venous (p<0.001), and delayed phase images (p=0.005), and 
larger size (p<0.001) were more likely to be G3. The area under the curve of 
ADC and D to differentiation between G3 and G1-2 were 0.96±0.02 and 
0.95±0.02 (p<0.001). The best cutoff values for ADC and D for the identifica-
tion of G3 were 1.19 10-3mm2/s (sensitivity 100%, specificity 92%), and 1.04 
10-3mm2/s (sensitivity 82%, specificity 92%), respectively.
Conclusion: Morphological and functional MRI features of pNETS depend on 
tumor grade. DWI is useful for the identification of high-grade tumors.
SS 1.2 
Advanced pancreatic adenocarcinoma: CT evaluation 
before and after neoadjuvant treatment with 
fluorouracil, leucovorin, oxaliplatin and irinotecan and 
correlation with histopathology
E. Boninsegna1, B. Sureka2, R. Negrelli1, V. Di Paola1, 
G. Avesani1, S. Mehrabi1, R. Manfredi1, R.M. Pozzi Mucelli1; 
1Verona/IT, 2New Delhi/IN 
Purpose: Majority of patients with pancreatic cancer present with metastatic 
and locally advanced disease at the time of initial diagnosis. The action to 
control cardiovascular risk in diabetes trial demonstrated that the survival in 
pancreatic adenocarcinoma treated with neoadjuvant FOLFIRINOX (fluoroura-
cil, leucovorin, oxaliplatin, and irinotecan) is improved when compared with 
gemcitabine-based regime. We evaluated CT examinations of patients with 
adenocarcinoma before and after FOLFIRINOX to assess neoplasm modifica-
tions; we also compared imaging findings with histopathological results given 
by surgery or biopsy.
Material and methods: Twenty-two patients with pancreatic adenocarcinoma 
treated with FOLFIRINOX were enrolled; we evaluated: longest dimension and 
volume of the neoplasm, density of the lesion, vessels involvement, metastatic 
lymphnodes, perineural invasion and resectability (according to Americas 
hepato-pancreato-biliary association guidelines). After FOLFIRINOX every pa-
tient underwent exploratory laparotomy with multiple biopsies of peritumoral 
tissue.
Results: After FOLFIRINOX treatment we observed significant reduction of 
tumor volume and longest dimension (p<0,01); increase of density and vascu-
larisation; reduction of cases with major vessels involvement. In 6/22 patients 
(27.3%) CT showed vessels encasement but biopsy results were only fibrosis. 
CT sensitivity and specificity to assess perineural invasion were, respectively, 
22% and 86%; CT sensitivity and specificity to evaluate resectability were 
92% and 60%. CT did not recognize metastatic lymphnodes.
Conclusion: FOLFIRINOX is a highly effective treatment for advanced pancre-
atic adenocarcinoma; CT is indicated to evaluate tumor response, but it might 
underestimate the percentage of successfully resectable patients.
SS 1.3 
Correlation between appearance of the retroportal fat 
plane at preoperative CT and pathology findings in 
resected adenocarcinoma of the pancreatic head
F. Lombardo, G.A. Zamboni, M.C. Ambrosetti, M. Chincarini, 
G. Malleo, G. Marchegiani, R.M. Pozzi Mucelli; Verona/IT 
Purpose: To correlate the CT and pathology findings in resected adenocarci-
nomas of the pancreatic head (PDAC).
Material and methods: We included 41 patients with resected PDAC of the 
pancreatic head (25M, 16F, mean age 65 years). All patients had a multiphasic 
preoperative MDCT. All cases were re-evaluated at pathology for the state of 
the retroportal lamina, lymphnode and perineural invasion. CT images were 
reviewed in consensus by two radiologists for assessment of the fat plane 
between the pancreatic head and the mesenteric artery and vein: this was 
graded in 3 categories (clear, effaced, infiltrated). Fisher’s test was used to as-
sess the correlation between CT and pathology findings.
Results: A clear fat plane between the pancreatic head and the mesenteric 
vessels was significantly associated with a negative retroportal lamina at pa-
thology (p=0.0266). This was also observed for the plane between the head 
and the superior mesenteric artery (p=0.0011) and the superior mesenteric 
vein (p=0.0327). No different results were observed between effaced and 
clearly infiltrated fat. No association was observed between the appearance of 
the fat planes at CT and the presence of lymphnode or perineural invasion 
(p=n.s.).
Conclusion: A clear fat plane between the pancreatic head and the mesen-
teric vessels is significantly associated with negative retroportal lamina at pa-
thology. CT is not accurate in predicting perineural or nodal invasion.
SS 1.4 
Pancreatic neuroendocrine tumor: prediction of the 
tumor grade using CT findings and computerized 
texture analysis
J.H. Kim, T.W. Choi, S.J. Park, J.K. Han; Seoul/KR 
Purpose: To investigate the important CT findings and computerized CT tex-
ture variables for prediction of grade of pancreatic neuroendocrine tumor 
(PNET).
Material and methods: 66 patients with pathologically confirmed PNETs 
(G1=45, G2/3=21) underwent preoperative contrast-enhanced CT. Two review-
ers determined the presence of predefined CT findings. Computerized CT tex-
ture was also analyzed on arterial (AP) and portal phase (PP) using both 2D and 
3D analysis. Multivariate logistic regression analysis was performed to identify 
significant predictors for tumor grade.
Results: Among CT findings and CT texture variables, the significant predic-
tors for grade 2/3 tumor were an ill-defined margin (OR, 7.273), lower spheric-
ity (OR, 0.491) and lower grey level co-occurrence matrices moments (OR, 
0.563) on AP-2D analysis, higher skewness (OR, 1.972) and lower sphericity 
(OR, 0.408) on AP-3D analysis, lower kurtosis (OR, 0.436) and lower sphericity 
(OR, 0.420) on PP-2D analysis, and larger surface area (OR, 2.007) and lower 
sphericity (OR, 0.503) on PP-3D analysis (P<0.05).
Conclusion: CT is useful for predicting grade 2/3 PNET using not only the 
imaging findings including an ill-defined margin, but also the CT texture varia-
bles such as lower sphericity, higher skewness, and lower kurtosis.
SS 1.5 
Pancreatic neuroendocrine neoplasms: MRI features 
and correlation with their histological grade
R. De Robertis1, M. D’Onofrio2, S. Ortolani2, P. Tinazzi 
Martini1, S. Cingarlini2, G. Butturini1, S. Gobbo1, P. Capelli2, 
R. Girelli1, P. Regi1, G. Tortora2, P. Pederzoli1, A. Scarpa2; 
1Peschiera del Garda/IT, 2Verona/IT 
Purpose: To describe MRI features including diffusion-weighted imaging (DWI) 
of pancreatic neuroendocrine neoplasms (PanNENs) according to their histo-
logical grade.
Material and methods: Preoperative MR examinations of 50 PanNEN patients 
were retrospectively reviewed. Qualitative and quantitative MR features were 
evaluated by two radiologists. All MR features were compared between histo-
logical grades using Chi-square/Fisher’s exact test and Student’s T/ANOVA 
test. P values <0.05 were considered statistically significant.
Results: Ill-defined margins, local infiltration, vascular involvement and liver 
metastases were significantly more common among G2-3 PanNENs com-
pared to G1 tumors. G1 tumors were significantly smaller than G2-3 tumors 
(22.8 vs 38.1 mm, p=0.016); the mean ADC value was significantly lower 
among G2-3 tumors as compared to G1 tumors (1.03±0.3 vs 1.38±0.6, 
p=0.010).
Conclusion: MR features of PanNENs vary according to their histological 
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11:00 - 12:30 Forum Hall
Scientific Session SS 2
HCC: imaging and assessment
SS 2.1 
MRI features of hepatocellular carcinoma capsule 
appearance in cirrhotic liver: comparison of gadoxetic 
acid and gadobenate dimeglumine
M. Dioguardi Burgio, D. Picone, G. Cabibbo, M. Midiri, 
R. Lagalla, G. Brancatelli; Palermo/IT 
Purpose: To compare the MRI features of HCC capsule appearance on ga-
doxetic acid and gadobenate dimeglumine-enhanced MRI.
Material and methods: Gadoxetic acid and gadobenate dimeglumine-en-
hanced MRI of 51 patients with 71 HCCs were reviewed. Three readers graded 
in consensus, using a five-point scale, the presence (score 4-5) of capsule 
appearance on images obtained during T1-weighted GRE portal venous phase 
(PVP), three minutes phase and hepatobiliary phase (HBP).
Results: A hyperintense capsule appearance was present either on PVP or 
three minutes phase in 11/46 and in 24/25 HCCs imaged with gadoxetic acid 
and gadobenate dimeglumine-enhanced MRI, respectively (24% vs 96% 
p<0.0001). A hypointense capsule appearance was present on HBP in 8/46 
and 0/22 HCCs evaluated with gadoxetic acid and gadobenate dimeglumine-
enhanced MR imaging, respectively (17% vs 0% p=0.046). A capsule appear-
ance was detected either on PVP, three minutes phase or HBP in 17/46 (37%) 
HCCs after gadoxetic acid injection and in 24/25 (96%) HCCs after gado-
benate dimeglumine injection (p<0.0001).
Conclusion: A capsule appearance was more frequently seen on gadobenate 
dimeglumine-enhanced MRI when compared to gadoxetic acid-enhanced 
MRI.
SS 2.2 
Comparing the results of intravoxel incoherent motion 
diffusion-weighted imaging calculated by different 
estimation methods: discrimination of histological grade 
of HCC
S. Ichikawa1, U. Motosugi1, D. Hernando2, H. Morisaka3, 
H. Onishi1; 1Yamanashi/JP, 2Madison, WI/US, 3Saitama/JP 
Purpose: To compare the measurement repeatability of intravoxel incoherent 
motion (IVIM) imaging using 3 different approximation methods for discriminat-
ing the histological grade of HCC.
Material and methods: Fifty-eight patients (60 HCCs) underwent IVIM imag-
ing with 11 b values (0–1000s/mm2). Slow (D) and fast diffusion coefficients 
(D*) and the perfusion fraction (f) were calculated for HCCs using regions of 
interest placed individually by two radiologists. The following approximation 
methods were used during calculation. First, all 3 parameters were obtained 
simultaneously, using non-linear fitting (method A). Second, D was first ob-
tained using linear fitting (b = 500 and 1000), followed by non-linear fitting for 
D* and ƒ (method B). Third, D was obtained by linear fitting, after which, ƒ was 
obtained using the regression line intersection and signals (b = 0) and non-
linear fitting was used for D* only (method C).
Results: Methods B and C (Az-value, 0.707–0.881) yielded better HCC grade 
discrimination ability, compared with method A (Az-value, 0.537–0.583). The 
ICCs of D and f were good-to-excellent (0.639–0.835) with all methods. The 
ICCs of D* were moderate with method B (0.580) and C (0.463), and good with 
method A (0.705).
Conclusion: Compared with partial linear fitting, complete non-linear fitting, 
although reproducible, exhibited worse discrimination ability.
SS 2.3 
Evolution of indeterminate hepatocellular nodules at 
initial gadolinium-ethoxybenzyl-diethylenetriamine 
pentaacetic acid-enhanced MRI in cirrhotic patients
F. Agnello, M. Galia, R. Cannella, F. Midiri, G. Lo Re, 
L. La Grutta, T.V. Bartolotta, G. Brancatelli; Palermo/IT 
Purpose: To retrospectively evaluate the evolution of indeterminate hepatic 
nodules at initial gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic 
acid (Gd-EOB-DTPA)-enhanced MRI in cirrhotic patients.
Material and methods: 33 cirrhotic patients (24 males; mean age, 64.9 years) 
with 69 indeterminate nodules (mean diameter, 1.1 cm; range, 0.5-2) at initial 
Gd-EOB-DPTA-enhanced MRI and a Gd-EOB-DPTA-enhanced MRI follow-up 
of at least 2 years (mean, 805 days; range, 745-2440) were evaluated. Indeter-
minate hepatocellular nodules were defined as nodules that cannot be diag-
nosed as HCC according to ASSLD 2010 criteria. Based on signal intensity at 
initial MRI, each nodule was classified into 6 groups: A) hyperintense on pre-
contrast T1 phase (12/69); B) hyperintense on precontrast T1 and hepatobiliary 
phase (4/69); C) hyperintense on hepatobiliary phase (23/69); D) hypointense 
on hepatobiliary phase (9/69); E) hypointense on transitional and hepatobiliary 
phase (20/69); F) hypointense on portal-venous, transitional and hepatobiliary 
phase (1/69). Changes in size (disappearance, regression, no change, growth) 
and rate of progression to HCC were compared among groups using Chi-
square test. Diagnosis of HCC was done by pathology and ASSLD 2010 crite-
ria.
Results: 5/69 (7%) nodules (3 Group E; 2 group D) become HCC. There was 
no statistically significant difference in progression to HCC among groups. 
There was no statistically significant difference in rate of nodule disappearance 
(6%; 8/69), regression (4%; 7/69), no change (55%; 38/69) and growth (23%; 
16/69) among groups.
Conclusion: Indeterminate hepatic nodules at Gd-EOB-DPTA-enhanced MRI 
in cirrhotic patients rarely progress to HCC.
SS 2.4 
Noninvasive biomarker for prediction of treatment 
response to concurrent chemo-radiotherapy in patients 
with locally advanced HCC
Y.E. Chung, J. Seong, J.Y. Park, M.-S. Park, M.-J. Kim; 
Seoul/KR 
Purpose: To investigate noninvasive biomarker for prediction of treatment re-
sponse in patients with locally advanced HCC.
Material and methods: Thirty patients (55.5±10.2 years old, M:F=24:6) who 
underwent concurrent chemo-radiotherapy (CCRTx) due to advanced HCC 
were prospectively enrolled. Contrast-enhanced US (CEUS) and perfusion MRI 
were obtained before and immediately after CCRTx. The third CEUS was ob-
tained 1 month after the end of CCRTx. Response assessment was performed 
3 months after the end of CCRTx based on RECIST criteria. Quantitative bio-
markers measured by CEUS including peak enhancement (PE), time to peak 
enhancement (TTP), and mean transit time (MTT) and by perfusion MR includ-
ing volume transfer constant (Ktrans), reflex constant (Kep), and extravascular-
extracellular volume fraction (Ve) were compared with the Mann-Whitney U 
test. A cutoff value of PE was calculated with ROC analysis and overall sur-
vival (OS) was compared by Breslow method.
Results: PE of the first CEUS before CCRTx was significantly lower in re-
sponder (median, 18.6%; IQR, 20.9%) than in non-responder (59.1%, 13.5%; 
P=0.002). There was no significant difference between two groups in other 
quantitative biomarkers. In receiver operating characteristic analysis, respond-
er could be diagnosed with sensitivity of 90.9% and specificity of 100% with a 
cutoff value of 42.6% of PE. OS was also significantly longer in patients with 
PE<42.6% than the others (P=0.014).
Conclusion: Early treatment response and OS could be predicted by PE on 
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SS 2.5 
Usefulness of multi-arterial phase for characterization 
of liver hypervascular focal lesions using gadoxetic acid 
in liver MRI
R. Faletti1, L. Grazioli2, G. Battisti3, B. Frittoli2, P. Fonio1, 
G. Gandini1; 1Turin/IT, 2Brescia/IT, 3Spoleto/IT 
Purpose: To evaluate the hypervascular liver lesion studied by a single arterial 
phase protocol and by a multiarterial phase with CAIPIRINHA (Controlled 
Aliasing In Parallel Imaging Results IN Higher Acceleration) technique protocol.
Material and methods: MR examinations of 148 patients: 70 with a single 
phase optimized protocol and 78 with the CAIPIRINHA multi-arterial phase 
protocol. We analyzed the signal intensities from aorta, portal vein, liver paren-
chyma and lesions on the pre-contrast phase and on all arterial phase images.
Results: The lesions were 33 in the standard protocol and 50 in the CAIPIR-
INHA protocol. We identified three groups: A (maximum lesion-to-liver contrast 
ratios LLCR at 1st phase), B (maximum LLCR at 2nd phase) and C (maximum 
LLCR at 3rd phase). Group C includes 30% of HCC lesions, and none of be-
nign lesions. The comparison with the standard protocol shows that the aorta 
enhancement for the latter is significantly higher than the one observed in the 
1st arterial phase of the CAIPIRINHA protocol (p<0.0001), whereas all other 
values are midway between the values achieved in the first two arterial phases 
of the CAIPIRINHA protocol, and significantly inferior (p=0.0003) to the values 
relative to the latest arterial phase.
Conclusion: The existence of three useful phases not only drastically reduces 
the chance of missing lesions but also allows estimating the lesion enhance-
ment as a function of time.
SS 2.6 
Added value of hepatobiliary-phase and T2-weighted 
images to the liver imgaing reporting and data system 
for the diagnosis of HCC: preliminary results
G. Rosiak, A. Grodzicka, E. Rosiak, B. Górnicka, 
O. Rowinski, A. Cieszanowski; Warsaw/PL 
Purpose: To retrospectively assess the added value of T2-weighted and hepa-
tobiliary-phase (HP) images in the liver imaging reporting and data system (LI-
RADS) for the diagnosis of HCC in patients with chronic liver disease.
Material and methods: 22 patients (18 men, 5 women) in the mean age of 65 
years (range, 34-87) with chronic liver disease and 35 histopathologically con-
firmed HCC (mean diameter of 33 mm, range: 7-138 mm) underwent magnetic 
resonance imaging (MRI) with hepatobiliary contrast agent (Gd-BOPTA in 15, 
Gd-EOB-DTPA in 7 patients). Lesions were solitary in 10 patients and multiple 
in 12 patients. Two abdominal radiologists evaluated dynamic contrast-en-
hanced images, T2-weighted images and HP images. In case of disagreement 
between readers, a consensus interpretation was formed. The diagnostic per-
formance of LI-RADS was assessed and compared to T2-weighted and HP 
images.
Results: Nineteen of 35 HCCs (54.3%) were classified as LI-RADS category 5 
lesions, 12 (34.3%) as LI-RADS category 4 lesions and 4 (11.4%) as LI-RADS 
3 category lesions. Combining LI-RADS category 4 lesions with hypointensity 
on HP images and hyperintensity on T2-weighted images for the diagnosis of 
HCC would improve the sensitivity from 54.3% (for LI-RADS category 5 lesions 
only) to 80%.
Conclusion: The combined interpretation of T2-weighted and HP images for 
LI-RADS category 4 lesions significantly improved the sensitivity of MRI for the 
diagnosis of HCC.
SS 2.7 
withdrawn by the authors
SS 2.8 
Efficacy of abdominal US surveillance for HCC detection 
in cirrhotic patients: our experience
F. Agnello, M. Antonucci, F. Midiri, A. Taibbi, T.V. Bartolotta; 
Palermo/IT 
Purpose: To retrospectively evaluate the efficacy of abdominal US surveil-
lance in the detection of HCCs in cirrhotic patients.
Material and methods: In a 24-month period, 224 cirrhotic patients under-
went US surveillance. 164/224 (73%) patients (112 men; mean age 64.5 years 
± 10; 26-84) underwent subsequent contrast-enhanced CT (n= 56) and Gd-
EOB-DTPA-enhanced MRI (n=108). US reports were correlated with CT and 
MR images. Nodules were classified as true positive (nodules detected by US 
and confirmed as HCC), false positive (nodules detected by US but not con-
firmed as HCC) and false negative (HCCs not detected by US). Reference 
standard for HCC diagnosis was AASLD 2010 criteria and pathology. US sen-
sitivity for HCC detection and agreement among US and CT/MRI were calcu-
lated.
Results: Our final study comprised 220 nodules. There were 89/220 (41%) true 
positive (mean diameter 2.7 cm±1.4; 7-15), 12/220 (5%) false negative (mean 
diameter 5.7 cm±0.7; 1-4) and 119/220 (54%) false positive (mean diameter 
1.3 cm±0.4; 1-3.6). Causes of false-positive were regenerative nodules (n= 
20/119), dysplastic nodules (n=16/119), hemangiomas (n=7/119), cysts 
(n=6/119), other (n=5/119). No explanation for false-positive was found in 
65/119 nodules. US sensitivity was 88%. Intermodality agreement was 
35.02% (K=0.390).
Conclusion: Abdominal US shows high sensitivity for HCC detection. The 
agreement among US and CT/MRI for HCC detection is fair.
SS 2.9 
MDCT perfusion imaging biomarkers as prognostic 
indicators of survival in hepatocarcinoma
A. Alberich-Bayarri, A. Torregrosa Andrés, R. Nombela, 
J. Tomás Cucarella, L. Martí-Bonmatí; Valencia/ES 
Purpose: To analyze the relationship of perfusion CT imaging biomarkers in 
treated hepatocarcinoma with overall survival (OS) to add insights into progno-
sis evaluation of the disease.
Material and methods: A total of 28 patients with hepatocarcinoma were in-
cluded in the study (mean age 68±10). Perfusion MDCT acquisitions were per-
formed in a scanner with 256 detectors (Brilliance iCT, Philips Healthcare, The 
Netherlands). The acquisition had a voxel size of 0.25x0.25x5mm. A mean 
volumen of 41±5 ml of iodated contrast was administered (IOMERON 400©). 
Images were pre-processed by a gaussian filtering and a non-linear registra-
tion. The parametric maps of arterial perfusion (AP), perfusion index (PI), arte-
rial time-to-peak (TTP) and permeability (P) were calculated. The pre-process-
ing and parametric maps calculation was performed at the IntelliSpace Portal© 
platform of Philips. Finally, regions of interest (ROI) were placed in the lesions 
to register the mean values obtained. OS was calculated using the date of the 
first MR post-treatment.
Results: The values obtained for lesions were of 108.40±38.53 for AP[l/
min/100]; 0.61±0.13 for HP; 23.02±8.36 for TTP[s]; 19.07±8.27 for P[l/min/100]. 
OS was higher in the group with an HP>=0.6 (354 days) vs HP<0.6 (226 days). 
No differences were observed for the other parameters.
Conclusion: Perfusion CT and especially the hepatic perfusion index is an 
imaging biomarker with growing applications in HCC prognosis evaluation, as 
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SS 2.10 
Unenhanced MRI immediately after ablation of liver 
malignancies to assess treatment efficacy
M. D’Onofrio, N. Cardobi, V. Ciaravino, R. De Robertis, 
R.M. Pozzi Mucelli; Verona/IT 
Purpose: To assess the accuracy of unenhanced MRI immediately after the 
percutaneous ablation of liver malignancy in predicting the treatment efficacy 
at CT follow-up.
Material and methods: Percutaneous ablation was prospectively performed 
in 17 liver malignancies (14 HCCs, 3 METs). After the procedure, on the same 
day all the lesions were studied with unenhanced MRI. The MRI protocol was 
essential (T2, FST2, T1, FST1 and DWI) to be performed in short time. The best 
sequence to detect the coagulative necrosis was established. Sensitivity, 
specificity, positive predictive value (PPV), negative predictive value (NPV) and 
accuracy of MRI in predicting the correct centring and the complete treatment 
of the lesion were calculated with respect to the standard one month follow-up 
CT.
Results: Coagulative necrosis was hyperintense in T1 sequences in 13/17 
(76%). FST1 was the sequence in which the best conspicuity of the ablated 
area was depicted. With respect to follow-up CT, MRI predicted the correct 
centring of the lesions in 13/17 (76%) lesions with sensitivity, specificity, PPV, 
NPV and accuracy of 100%, 75%, 93%, 100% and 94%, respectively. MRI 
predicted the complete treatment of the lesions in 12/17 lesions with sensitiv-
ity, specificity, PPV, NPV and accuracy of 100%.
Conclusion: MRI with the single T1FS weighted sequence was highly accu-
rate in predicting the treatment efficacy of percutaneous ablation of liver ma-
lignancies as shown at CT follow-up. Unnecessary CT in case of incomplete 
treatment can be, therefore, easily avoided.
11:00 - 12:30 Meeting Hall V
Scientific Session SS 3
Percutaneous HPB intervention: novel 
advances 
SS 3.1 
Percutaneous electrochemotherapy of malignant main 
portal veins thrombosis: a prospective case series
L. Tarantino1, G. Busto1, A. Nasto1, R. Fristachi1, L. Cacace1, 
M. Talamo1, P. Ambrosino2, P. Gallo3, P. Tarantino2, 
C. Accardo1; 1Pagani/IT, 2Naples/IT, 3Rome/IT 
Purpose: We report our experience in thrombosis of portal vein and/or first-
order branches (Vp3-4PVTT) from HCC treated with percutaneous electro-
chemotherapy (ECT).
Material and methods: Six cirrhotics (5 males; 61–85 years, 4 in Child-Pugh 
A, 2 in Child-Pugh B class) prevously studied with three-phase CT, contrast-
enhanced ultrasound (CEUS) and US-guided percutaneous biopsy of the 
thrombus, underwent ECT (Cliniporator Vitae - IGEA, Carpi, Italy) of Vp3-
4PVTT and the associated HCC nodule in the same session, under general 
anesthesia.
Results: 24-hour posttreatment CEUS showed complete absence of en-
hancement of the treated trhombus in all cases. Post-treatment biopsy 
showed apoptosis and necrosis of tumor cells in all cases. The follow-up rang-
es from 3 to 12 months (median: 8 months). In 1 patient, the 3-6-9-12 months 
CEUS and CT demonstrate complete recanalization of the treated PVTT; in 
another patient, 3-6-9 months CEUS and CT show a partially patent portal 
vein; other 3 patients (8, 4 and 3 month follow-up, respectively) show avascu-
lar complete thrombosis at CEUS and CT. In all 5 patients, CEUS and CT show 
absence of abnormal intravascular or perivascular enhancement consistent 
with residual tumor or local recurrence. One patient, was lost to follow-up be-
cause of death from gastrointestinal hemorrhage 5 weeks after ECT.
Conclusion: ECT seems effective and safe for curative treatment of Vp3-Vp4 
PVTT from HCC.
SS 3.2 
Microwave ablation of large HCCs by simultaneous 
multiple antennae insertion: long-term follow-up
L. Tarantino1, P. Ambrosino2, P. Gallo3, P. Tarantino2, 
A. Nasto1; 1Pagani/IT, 2Naples/IT, 3Rome/IT 
Purpose: We report long-term results of microwawe (MW) ablation with simul-
taneous insertion of multiple antennae in the treatment of large HCC.
Material and methods: Between 2008 and 2013, 36 cirrhotics with a single 
HCC nodule >3 cm (3.2-7.0 cm; mean: 4.4 cm) underwent MW ablation in a 
single session by simultaneous insertion of multiple 13-gauge-MW-antennae 
(Viva-Wave, Covidien, USA). After intraoperative contrast-enhanced ultra-
sound (CEUS), residual viable tumor was treated in the same session by rein-
sertion of 2-3 MW antennae.
Results: According to the tumor size, 10 and 18 patients were treated with a 
single insertion of 2-3 synchronous antennae, respectively. 8 patients were 
treated with 2 insertions of 3 antennae in the same session. Intraoperative 
CEUS showed residual tumor in 12 patients and these patients underwent an 
additional insertion of 2 or 3 antennae. Intraoperative CEUS at the end of the 
procedure showed complete necrosis in all patients. 1-month CT showed 
complete necrosis in 33/36 patients. Only a severe hemoperitoneum occurred 
in one patient after treatment. Local recurrence occurred in 7 patients. Recur-
rences in other liver segments occurred in 35/36 patients within 6 to 24 months 
(mean: 15 months). 20 patients were alive at 18-78 months follow-up (mean: 
42 months).
Conclusion: Aggressive ablation of large HCC by simultaneous insertion of 
multiple MW antennae is safe and seems to result in patients’ survival compar-
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SS 3.3 
Tumor seeding after percutaneous US-guided FNA of 
solid pancreatic neoplasms
R. De Robertis1, C. Sozzi2, M. D’Onofrio2, E. Barbi1, 
E. Manfrin2, S. Gobbo1, G. Butturini1, S. Ortolani2, 
G. Tortora2, C. Bassi2, P. Pederzoli1; 1Peschiera del Garda/IT, 
2Verona/IT 
Purpose: To determine the frequency of tumor seeding after percutaneous 
US-guided FNA of solid pancreatic neoplasms.
Material and methods: Follow-up examinations (CT or MR) of 124 patients 
with solid pancreatic neoplasms who underwent US-FNAs were retrospec-
tively evaluated. Two radiologists evaluated the presence of imaging features 
suggesting tumor seeding as peritoneal/subcutaneous solid nodules or as-
cites.
Results: Median follow-up length was 197 days. Subcutaneous nodules along 
the needle track were found in 1/124 cases (0.8%). Ascites without local or 
systemic disease progression was found in 7/124 patients (5.6%), after a me-
dian time interval of 210 days after FNA.
Conclusion: Tumor seeding is uncommon after percutaneous US-FNA of 
solid pancreatic neoplasms. Ascites without any sign of local/systemic dis-
ease progression can develop after US-FNA and may suggest microscopic 
peritoneal tumor seeding; nevertheless, as the time interval to the develop-
ment of ascites is comparable to the disease-specific time to progression, 
ascites may also be the consequence of disease progression unrelated to the 
procedure.
SS 3.4 
Microwave ablation of large HCCs using a new device: a 
case series
L. Tarantino1, P. Ambrosino2, P. Gallo3, P. Tarantino2, 
A. Nasto1; 1Pagani/IT, 2Naples/IT, 3Rome/IT 
Purpose: We evaluated a device designed to achieve large volumes of necro-
sis in HCC by synchronous activation of multiple microwave (MW) antennae.
Material and methods: 10 consecutive patients with a single large HCC nod-
ule (3.5-6.5 cm; mean: 4.6 cm) underwent US-guided percutaneous MW abla-
tion by synchronous insertion of multiple MW antennae (SynchroWave 915 
MHz antennas - MicroThermX® microwave ablation system, Terumo, Belgium, 
Europe). A single insertion of 2 antennae (3 cases), and 3 antennae (5 cases) 
was performed. 2 insertions of 3 antennae in the same session were performed 
in 2 cases. Treatment efficacy was assessed by CT and bimonthly US follow-
up.
Results: Post-treatment CT showed complete necrosis in 8/10 HCC nodules 
(80%). 2 patients with incomplete ablation underwent an additional MW abla-
tion session. CT showed complete necrosis in both of them. Several major 
complications (recovered with medical treatment) occurred: anaerobic infec-
tion of the treated necrotic area in 2 cases, severe right pleural effusion in one 
case, jaundice from transient liver failure. All patients are still alive (follow-up 
12-20 months). In 6/10 (60%) cases, intrahepatic recurrence occurred within 
6-14 months (mean 10 months) and it could be successfully treated with abla-
tion in 3 cases. The other 3 patients underwent chemotherapy with sorafenib 
and/or best supportive care.
Conclusion: The MicroThermX microwave ablation system seems an effective 
and relatively safe device for treatment of large HCC.
SS 3.5 
withdrawn by the authors
SS 3.6 
CT findings of hepatic abscess: predicting the outcome 
of percutaneous catheter drainage or percutaneous 
needle aspiration
J. Lee1, M. Kang1, S.C. Baek1, B.S. Cho1, K.S. Park1, 
J.Y. Moon2; 1Cheongju/KR, 2Seoul/KR 
Purpose: To evaluate association between CT findings and outcome of percu-
taneous catheter drainage (PCD) or percutaneous needle aspiration (PNA) in 
patients with hepatic abscess.
Material and methods: 93 patients who had undergone PCD or PNA in a 
5-year period were included. Clinical data, microbiologic characteristics, and 
outcome of treatment were reviewed. Three radiologists evaluated CT findings 
of hepatic abscess including diameter, volume, mean attenuation values, num-
ber, location, configuration, presence of cystic component and gas, rim en-
hancement, wall thickness, and shortest length to hepatic capsule. Patients 
were divided into two groups: group 1 (≥50%) and group 2 (<50%) according 
to ratio of initial-drainage volume to CT-determined abscess volume. Univari-
ate and multivariate statistical analyses were used to examine association of 
CT and clinical findings between two groups. Statistical relationship between 
mean attenuation values and outcome of PCD or PNA was assessed using 
Spearman correlation analysis.
Results: There were 32 patients in group 1 and 61 in group 2. Multivariate 
analysis revealed that cystic appearance (P=.028) and thick wall (P=.002) were 
significant in group 1, and there was a tendency to shorter hospital stay 
(P=.061) in group 1. There was negative correlation between mean attenuation 
values and ratio of initial-drainage volume to CT-determined abscess volume.
Conclusion: CT findings may be useful predicting factors for outcome of PCD 
or PNA in patients with hepatic abscess.
SS 3.7 
Endoluminal radiofrequency ablation of hilar 
cholangiocarcinoma
T. Andrasina, J. Panek, J. Hlavsa, V. Bernard, V. Valek;  
Brno/CZ 
Purpose: To prove efficacy of endoluminal radiofrequency ablation in palliative 
treatment of hilar cholangiocarcinoma.
Material and methods: 35 patients with hilar cholangiocarcinoma have been 
enrolled in a prospective randomised study since 2010. The infiltrative type of 
cholangiocarcinoma was predominant. 65 non-covered self-expandable metal 
stents were inserted. In group A (n=18) the endoluminal ablation with a bipolar 
radiofrequency catheter (EndoHPB; EMcision Ltd., London, UK) was per-
formed 0-48 hours prior to the stent insertion, in group B (n=17) the stent was 
implanted without a prior ablation. The primary endpoints of the study were to 
determine the rate of complications, duration of stent patency and survival of 
patients (Kaplan-Meier analysis).
Results: The rate of biochemical pancreatitis, which was resolved in 3 days 
after stent insertion, was significantly higher in group A. The average primary 
stent patency was 5.9 and 5.7 months in groups A and B, respectively; 
3-month and 6-month stent failure was 0% and 6.1% in group A and 6.3% and 
25% in group B. The median survival from the initial drainage was 12.3 (6.7-
20.1) and 12.8 (5.7-14.7) months in groups A and B, respectively.
Conclusion: The effect of an endoluminal ablation on patients survival was not 
proven in the prospective randomised clinical study. However, in the group of 
patients undergoing ablation there is a tendency of a lower rate of early stent 
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SS 3.8 
Bacterial isolates from biliary cultures obtained during 
percutaneous biliary intervention. Are we prescribing 
the right antibiotics?
P.S. Najran, E. Barclay, J. Bell, D. Mullan, H.-U. Laasch; 
Manchester/GB 
Purpose: To identify the most common pathogens isolated from biliary cul-
tures in patients undergoing percutaneous transhepatic intervention and to 
assess antibiotic sensitivity. To establish the optimal prophylactic antibiotic 
regime.
Material and methods: All percutaneous transhepatic interventions per-
formed over a two-year period were reviewed retrospectively. Those where no 
biliary culture was obtained were excluded. Analysis of the culture results in-
cluding pathogens grown and antibiotic sensitivity was performed.
Results: A total of 58 patients were included in the analysis. No pathogens 
were grown in 27.6% of cultures (n=16). Of those with positive cultures Ente-
rococci and Pseudomonas were the most common pathogens grown in 59.5% 
of cases (n=25). Vancomycin was the most effective antimicrobial demonstrat-
ing sensitivity in 31% (n=16) of positive cultures followed by ciprofloxacin 
showing sensitivity in 26.2% (n=11). Gentamycin was the fifth most effective 
antimicrobial demonstrating sensitivity in only 14% (n=6).
Conclusion: Effective antibiotic prophylaxis requires knowledge of likely path-
ogens and procedure-specific infection risks, which may vary between hospi-
tals and patient cohorts. In our institution, gentamycin is traditionally adminis-
tered prophylactically prior to percutaneous biliary intervention; however, this 
study has demonstrated this is comparably ineffective, necessitating a change 
in protocol. The choice of antimicrobial requires continued review due to 
emerging antibiotic resistance.
SS 3.9 
Irreversible electroporation of locally advanced 
pancreatic cancer: case study of a next day post-
interventional fluorodeoxyglucose positron emission 
tomography in one patient
L. Lambert, Z. Meckova, J. Horejs, Z. Krska, D. Hoskovec, 
L. Petruzelka, V. Cerny, P. Kriz, J. Briza; Prague/CZ 
Purpose: To demonstrate the early effect of irreversible electroporation (IRE) 
on fluorodeoxyglucose (18F-FDG) consumption in locally advanced pancreatic 
cancer.
Material and methods: We present an 86-year-old female patient with locally 
advanced pancreatic cancer (stage III) located in the head of pancreas, who 
was treated by intraoperative IRE. 18F-FDG PET-CT was preformed 2 days 
prior to IRE and 1 day after IRE.
Results: PET-CT performed prior to IRE confirmed marked accumulation of 
18F-FDG within the malignant tissue without involvement of peripancreatic 
lymph nodes or distant metastatic disease. One day after IRE, PET-CT demon-
strated absence of accumulation in the tumoral mass. However, accumulation 
was present in the duodenal wall, which was infiltrated by remnants of the tu-
moral tissue. The patient died six months later of pulmonary embolism.
Conclusion: In this case study, we demonstrated nearly complete destruction 
of the tumoral mass in the pancreatic head by IRE with remnants in the duode-
nal wall using 18F-FDG PET-CT one day following the intervention.
SS 3.10 
Irreversible electroporation of locally advanced 
pancreatic adenocarcinoma: long-term follow-up
L. Tarantino1, V. Iovino1, G. Busto1, A. Nasto1, P. Gallo2, 
C. Accardo1, R. Giordano1; 1Pagani/IT, 2Rome/IT 
Purpose: We report our experience and 2 years follow-up in a locally ad-
vanced pancreatic adenocarcinoma (LAC) successfully treated with irreversi-
ble electroporation (IRE).
Material and methods: In a female patient, 24 years, CT and MR showed a 
pancreatic mass (diam.=6.5cm) with complete thrombosis of the middle and 
distal portions of splenic vein and infiltration of the mesenteric and portal vein 
wall. Biopsy showed pancreatic “aggressive type of solid papillary adenocar-
cinoma”. Imaging did not show any lymphnode or distant metastasis. The sur-
gical team excluded indication to resection. We offered the patient IRE as al-
ternative treatment, and she was treated with open laparotomy under general 
anesthesia with IRE. Six insertions of multiple electrodes (up to 4 per insertion) 
were performed.
Results: The patient left the hospital 5 days after treatment. Post-treatment 
1-month CT and MR showed “shrinkage of the tumor, partial bland thrombosis 
of the splenic vein, patent mesenteric and portal vein, small splenic infarction”. 
CT follow-up at 6-12-18-24 months, showed complete regression of the mass, 
patent splenic/mesenteric veins and absence of local recurrence or distant 
metastasis.
Conclusion: In cases with poor indications for surgical resection, IRE seems 
to be a safe and highly effective alternative treatment for advanced stage pan-
creatic solid papillary adenocarcinoma, even in presence of extensive throm-
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11:00 - 12:30 Chamber Hall
Scientific Session SS 4
Abdominal vasculature: imaging and 
intervention
SS 4.1 
Dual-energy CT angiography of the abdomen: 
optimization of window/level settings
D. Caruso1, C.N.N. De Cecco1, U.J. Schoepf2, 
J.L. Wichmann3, A. Varga-Szemes2, A. Laghi1; 1Rome/IT, 
2Charleston, SC/US, 3Frankfurt am Main/DE 
Purpose: To evaluate the optimal window settings to display virtual monoen-
ergetic images using third-generation dual-source, DECT angiography.
Material and methods: 45 patients were clinically evaluated with DECT angi-
ography. Standard linear blending (M_0.6), 70 keV standard virtual monoener-
getic (M70), and 40 keV advanced virtual monoenergetic (M40+) datasets were 
reconstructed. Two readers determined the best window settings (width and 
length, W/L), which were correlated with the aortic attenuation to obtain opti-
mized W/L settings.  Subjective image quality was assessed and vessel diam-
eters were measured to determine the influence of different W/L settings. Re-
peated measures of variance were used to assess differences in image quality 
and vessel sizing between M_0.6, M70, and M40+.
Results: The best W/L for M70 was 880/280 and 1410/450 for M40+. From the 
results of the regression analysis, we found an optimized W/L of 850/270 for 
M70 and 1350/430 for M40+. A significant difference was found between the 
best and optimized W/L for M40+ (p<0.001), as well as between M70 and 
M40+ for both the best and optimized W/L (all (p<0.001). Significant differ-
ences were reported in vessel diameters (p≤0.04).
Conclusion: When using virtual monoenergetic imaging both for standard 
M70 and advanced M40+ reconstructions, adjusting the W/L settings is man-
datory. Optimized W/L settings that correlate with aortic attenuation are advis-
able. We suggest a W/L setting of 850/270 for M70 and 1350/430 for M40+.
SS 4.2 
Comparison of image quality of various virtual 
monoenergetic algorithms for dual-energy CT 
angiography of thorax and abdomen
S.S. Martin, M.H. Albrecht, J.-E. Scholtz, D. Leithner, 
S. Fischer, R.W. Bauer, T. Vogl, J.L. Wichmann; Frankfurt am 
Main/DE 
Purpose: To comprehensively compare objective and subjective image quality 
of traditional and advanced noise-optimized virtual monoenergetic and stand-
ard linearly blended image reconstruction algorithms in third-generation dual-
source dual-energy CT angiography (DE-CTA) of the thorax and abdomen.
Material and methods: DE-CTA image series of 55 patients were reconstruct-
ed using linearly blended M_0.6 (60% low-kV spectrum), traditional monoen-
ergetic (VMI), and advanced noise-optimized monoenergetic (VMI+) algo-
rithms. Monoenergetic image series were calculated with 10 keV increments 
from 40-120 keV. Attenuation and standard deviation of region-of-interest 
measurements in various arteries and anatomical landmarks of the thorax and 
abdomen were taken to calculate contrast-to-noise ratio (CNR) values. Two 
radiologists assessed subjective image quality, contrast conditions, image 
noise, and visualization of small arterial branches using 5-point Likert scales.
Results: VMI+ 40-keV series showed the highest CNR for both thoracic and 
abdominal DE-CTA (p<0.001) and were subjectively rated highest for visualiza-
tion of small arterial branches (p<0.109). VMI+ images at 70 keV demonstrated 
superior subjective image quality (p<0.031) except compared to 60 and 80 keV 
VMI+ series (p<0.587). Contrast conditions at 50-keV VMI+ were rated supe-
rior compared to 60-100 keV VMI and VMI+ (p<0.01) reconstructions. VMI+ 
images at 100 keV were rated best regarding image noise (p<0.843).
Conclusion: Image quality of DE-CTA can be substantially increased and im-
proved contrast and visualization of small arterial branches can be achieved 
with low-keV VMI+ reconstructions and should be preferred over traditional 
VMI or standard linearly blended reconstructions.
SS 4.3 
Long-term outcome of transjugular intrahepatic 
portosystemic shunt placement in primary Budd-Chiari 
syndrome
M. Ronot, G. Hayek, M. Lagadec, C. Garcia-Alba, M. Zappa, 
A. Sibert, V. Vilgrain; Clichy/FR 
Purpose: To evaluate the long-term efficacy of transjugular intrahepatic porto-
systemic shunt (TIPS) placement for the treatment of primary Budd-Chiari syn-
drome (BCS).
Material and methods: From 2004 to 2013, all patients with primary BCS re-
ferred for TIPS placement were included in the study. The primary and second-
ary technical success rates, the number and types of early (<day 7) complica-
tions were noted. Survival was analyzed.
Results: Fifty-four patients (34 women, 63%), mean age 36±12 years were 
included. Twenty-eight patients (52%) had myeloproliferative neoplasms. The 
mean MELD score was 14.5±4. The most frequent indication for TIPS was re-
fractory ascites (50/54, 93%). Primary and secondary technical success rates 
were 93% and 98%, respectively. Early complications occurred in 17 patients 
(32%). After a mean follow-up of 56±41 months, 22 patients (42%) experi-
enced at least one episode of TIPS dysfunction (median delay between TIPS 
and first episode of dysfunction 10.8 months). Cumulative 1-, 2-, 3-, 5-, and 
10-year dysfunction-free rates were 64%, 59%, 54%, 45%, and 45%, respec-
tively. Dysfunction was associated with a myeloproliferative disorder (HR=8.18, 
95%CI 1.45–46.18, p=0.017), more than two initial stents (HR=3.90, 95%CI 
1.16–13.10, p=0.027), and the occurrence of early complications (HR=11.34, 
95%CI 1.82–70.69, p=0.009). The 10-year survival rate was 76%.
Conclusion: TIPS placement in patients with primary BCS was associated 
with a non-negligible rate of early complications, and required endovascular 
revision(s) in 42% of patients. Nevertheless, secondary permeability was close 
to 100%, and long-term survival was good.
SS 4.4 
Outcome of transhepatic intravascular porto-systemic 
shunt in older patients
N. Shah, G. Sheiybani, J. Acevedo, N. Gafoor, M.E. Cramp, 
S.A. Jackson; Plymouth/GB 
Purpose: Transhepatic intravascular porto-systemic shunt (TIPS) is a well-es-
tablished treatment for complications of portal hypertension. Older patients 
are a challenging group to treat.
Material and methods: Retrospective study reviewing patients undergoing 
TIPS between 2004 and 2015 and to determine outcomes according to age.
Results: 141 patients underwent TIPS, 132 were performed successfully (5 
patients excluded - insufficient data). 63% were male (81/127) and 28% 
(36/127) >65 years. Indications were variceal bleeding 60% (76/127), refrac-
tory ascites 30% (38/127), TIPS restenosis, 3% (4/127) other 7% (9/127). Aeti-
ology - alcohol-related liver disease (ARLD) 62%, non-alcoholic steato-hepati-
tis (NASH) 25% and other chronic aetiology 13%. The indications and 
aetiology were similar between patients >65 and <65 years of age. The most 
common complication post-TIPS was hepatic encephalopathy (HE) in 33% 
(12/36) >65 years vs 15% (14/91) <65 years. Patients >65 years had an overall 
mortality of 30% (13/44), with a 30-day (30%) and 3-year (40%) mortality. Pa-
tients with MELD >25 were associated with mortality of 75% (6/8) vs 25% 
(38/119) in patients with MELD <25. MELD was comparable between the 
groups with median of 14. 69% (9/13) of patients with Child’s class C ac-
counted for a high 30-day mortality.
Conclusion: Patients >65 years are at increased risk of mortality and HE. Age 
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SS 4.5 
Dynamic 4D-CT angiography for planning of liver tumor 
transarterial chemoembolization: effect on contrast 
material reduction, operator radiation exposure, 
catheter consumption, and diagnostic confidence
J.L. Wichmann, M.H. Albrecht, T. Vogl, S. Fischer, 
R. Hammerstingl, M. Harth, A. Thalhammer, S. Zangos, 
R.W. Bauer; Frankfurt am Main/DE 
Purpose: To evaluate the usefulness of 4D computed tomography angiogra-
phy (4D-CTA) prior to transarterial chemoembolization (TACE) regarding ad-
ministered volume of contrast media, operator radiation exposure, catheter 
consumption, and diagnostic confidence.
Material and methods: 4D-CTA examinations prior to initial TACE of 29 pa-
tients with malignant liver tumors were analyzed. Multiplanar-reformate (MPR), 
volume-rendering technique (VRT) and maximum-intensity projection (MIP) 
series were used to plan a direct selective catheterization of the tumor-supply-
ing artery without prior conventional digital subtraction angiography (DSA) of 
the abdominal aorta, coeliac trunk, superior mesenteric artery, and indirect 
portography. 29 patients who underwent traditional TACE served as the con-
trol group. The amount of administered contrast media, operator radiation ex-
posure, and catheter consumption were compared between both groups. Di-
agnostic confidence in the exclusion of portal vein thrombosis was assessed 
by two radiologists using 5-point Likert scales.
Results: The 4D-CTA TACE group showed a significant overall contrast media 
reduction of 12.8ml (-13.8%, p<0.001) and 61ml less contrast were adminis-
tered arterially (-66.3%, p<0.001) compared to traditional TACE. Operator ra-
diation could be reduced by 50.5% (p<0.001). 4D-CTA TACE was performed 
using on average 0.7 less catheters (p=0.063). Diagnostic confidence in the 
exclusion of portal vein thrombosis was significantly increased using 4D-CTA 
compared to traditional DSA images (scores, 3.9 and 2.4, respectively; 
p<0.001).
Conclusion: 4D-CTA facilitates TACE with substantially reduced contrast ma-
terial volume and operator radiation exposure, while increasing diagnostic 
confidence in the exclusion of portal vein thrombosis.
SS 4.6 
Simultaneous trans-hepatic portal and hepatic vein 
embolization before major hepatectomy: the liver 
venous deprivation technique
B. Guiu1, P. Chevallier2, A. Denys3, M.-A. Pierredon1, 
J. Ramos1; 1Montpellier/FR, 2Nice/FR, 3Lausanne/CH 
Purpose: To assess feasibility, safety, and efficacy of the liver venous depriva-
tion (LVD) technique that combines both portal and hepatic vein embolization 
during the same procedure for liver preparation before major hepatectomy.
Material and methods: Seven patients (mean age: 63.6y [42-77y]) underwent 
trans-hepatic LVD for liver metastases (n=2), HCC (n=1), intrahepatic cholan-
giocarcinoma (n=3) and Klatskin tumour (n=1). The PVE procedure was con-
ducted using a Lipiodol:n-butyl-cyanoacrylate. The right hepatic vein (HV) was 
accessed through the liver using a micropuncture set. An Amplatzer Vascular 
Plug II of 18-22mm was deployed in HV. Then, embolization of distal branches 
and collaterals of the right HV was conducted using a 1:1 mixture of lipiodol:n-
butyl-cyanoacrylate. Assessment of future remnant liver (FRL) volume, liver 
enzymes and histology was performed.
Results: Technical success was 100%. No complication occurred before sur-
gery. Resection was performed in 6/7 patients. CT scan revealed hepatic con-
gestion in the venous-deprived area (6/7 patients). Twenty-three days 
(range:13–30days) after LVD, FRL increased from 28.2% (range: 22.4–33.3%) 
to 40.9% (range:33.6–59.3%). During the first 7 days, venous-deprived liver 
volume increased (+13.4%) probably reflecting vascular congestion, whereas 
it strongly decreased (-21.3%) at 3-4 weeks. Histology (embolized lobe) re-
vealed sinusoidal dilatation, hepatocyte necrosis and important atrophy in all 
patients.
Conclusion: Trans-hepatic LVD technique is feasible, well tolerated and pro-
vides fast and important hypertrophy of the FRL. This new technique needs to 
be further evaluated and compared to portal vein embolization.
SS 4.7 
Risks factors for severe pain after selective liver 
transarterial chemoembolization
M. Ronot, J. Ben Zakoun, M. Lagadec, C. Garcia-Alba, 
A. Sibert, V. Vilgrain; Clichy/FR 
Purpose: To determine the risk factors of severe pain after selective transarte-
rial chemoembolization (TACE) for HCC.
Material and methods: From January 2012 to June 2014, all treatment-naïve 
patients undergoing a first session of selective TACE for HCC were included. 
Non-selective TACE were excluded. Risk factors for severe pain, defined as 
the need for opioid analgesics (grade II-III according to the World Health Or-
ganization), were identified by uni- and multivariate analyses.
Results: We analyzed 335 tumours (mean size 47±37mm) in 159 patients (131 
men, 82%), mean age 63.4 years old (20-92). Lesions were solitary in 78 pa-
tients (49%). Twenty-seven patients (17%) requested opioids. In univariate 
analysis, opioid intake was associated with young age (p=0.021), the dose of 
doxorubicin received (p=0.031), large HCC (p=0.038), an absence of chronic 
liver disease (p<0.001), and alphafoetoprotein levels (p=0.03). In multivariate 
analysis, opioid intake was associated with young age (p=0.048), an absence 
of chronic liver disease (p<0.001), and the dose of doxorubicin received 
(p=0.009).
Conclusion: In patients with HCC treated with TACE, a selective procedure 
does not always prevent severe pain. Young patients without chronic liver dis-
ease are at a higher risk of severe pain and should systematically receive pre-
ventive opioids.
SS 4.8 
Uncommon and ancillary vascular findings in common 
abdominal vascular compression syndromes
B. Öztoprak; Sivas/TR 
Purpose: Although defined as rare vascular pathologies in the literature, ab-
dominal vascular compression syndromes are becoming more commonly en-
countered with the increased use of MDCT and CT angiography (CTA) in the 
abdomen. The aim of this study is to investigate the vascular alterations sec-
ondary to common abdominal compression syndromes.
Material and methods: MDCT and CTA images of 33 patients with nutcracker 
(NC) and median arcuate ligament syndromes (MALS) were investigated for 
presence of secondary abnormal vascular appearances. In addition, 186 pa-
tients with retroaortic or circumaortic left renal vein were searched for exist-
ence of a posterior NC phenomenon.
Results: Dilatation of gonadal (33%), left lumbar (8%), hemiazygos/inferior 
phrenic (12%) and left suprarenal (9%) veins was identified. Pelvic varices/
varicoceles (15%) and pseudothrombosis of the left renal vein (9%) were also 
depicted. The incidence of having a secondary vascular finding was signifi-
cantly lower in pediatric age group, that is, none but one of the 13 pediatric 
patients showed dilated left lumbar vein. 24 (%14.2) patients had a posterior 
NC phenomenon among 168 patients with a retroaortic left renal vein. 4 (22%) 
of 18 patients with circumaortic left renal vein showed NC phenomenon.
Conclusion: Secondary vascular alterations are common in abdominal com-
pression syndromes in adults, and may be the first recognized finding on CT. 
Awareness and recognition of these findings is important, since they, them-
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SS 4.9 
Replaced common hepatic artery from the superior 
mesenteric artery: MDCT classification focused on 
pancreatic penetration and the course of travel
H.K. Lim1, H.I. Ha2, M.-J. Kim2; 1Seoul/KR, 2Anyang-si/KR 
Purpose: To categorize the subtypes of replaced common hepatic artery 
(RCHA) and evaluate the clinical implications.
Material and methods: 34 cases of the RCHA were evaluated retrospectively 
using MDCT. We categorized them into the three subtypes according to pan-
creatic penetration and the passing routes. The distance between the orifice of 
the superior mesenteric artery (SMA) and RCHA bifurcation (DSMA-RCHA) 
was measured using advanced 3D imaging software. Analysis of variance was 
used to evaluate the difference in DSMA-RCHA according to the RCHA sub-
type.
Results: Type A (n=17, 50%) referred to RCHA penetrating the pancreatic pa-
renchyma, all crossing the dorsal aspect of the SMV. Among them, three cases 
were accompanied by the circumportal pancreas. Type B (n=10, 29%) referred 
to RCHA without penetration of the pancreatic parenchyma and crossing of 
the dorsal aspect of the MPV or SMV. Type C (n=7, 21%) referred to RCHA 
without penetration of the pancreas parenchyma and crossing of the ventral 
aspect of the MPV or SMV. The mean DSMA-RCHA of each subtype was as 
follows: type A, 3.13 cm (95% CI, 2.70-3.57); type B, 2.04 cm (95% CI, 1.40-
2.68); and type C, 2.14 cm (95% CI, 2.23-2.92). The DSMA-RCHA of the pen-
etrating pancreatic parenchyma of the RCHA was significantly longer than that 
of the non-penetrating pancreatic parenchyma (P=0.007).
Conclusion: Half of RCHA shows penetrating the pancreatic parenchyma and 
this type A takes off from the SMA more distally than RCHA without intrapan-
creatic penetration.
SS 4.10 
CT angiography protocol for pancreatic cancer essential 
for surgical resectability
J. Grubor-Pilipovic, T. Kokovic, U. Milosevic, S. Stojanovic; 
Novi Sad/RS 
Purpose: Early tumor detection and accurate radiological staging in patients 
with pancreatic carcinoma are crucial. The purpose was to review the technical 
aspects of the CT angiography (CTA) pancreas protocol and the findings rele-
vant to diagnosis and staging of pancreatic carcinoma.
Material and methods: CTA pancreas protocol included: IV spasmolytic and 
oral contrast agent prior to the study, bolus tracking at the level of the celiac 
axis using an enhancement threshold of 150HU, triple phase acquisition. Major 
vessels running within 1cm from the tumor margin were evaluated. CT appear-
ance was graded on a 0–4 scale (0: none, 1: <24%, 2: 25–49%, 3: 50–74%, 4: 
75–100%) by circumferential contiguity of tumor to vessels.
Results: In forty-eight patients, CTA had the highest accuracy in assessing 
extent of primary tumor (73%), locoregional extension (74%), vascular invasion 
(83%), distant metastases (88%), tumor TNM stage (46%), and tumor resect-
ability (83%). Surgical correlation of CT findings was available in 89 veins and 
83 arteries, and both surgical and histologic correlations were available for 42 
veins and 29 arteries. At surgical observation, 29 of 35 veins (82.9%) evaluated 
as CT grade 3 or 4 were found to be involved, whereas only 18 of 30 arteries 
(60%) evaluated as CTA grade 3 or 4 were proved to be involved.
Conclusion: The key to management in pancreatic carcinoma evaluation is 
determining resectability. It is, therefore, important that radiologists describe in 
detail the findings that are relevant for staging of pancreatic carcinoma and 
have a clear understanding of the implications of these findings.
11:00 - 12:30 Meeting Hall IV
Scientific Session SS 5
GI tract: new paradigms in diagnosis and 
intervention
SS 5.1 
Positron emission tomography-defined tumour variables 
to predict pathological T-stage in patients with 
oesophageal cancer
K.G. Foley, B. Berthon, C. Parkinson, C. Marshall, 
W.G. Lewis, E. Spezi, S.A. Roberts; Cardiff/GB 
Purpose: Oesophageal cancer (OC) staging involves a combination of imaging 
techniques, each with strengths and limitations. A single modality that accu-
rately stages local and distant disease simultaneously does not currently exist. 
Local staging with EUS is an invasive procedure with associated risk of com-
plications. We investigate whether PET-defined tumour variables, including 
novel texture analysis, can predict pathological T-stage (pT).
Material and methods: Patients undergoing surgical resection were staged 
with PET/CT prior to neo-adjuvant therapy between October 2010 and De-
cember 2014. PET-defined tumour variables were obtained using PET-STAT 
software and tumours were outlined with ATLAAS, a learning algorithm for op-
timised automatic segmentation, both developed at Cardiff University. Seven-
teen variables describing tumour characteristics were analysed. A one-way 
ANOVA test was used to identify differences in PET-defined tumour variables 
between pT-stages, confirmed by histopathological examination.
Results: Sixty-three patients were included [median age 64 (range 39-78), 57 
adenocarcinoma, HGD=6, pT1=4, pT2=8, pT3=37, PT4a=8]. Nine PET-defined 
tumour variables including SUVmax (F=3.179, df=4, p=0.020), metabolic tu-
mour volume (F=5.124, df=4, p=0.001), standard deviation (F=3.741, df=4, 
p=0.013) and intensity variability (F=5.485, df=4, p=0.001) demonstrated sig-
nificant differences between pT-stages.
Conclusion: Preliminary data on 63 patients have shown that several PET-
defined tumour variables have the potential to predict pT, although small group 
numbers limit the strength of this current study. Texture analysis of PET images 
is a rapidly evolving field that may improve OC staging.
SS 5.2 
Positron emission tomography-defined tumour variables 
to predict lymph node metastases in patients with 
oesophageal cancer
K.G. Foley, B. Berthon, C. Parkinson, C. Marshall, E. Spezi, 
W.G. Lewis, S.A. Roberts; Cardiff/GB 
Purpose: The overall survival of oesophageal cancer (OC) is poor and the 
presence of lymph node metastases (LNMs) is a major prognostic indicator. 
Texture analysis of medical images enables additional data to be extracted 
from routine staging investigations, quantifying intra-tumoural characteristics 
via non-invasive methods. We investigate whether positron emission tomogra-
phy (PET)-defined variables and texture analysis of the primary tumour can 
predict LNMs.
Material and methods: Patients undergoing surgical resection were staged 
with PET/CT prior to neo-adjuvant therapy between October 2010 and De-
cember 2014. PET-defined tumour variables were obtained using PET-STAT 
software and tumours were outlined with ATLAAS, a learning algorithm for op-
timised automatic segmentation, both developed at Cardiff University. Seven-
teen variables describing tumour characteristics were analysed. A binary logis-
tic regression model was used to identify independent predictors of LNMs, 
confirmed by histopathological examination.
Results: Sixty-three patients were included [median age 64 (range 39-78), 57 
adenocarcinoma, N0=25, N1-3=38]. Multivariate analysis demonstrated 8 
variables that were significantly and independently predictive of LNMs, includ-
ing SUVmean (HR 0.025, 95% CI 0.001–0.426, p=0.011), dissimilarity [differ-
ence compared to adjacent voxel (HR 0.100, 95% CI 0.012–0.832, p=0.0.033)] 
and intensity variability [variation in intensity values across tumour (HR 1.752, 
95% CI 1.032–2.972, p=0.038)].
Conclusion: Although small numbers limit this study, these preliminary results 
demonstrate texture variables that could predict LNMs, a major prognostic 
indicator. On-going work at our institution will investigate the added prognostic 
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SS 5.3 
Treatment of benign esophageal fistulae by covered 
biodegradable stents
M. Hazlinger, M. Cerna, M. Kocher, V. Prasil; Olomouc/CZ 
Purpose: To evaluate our experience with the treatment of postoperative 
anastomotic leaks and benign esophageal perforations with covered biode-
gradable stents.
Material and methods: From 2008 to 2015, we treated 25 patients with either 
an anastomotic leak or benign esophageal perforation by implanting covered 
biodegradable Ella-BD stents. The average age of patients was 59 years. Post-
operative anastomotic leaks were treated in 14 patients; postdilatation rupture 
of benign stricture in 2 patients; spontaneous rupture after vomiting in 4 pa-
tients; in 2 patients rupture occurred iatrogenically, 1 patient had perforation in 
postradiation stricture and in 2 patients perforation occurred as a complication 
after metallic stent implantation.
Results: Thirty-nine covered biodegradable stents were implanted in 25 pa-
tients. Primary technical success was 100%. Small leakages were treated in 
12 patients, 13 patients had significantly great to massive leakage. Clinical 
success (leak sealing) was achieved in small leakages in 11 patients (91.7%), 
1 patient died after procedure due to circulatory collapse. In significantly great 
leakages clinical success was achieved in 4 patients (30.8%), 8 patients 
(61.5%) had proven leakage on control examination and 1 patient died after 
procedure due to circulatory collapse.
Conclusion: The use of biodegradable covered stents in the treatment of 
small anastomotic leaks or esophageal perforations is technically feasible and 
safe with significantly good clinical success. In great or massive leakages, 
despite worse clinical success, covered biodegradable stents implantation 
makes subsequent surgery easier.
SS 5.4 
CTC versus transvaginal ultrasonography in the 
diagnosis of rectosigmoid endometriosis: a preliminary 
experience
E. Biscaldi, S. Ferrero, V. Remorgida, V. Vellone, 
U. Leone Roberti Maggiore, P.L. Venturini, G.A. Rollandi; 
Genoa/IT 
Purpose: Rectosigmoid form is a severe presentation of deep endometriosis. 
Many techniques (endoscopy, CTenema, MRI) have been explored for diagno-
sis, few experiences are available on CTC. We compared the accuracy of CTC 
and transvaginal ultrasonography (TVS), evaluating the precision in estimating 
the length of the rectosigmoid nodules and the distance between them and the 
anal verge.
Material and methods: All patients recruited, scheduled for laparoscopy, had 
strong suspicion of intestinal endometriosis. TVS was performed contempo-
rary to water distension of the rectum with 200mL of saline solution. CTC was 
performed with fecal tagging. A standardized CT examination protocol was 
used: 16-row CT, supine and prone acquisitions, decreasing of radiation dose 
(ASIR algorithm). CTC and TVS results were compared with surgical and path-
ologic findings.
Results: 45patients were included (mean age 34.2 (±5.1)). At the time of the 
study, 14 patients did not use hormonal therapies, 31 used it. 26 (57.1%) had 
surgical diagnosis of rectosigmoid endometriosis. In 11, endometriosis was 
located on the rectosigmoid, in 9 on the upper rectum and in 6 on the lower 
rectum. The mean (±SD) length of the nodules was 25.4(±6.1)mm. Significant 
difference in the accuracy of the two techniques was detected in the diagnosis 
(p=0.508). TVS and CTC similarly estimated the length of the endometriotic 
nodules (p=0.077). CTC was more precise than TVS in estimating the distance 
from the anal verge (p<0.001).
Conclusion: TVS and CTC have comparable accuracy in the diagnosis, similar 
precision in estimating the size of nodules; CTC is more precise in estimating 
the distance from the anal verge. Patients better tolerated TVS than CTC.
SS 5.5 
Evaluation of rectal cancer response to therapy: role of 
MR-tumour regression grade to predict pathological 
complete response
S. Picchia, M. Rengo, D. Bellini, D. Caruso, D. De Santis, 
A. Laghi; Latina/IT 
Purpose: To determine if a pathological complete response to therapy in rectal 
cancer can be predicted by tumour regression grade evaluated by MR (MR-
TRG).
Material and methods: 65 patients, diagnosed with locally advanced rectal 
cancer were prospectively enrolled in the study. All patients underwent MRI on 
a 3-Tesla before, during and after chemoradiotherapy (CRT). All patients un-
derwent total mesorectal excision (TME). MR-TRG was evaluated on T2-
weighted fast spin-echo (FSE) multi-planar imaging. The MR-TRG was deter-
mined by the fibrosis/tumour ratio and was divided into 4 grades based on the 
percentage of fibrosis (<25%, <50%, <75%, 100%). Measurements were per-
formed on all axial images including the tumour. MR-TRG evaluated on the 
second examination (during therapy) was correlated to the pathological finding 
after surgery, defined as partial response or complete response.
Results: A complete pathological response was observed only in patients with 
MR-TRG 4 (100% fibrosis) with a negative predictive value of 100%. In lower 
MR-TRG groups (1, 2 and 3), a partial response was observed.
Conclusion: MR-TRG 4 is an accurate predictor of complete response after 
CRT. When a lower MR-TRG is observed the persistence of disease should be 
suspected. This method, applied during therapy, may reduce the time to sur-
gery.
SS 5.6 
Long-term follow-up features on rectal MRI during 
“wait-and-see” in clinical complete responders after 
chemoradiotherapy: an update of 68 patients
M.M. Van Heeswijk1, D.M.J. Lambregts2, B. Hupkens1, 
R. Beckers1, M. Maas1, M. Van Der Sande2, G.L. Beets2, 
R.G.H. Beets-Tan2; 1Maastricht/NL, 2Amsterdam/NL 
Purpose: Non-operative treatment with stringent follow-up (“wait-and-see”) is 
emerging as an alternative to surgery in clinical complete responders after 
chemoradiotherapy for rectal cancer. MRI is one of the main follow-up tools. 
The aim was to describe the long-term evolution in the morphology of the 
rectal wall during long-term follow-up of these patients.
Material and methods: 68 patients with a sustained complete response dur-
ing “wait-and-see” follow-up were analysed. Patients underwent MRI 3 
monthly (first year) and 6 monthly (second to fifth year). Two readers in consen-
sus analysed the rectal wall morphology on the initial post-CRT scan and the 
evolution in morphology on the various sequential follow-up MRIs.
Results: Median follow-up was 30 months (range 6-98). 512 MRIs were ana-
lysed (median 7, range 3-15/patient). In 7% of patients, the rectal wall com-
pletely normalised post-CRT. The other 93% showed a fibrotic remnant (60% 
minimal fibrosis limited to the bowel wall; 21% thick/mass-like fibrosis and 
12% irregular/spicular fibrosis). In 94% the rectal wall morphology remained 
unchanged during long-term follow-up, in 2% initial fibrosis later developed 
into a normalised wall, in 3% the fibrosis slightly thickened (without evidence 
of recurrence).
Conclusion: In the majority of patients with a complete response residual fi-
brosis is present post-CRT, which remains unchanged during long-term fol-
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SS 5.7 
Assessment of rectal tumour height and length on MRI: 
effect of using diffusion-weighted MRI instead of 
T2-weighted MRI
M.M. Van Heeswijk1, D.M.J. Lambregts2, L. Den Ouden1, 
M. Ageitos Casais1, M. Maas1, G.L. Beets2, 
R.G.H. Beets-Tan2; 1Maastricht/NL, 2Amsterdam/NL 
Purpose: MRI is used to assess tumour height (distance from anorectal junc-
tion) and length, factors that influence treatment planning: large, distal tumours 
often require neoadjuvant chemoradiotherapy (CRT) and more extensive sur-
gery. Diffusion-weighted MRI (DWI) is known to improve tumour conspicuity 
and may thus influence the assessment of tumour height/length. The aim was 
to compare DWI to standard (T2-weighted) MRI for the assessment of tumour 
height and length.
Material and methods: 72 patients were included: 23 non-locally advanced 
cases underwent a staging MRI followed by (5x5 Gy+) immediate surgery, 49 
locally advanced cases underwent CRT followed by a second restaging MRI 
post-CRT. The MRI protocol (1.5T) included T2-weighted and DWI (highest b-
value b1000) sequences. On each MRI scan, tumour length/height were meas-
ured by two readers (1) using T2W-MRI and (2) using b1000-DWI.
Results: Tumour length (averaged for two readers) pre-CRT was 4.8cm on 
T2W-MRI and 4.5cm on DWI (P=0.01), post-CRT it was 3.1cm on T2W-MRI 
and 2.2cm on DWI (P<0.001). Tumour height pre-CRT was 5.0cm for both 
T2W-MRI and DWI (P=0.86), post-CRT it was 5.4cm on T2W-MRI and 5.9cm 
on DWI (P=0.006).
Conclusion: T2W-MRI may systematically overestimate the distal tumour 
margin and tumour length, particularly after CRT. Since the tumour length and 
height influence treatment planning, it may be more appropriate to use DWI to 
assess these factors for clinical decision making.
SS 5.8 
Additional value of diffusion-weighted imaging over 
standard MRI in the detection of pelvic recurrences
R. Kochhar, B. Carrington, B. Taylor; Manchester/GB 
Purpose: To evaluate the additional value of diffusion-weighted imaging (DWI) 
over standard MRI sequences in the detection of pelvic recurrence in patients 
with treated pelvic malignancy.
Material and methods: We prospectively recruited 84 patients referred for 
MRI with clinical suspicion of pelvic recurrence into our study approved by the 
local ethics committee. Cases were consensus read and any lesions identified 
were scored on a 5-point scale (1=benign and 5=malignant) firstly on standard 
sequences (T1W and high-resolution T2W) alone and then scored again using 
both standard and DWI sequences. The 2 sets of scores were correlated with 
patient outcome based on histology and/or clinical/imaging follow-up of at 
least 2 years.
Results: 86 lesions were identified in 76 patients (8 patients excluded due to 
insufficient follow-up), 55 of these were benign and 31 malignant. The final 
score after addition of DWI increased in 14%, decreased in 49% and in 37% 
stayed the same. Standard MRI alone was compared to standard MRI plus 
DWI as below: sensitivity 71% versus 77%, specificity 62% versus 82% and 
accuracy 65% versus 80%. The median apparent diffusion coefficient (ADC) 
was 1.70 (benign lesions) and 0.94 (malignant lesions). A threshold ADC value 
of ≤1.1 had an accuracy of 88% for diagnosis of malignancy.
Conclusion: The addition of DWI to standard MRI sequences was helpful in 
assessing patients with suspected recurrence of previously treated pelvic ma-
lignancies.
SS 5.9 
High-resolution MRI criteria for deferral of surgery trial
S. Balyasnikova1, J. Bhoday1, M. Siddiqui1, S. Chua1, 
D. Tait1, I. Chong1, B. Heald2, P. Tekkis1, A. Wotherspoon1, 
G. Brown1; 1Surrey/GB, 2Basingstoke/GB 
Purpose: Pathological complete response (cr) is observed in over 25% of rec-
tal cancer patients treated with neoadjuvant chemoradiotherapy (CRT). Stud-
ies have shown that several MRI techniques could help in post-CRT response 
assessment and identifying imaging cr. We compared: mrVolumetric regres-
sion (VR), mrRECIST craniocaudal-length (ccl), DW-MRI against MR tumour-
regression-grade system (mrTRG) to determine which method performed best.
Material and methods: We performed a retrospective analysis of 70 mrTRG 
(1-3) patients with low rectal cancer who had undergone neoadjuvant CRT and 
deferred surgery. High-resolution pre- and post-CRT MRI scans using stand-
ard T2 and DW imaging was performed. Incomplete response was defined for 
each method: <80% volume tumor regression and <50% ccl regression, pres-
ence of hyperintense MR signal on high B-value (>800) DWI and compared 
against mrTRG1-3 for regrowth rates.
Results: Median follow-up was 2.5 years. There was a lack of regrowth and 
sustained complete response in 70% of mrTRG1-3 patients. Using ccl, 62% 
were defined as incomplete response with 44/70 ineligible for deferral, of 26 
eligible according to ccl, regrowths occurred in 19%. Using the VR definition, 
54% (38/70) were defined ineligible and of the 32 VR eligible patients, 31% 
showed regrowth. Only 24% (17/70) patients showed no residual tumour on 
DW-MRI, with a 41% rate of regrowth.
Conclusion: Compared with mrTRG as a selection criterion for deferral-of-
surgery, other modalities such as volume reduction and DWI are of insufficient 
sensitivity or specificity to enable accurate patient selection.
SS 5.10 
Comparing MRI with fluoroscopy in defaecating 
proctography: the patient’s perspective
R. Prasad, C. White, R. Wiles; Liverpool/GB 
Purpose: Flouroscopy and MRI are currently used to investigate defaecation 
and pelvic floor problems. Fluoroscopy has advantages of imaging in a physi-
ological sitting position and may better demonstrate intussusception. MRI has 
advantages of imaging all pelvic compartments and avoiding ionising radia-
tion. Anecdotally it is suspected that MRI, allowing more privacy, may be better 
tolerated by patients. The authors aimed to evaluate patient experience of 
both techniques to potentially guide future modality choice.
Material and methods: This prospective study was conducted during June-
December 2015 in a large teaching hospital. Patients completed a post-proce-
dure questionnaire rating out of 5 (1=strongly disagree and 5=strongly agree) 
their satisfaction of each test including staff communication, patient facilities, 
replication of symptoms and whether it was comfortable, dignified and pain 
free.
Results: There were 19 and 8 patients in the fluoroscopy and MRI cohorts, 
respectively. Every question for both modalities scored median 5.0 and mean 
4.4 or more, except for ease of replicating symptoms, for which MRI scored 
less than fluoroscopy at median 4.5 and mean 3.8 (vs 5 and 4.6, respectively). 
Conclusion: Overall satisfaction for both tests was very high. Despite the an-
ecdotal suspicion that MRI may be better tolerated by patients, this study did 
not find this. For ease of replicating symptoms MRI scored less than fluoros-
copy. This may be due to the non-physiological positioning, potentially indicat-
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11:00 - 12:30 Congress Hall
Scientific Session SS 6
HCC: imaging and assessment II 
SS 6.1 
Comparison of pulsed and oscillating gradient diffusion-
weighted MRI for the characterization of hepatocellular 
nodules in liver cirrhosis: ex-vivo study in a rat model
M. Wagner, M. Ronot, S. Doblas, N. Pote, S. Lambert, 
V. Vilgrain, V. Paradis, B. Van Beers; Clichy/FR 
Purpose: To compare the performance of pulsed-gradient-spin-echo (PGSE) 
and oscillating-gradient-spin-echo (OGSE) diffusion-weighted imaging for 
characterization of hepatocellular nodules in liver cirrhosis.
Material and methods: Twenty-four Wistar rats were included. Cirrhosis was 
induced by weekly intra-peritoneal injection of diethylnitrosamine (50mg/kg) 
during 16 weeks. After sacrifice, a cylindrical liver sample was resected and 
imaged in a 7T MR scanner. The protocol included T1-weighted/T2-weighted/
PGSE/OGSE images (b=0/150/300/500s.mm-2). For precise radio-pathologi-
cal correlations, only 80 nodules identified on T1/T2-weighted images and on 
pathological examination were analysed. Apparent diffusion coefficient (ADC) 
was calculated with a monoexponential fit. Two pathologists classified the 
nodules in regenerative (RN), low (LGDN) or high (HGDN) grade dysplastic 
nodules, early or progressed HCC. ADC were compared in group 1 (RN+LGDN), 
group 2 (HGDN+HCCearly) and group 3 (HCCprogressed) with Kruskal-Wallis 
test and areas under the receiver operating characteristic curves (AUROCs).
Results: ADCPGSE and ADCOGSE differed between the 3 groups (P=0.047/
P=0.002). ADC increased in group 2 (ADCPGSE=0.753±0.255 in group 2 ver-
sus 0.812±0.198 in group 1; ADCOGSE=0.638±0.066 versus 0.654±0.125) 
and decreased in group 3 (ADCPGSE=0.601±0.080/ADCOGSE=0.682±0.083). 
AUROC for differentiating groups 1 and 2 was higher for ADCOGSE(0.77) than 
for ADCPGSE(0.68). AUROCs for differentiating groups 2 and 3 were similar for 
ADCPGSE(0.77) and ADCOGSE(0.72).
Conclusion: In this study, ADC during hepatocarcinogenesis had a complex 
behaviour and increased before decreasing. Our results suggest that OGSE 
seems to be more sensitive than PGSE to the first step of carcinogenesis.
SS 6.2 
Comparison of gadoxetic acid-enhanced MRI and 
non-specific extracellular gadolinium contrast-
enhanced MRI for the assessment of HCC response to 
loco-regional treatment
J. Rimola1, M. Davenport2, P.S. Liu2, T. Brown2, N. Parikh2, 
B. Mckenna2, J. Marrero2, H.K. Hussain2; 1Barcelona/ES, 
2Ann Arbor, MI/US 
Purpose: Imaging assessment of HCC response to locoregional therapy (LRT) 
is critical for patient management. The aim was to compare the accuracy of 
gadoxetic acid-enhanced MRI (EOB-MRI) and non-specific extracellular gad-
olinium-based contrast-enhanced MRI (Gd-MRI) for the assessment HCC re-
sponse to LRT using explant correlation as the reference standard.
Material and methods: Patients with cirrhosis and HCC treated with LRT who 
underwent EOB-MRI or Gd-MRI within 90 days of liver transplantation consti-
tuted the study population (n=49; 23 EOB-MRI, 26 Gd-MRI). Two radiologists 
independently reviewed the MR images blinded to histology to determine the 
percentage of viable residual HCC compared to the pre-treatment tumor vol-
ume. Liver explant histology (by lesion) was the reference standard. Sensitivi-
ties, specificities, and diagnostic accuracy determined by area under ROC 
curves were calculated. Agreement with pathology (i.e., percent necrosis) was 
assessed with intraclass correlation. Numbers in brackets are 95% confidence 
intervals.
Results: Gd-MRI had significantly greater agreement with histology than EOB-
MRI (ICC: 0.98 [0.95-0.99] vs. 0.80 [0.63-0.90]). Sensitivities (EOB-MRI: 58% 
[28-85%] vs. Gd-MRI: 76% [50-93%]) and specificities (EOB-MRI: 85% [66-
96%] vs. Gd-MRI: 84% [60-97%]) were statistically similar with wide confi-
dence intervals. AUROC curves were 0.72 (0.55-0.85, EOB-MRI) and 0.80 
(0.63-0.92, Gd-MRI).
Conclusion: Gd-MRI is more accurate than EOB-MRI for the determination of 
viable HCC following LRT, and therefore the preferred contrast agent to be 
used for its assessment in patients with cirrhosis. Specificity for Gd-MRI and 
EOB-MRI is similar.
SS 6.3 
Comparison of the efficiency of tenth and twentieth 
minute delayed gadoxetate disodium (Gd-EOB-DTPA) 
enhanced MR images for diagnosis of small HCC (less 
than 2 cm)
A. Gocmez, M.G. Kartal, B. Bakir, B. Acunas; Istanbul/TR 
Purpose: To find out whether 10-minute delayed images obtained after the 
injection of Gd-EOB-DTPA are sufficient to characterize small HCC (<2cm) in 
comparison to the images obtained at 20-minute delayed images, the recom-
mended optimal image acquisition time.
Material and methods: 63 lesions in 48 patients diagnosed with small-sized 
(<2 cm) HCC on gadoxetate-enhanced MRI performed at Istanbul Medicine 
Faculty were retrospectively evaluated. MRI images were divided into 2 sets. 
10-minute set contained 10-minute images in addition to T1, T2, DWI, and 
postcontrast phases and 20-minute set contained 20-minute hepatobiliary im-
age in addition to T1, T2, DWI, and postcontrast phases for qualitative analy-
sis. Two independent observers scored focal lesion signal intensities at 10- 
and 20-minute images. For the quantitative analysis, signal intensities were 
measured by placing ROI and calculated as was the contrast ratio.
Results: The quantitative analyses showed significant positive correlation be-
tween the 10-minute and 20-minute contrast ratio of the lesions. In qualitative 
analyses (rs=0.914,p<0.001), there was an excellent concordance between 
both observers for 10-minute and 20-minute images (Kappa for 10-minute im-
ages 0.907±0.053, for 20-minute images 0.930±0.049, p<0.001). There was 
moderate concordance between 10- and 20-minute images for each observer 
(Kappa for the first observer 0.523±0.095, for the second observer 0.490±0.095, 
p<0.001).
Conclusion: Compared to 10-minute images, 20-minute images did not reveal 
significant differences between HCC-liver signal ratio and diagnostic efficency. 
Therefore, especially for HCC evaluation in Child A group cirrhotic patients, 
obtaining only 10-minute images for delayed phase images depending on rou-
tine clinical needs will shorten image acquisition time but not affect the accu-
racy of the technique to a significant degree.
SS 6.4 
Computed tomographic perfusion imaging for 
monitoring of transarterial chemoembolization 
treatment of HCC
H.P. Marquez Masquiaran1, O. Karalli2, H. Haubenreisser3, 
H. Alkadhi1, T. Brismar2, T. Henzler3, M.A. Fischer1;  
1Zurich/CH, 2Stockholm/SE, 3Mannheim/DE 
Purpose: To prospectively monitor changes in tumor perfusion of HCC in re-
sponse to transarterial chemoembolization (TACE) using perfusion-CT (P-CT).
Material and methods: 19 patients (mean age 69±6) undergoing P-CT before 
and directly after TACE due to multifocal HCC were prospectively included in 
this dual center study. Two readers determined arterial-liver-perfusion (ALP, in 
mL/min/100mL), portal-venous-perfusion (PLP, in mL/min/100mL) and hepat-
ic-perfusion-index (HPI, in%) placing circular regions-of-interest covering the 
maximum diameter of each lesion (N=19) before and after TACE. Imaging fol-
low-up with contrast-enhanced CT or MRI was used to distinguish responders 
(complete response/partial response) from non-responders (stable disease/
progressive disease) following EASL criteria. Diagnostic performance of per-
centual changes in perfusion parameters before and after treatment (Δ) for 
early assessment of treatment response was determined using receiver oper-
ating characteristics.
Results: Mean ALP, PLP and HPI were 36.5, 16.6 and 75.9 before and 11.9, 
23.3 and 46.8 after TACE, resulting in a ΔALP, ΔPLP and ΔHPI of -53%, 17% 
and -25%. Interreader agreement was fair to excellent for all perfusion param-
eters (ICC, 0.758-0.978). Before TACE, no significant correlations were found 
between perfusion parameters and treatment response (all p>0.05). After 
TACE, PLP was the only parameter to significantly correlate with treatment 
response (p<0.003) showing high accuracy for identification of TACE non-re-
sponders (AUC 0.943, 95% confidence interval 0.808-1.000, p<0.01).
Conclusion: P-CT is useful for monitoring the effects of TACE in HCC patients. 
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SS 6.5 
Volumetric analysis versus response evaluation criteria 
in solid tumors and modified response evaluation 
criteria in solid tumors in the evaluation of HCC after 
transarterial chemoembolization
M. Stankova, T. Andrasina, J. Sedmik, V. Valek, 
L. Ostrˇ ížková, S. Tucek; Brno/CZ
Purpose: To compare volumetric analysis with the standard criteria - response 
evaluation criteria in solid tumors (RECIST) and modified response evaluation 
criteria in solid tumors (mRECIST) - for the evaluation of HCC and its response 
to transarterial chemoembolization (TACE).
Material and methods: The total of 40 patients treated in the University Hos-
pital Brno with HCC were included in this study. All of them underwent TACE 
and their tumor range was evaluated on the CT/MR input and output. The 
volumetric analysis was performed semiautomatically. The survival of the pa-
tients was evaluated since the date of the first chemoembolization. The overall 
survival was evaluated by the Kaplan-Meier method and the differences in 
survival by the log-rank test.
Results: The strongest correlation has been proven between the length of 
survival and determination of the viable part of a tumor using volumetric analy-
sis, and between the length of survival and the ratio viable/nonviable parts of 
the tumor. The median of survival since the first performed TACE is 15.0 
months. RECIST and mRECIST have not been proven as a statistically signifi-
cant factor of correlation with the overall survival.
Conclusion: Volumetric analysis was statistically proven the strongest factor 
of the correlation with the length of the survival of the patients, contrary to 
RECIST and mRECIST. It is a convenient way to evaluate the response of HCC 
to treatment, particularly in complex tumors after TACE.
11:00 - 12:30 Forum Hall
Scientific Session SS 7
Diffuse liver disease: technical update
SS 7.1 
US-guided percutaneous liver biopsy: is pathological 
analysis affected by needle type?
A. Walker, P. Fineron, L. Wong; Edinburgh/GB 
Purpose: Quantitative studies have shown that pathological assessment of 
disease stage is compromised in inadequate biopsies (<25mm in length, fewer 
than 11 portal tracts, or tissue area less than 22mm2). This study aimed to 
determine if the liver biopsy sample affected pathological analysis between 
side-notch and end-cutting needles.
Material and methods: Retrospective analysis of a total of 105 non-targetted 
US liver biopsies was carried out using either end-cutting and side-notch nee-
dles within a 42-month period (2011–2014). Blinded pathological analysis of 
the samples was performed by a consultant pathologist for adequacy, length 
and fragmentation. Furthermore, each biopsy was reviewed for associated 
complications, gauge of needle and number of throws.
Results: 49 biopsies using end-cutting needle and 56 with side-notch needle 
were analysed. The samples were deemed inadequate from 0% of the end-
cutting group vs 24.5% of the side-cutting group. Length yield was higher in 
the end-cutting group (mean of 26.7mm vs 20.1mm), respectively, with less 
fragmentation in the end-cutting group (12% v 50%). Total number of portal 
tracts was also higher in the end-cutting group (mean 11.25 vs 7.3). The differ-
ence in length and number of portal tracts was statistically significant with p 
values of 0.0009 and 0.0263, respectively.
Conclusion: End-cutting needle performed better with regard to sample ade-
quacy, specifically the number of portal tracts, length yield and degree of frag-
mentation.
SS 7.2 
Evaluation of 3D VIBE-DIXON imaging sequence for 
quantification of hepatic iron overload at 3T
A. Kiani, E. Bannier, G. D’Assignies, G. Gambarota,  
H. Saint-Jalmes, Y. Gandon; Rennes/FR 
Purpose: To assess at 3T the ability of 3D gradient echo (GRE) imaging to 
quantify liver iron concentration (LIC).
Material and methods: After IRB approval and written consent from all par-
ticipants, 202 patients suspected of hepatic iron overload were included. Ex-
aminations were performed on a 3T MRI (MAGNETOM Verio, Siemens). Our 
reference 2D 11 echos multi-echo (ME)-GRE sequence (body coil), previously 
validated versus biopsy, was compared to a prototype 3D ME GRE (VIBE) se-
quence (surface coil). R2* mapping was computed and compared to R2* of 
reference sequence. VIBE R2* was converted to LIC according to Wood’s for-
mula adapted at 3T and compared to LIC provided by R2* and signal intensity 
ratio method of reference sequence. The shortest TE was 1.23 ms for both 
sequences.
Results: According, respectively, to 2D GRE and 3D ME VIBE results, mean 
R2* were 144±63Hz and 108±44Hz; mean LIC were 58±65µmol/g and 
24±10µmol/g (p<0.001). Over all patients, correlation coefficients were 0.33 
and 0.11 for R2* and LIC. Excluding patients with high LIC (>120 µmol/g), coef-
ficients were 0.74 and 0.66. LIC correlation curve slope was 0.24.
Conclusion: 3D ME VIBE results are well correlated to our reference method 
for patients with low/medium overloads. Evaluation of major overloads is lim-
ited at 3T using only R2* if the first TE is not short enough. 3T extrapolated 
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SS 7.3 
Assessment of liver, pancreas, spleen and bone marrow 
iron distribution in patients with diffuse liver diseases 
using a 3T single breath-hold MR sequence
M. França1, S. Silva1, A. Alberich-Bayarri2, L. Martí-Bonmatí2, 
G. Porto1, J.A. Oliveira1, H. Pessegueiro-Miranda1;  
1Porto/PT, 2Valencia/ES 
Purpose: Multiecho GRE MR imaging is being used to determine liver R2* as 
an imaging biomarker of iron overload. Our purpose was to determine the R2* 
of liver, pancreas, spleen and bone marrow in patients with diffuse liver dis-
eases and to evaluate their relationship.
Material and methods: The series included 100 consecutive patients with 
diffuse liver disorders, liver biopsy and abdominal MR examination (3T, single 
breath-hold, 12 echoes GRE sequence). Parametric iron R2* quantification 
was performed with a dedicated software selecting ROIs in liver, pancreas, 
spleen and vertebral bone marrow. Liver biopsy was used as gold standard for 
liver iron deposits grading (0-4).
Results: Regarding liver histologic iron grading, patients were distributed into 
none (49 cases), grade 1 (26), grade 2 (15), grade 3 (4) and grade 4 (6). Median 
(IQR) R2* values (s-1) in the liver were 42 (33); in pancreas: 30(10); in spleen: 28 
(33); and bone marrow: 167 (66), respectively. Liver R2* was highly correlated 
with histologic determined siderosis (ρ=0.65, p<0.001). Liver R2* measure-
ments were significantly correlated with pancreatic, splenic and bone marrow 
R2* measurements (ρ=0.22, ρ=0.55, ρ=0.32, p<0.05).
Conclusion: R2* measurements showed a correlation between liver, pancreas, 
spleen and bone marrow iron deposits in patients with diffuse liver diseases. 
These results add insights into liver iron disorders and their relationship with 
other abdominal organs and tissues.
SS 7.4 
Liver iron overload assessment by MRI T2* relaxometry: 
a systematic review
J.M. Alústiza, J.I. Emparanza, E. Garmendia Lopetegui, 
E. Inchausti, E. Salvador, M. Ubeda; San Sebastián/ES
Purpose: To systematically review the T2* relaxometry methods used to quan-
tify hepatic iron concentration.
Material and methods: A literature search was conducted in MEDLINE and 
EMBASE, using the search terms “MRI”, “Liver” and “Iron”, combined with 
appropriate boolean operators. Were considered relevant those articles that: 
(1) used T2* relaxometry to determine hepatic iron concentration and (2) in-
cluded acquisition parameter specifications. Four radiologists agreed on the 
parameters to be considered in each article and designed a data collection 
sheet.
Results: From all retrieved papers (357) only 61 were judged to be relevant for 
our purpose. Reference T2* values used to differentiate between normal and 
iron overload (n=16) varied from 6.3 to 21 ms. First echo time (TE) varied from 
0.8 to 4.7 ms. Only 14 articles compared the MRI results with direct biopsy 
measurement of hepatic iron. The threshold to differentiate normal from iron 
overload varied from 4.6 to 14.5 ms. Eighteen articles gave not only T2* values, 
but also its transformation into mg/ Fe/gr. Eight of them used the same math-
ematical formula but with different acquisition parameters.
Conclusion: There is no standard method. There is no standardised acquisi-
tion protocol. Results are not reproducible. Thus, T2* relaxometry is not yet a 
valid method for standardised assessment of hepatic iron concentration.
SS 7.5 
Failure of liver MR elastography: what are the predictive 
factors?
M. Wagner, I. Corcuera-Solano, G. Lo, S. Esses, J. Liao, 
C. Besa, B. Taouli; New York, NY/US 
Purpose: To determine the failure rate of liver magnetic resonance elastogra-
phy (MRE) and to assess predictive factors for failure.
Material and methods: 781 consecutive patients (mean age 58 y, 63% male) 
including 650 (83%) with chronic liver disease who underwent liver MRE be-
tween 6/2013 and 8/2014 were retrospectively evaluated. MRE was acquired 
either on a 3T [GE750, n=443(57%)] or 1.5T system [GE HDX n=338(43%)], 
using a 2D-gradient-recalled-echo MRE sequence (4 axial slices) with 60Hz 
frequency. Image analysis was performed by 2 observers. A failure was de-
fined as either no pixel with a confidence index higher than 95% on the confi-
dence map or no wave propagation. The following parameters were noted: 
presence of cirrhosis, degree of ascites, steatosis, iron deposition and subcu-
taneous fat thickness.
Results: Failure occurred in 80 cases (10%). The rate of failure was signifi-
cantly higher at 3T than 1.5T (n=68,15% vs. n=12,4%, P<0.0001). High weight, 
high BMI, presence of massive ascites, significant iron deposition, alcoholic 
liver disease and cirrhosis were all associated with a high failure rate (P<0.008). 
On multivariate analysis, only presence of iron, massive ascites and 3T were 
significantly associated with MRE failure (P<0.0001). Presence of steatosis 
and subcutaneous fat had no significant impact on failure rate (P>0.05).
Conclusion: Massive ascites, iron deposition and use of 3.0T were all inde-
pendent factors associated with liver MRE failure. Alternate sequences should 
be developed and used in these scenarios.
SS 7.6 
MR elastography of the liver: qualitative and quantitative 
comparison of gradient echo and spin echo echoplanar 
imaging sequences
M. Wagner1, C. Besa1, J. Bou Ayache1, O. Bane1, 
T.K. Yasar1, M. Fung1, R. Ehman2, B. Taouli1;  
1New York, NY/US, 2Rochester, NY/US 
Purpose: To compare 2D gradient recalled echo (GRE) and 2D spin echo 
echoplanar imaging (SE-EPI) magnetic resonance elastography (MRE) se-
quences of the liver in terms of image quality and quantitative liver stiffness 
(LS) measurement.
Material and methods: This prospective study involved 50 consecutive sub-
jects (M/F=33/17, mean age 58 y) who underwent liver MRI at 3.0T including 
two MRE sequences, 2D GRE and 2D SE-EPI (acquisition time 56s/16s). Im-
age quality scores were assessed by two independent observers based on 
wave propagation and organ coverage on the confidence map (range 0-15). A 
third observer measured LS on stiffness maps (kPa). Mean LS values, ROI size 
(based on confidence map) and image quality scores between SE-EPI and 
GRE-MRE were compared using paired nonparametric Wilcoxon test. Repro-
ducibility of LS values between the two sequences was assessed using intra-
class coefficient correlation (ICC), coefficient of variability (CV) and Bland-Alt-
man limits of agreement (BALA).
Results: There were 4 cases of failure with GRE-MRE and none with SE-EPI-
MRE. Image quality scores and ROI size were significantly higher using SE-
EPI-MRE vs. GRE-MRE (p<0.0001). LS measurements were not significantly 
different between the two sequences (3.75±1.87 vs. 3.51±1.53 kPa, p=0.062), 
were significantly correlated (ICC=0.909) with high reproducibility (CV=10.2%, 
bias=0.023, BALA=[-1.19; 1.66kPa]).
Conclusion: SE-EPI-MRE provided better image quality, larger confidence 
maps and faster acquisition time compared to standard 2D-GRE acquisition, 
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SS 7.7 
MR elastography and dynamic contrast-enhanced MRI 
for the non-invasive prediction of portal hypertension
M. Wagner, S. Hectors, O. Bane, T. Schiano, A. Fischman, 
B. Taouli; New York, NY/US 
Purpose: To assess the diagnostic performance of MR elastography (MRE) 
and dynamic contrast-enhanced MRI (DCE-MRI) of liver and spleen for predic-
tion of portal pressures.
Material and methods: This prospective study included 26 patients (M/F: 
11/15, mean age 50y) who underwent hepatic venous pressure gradient 
(HVPG) measurement. MRI examination (1.5T/3.0T) was performed within 3 
months of HVPG and included 2D-GRE-MRE of liver and spleen (n=25) and 
DCE-MRI using 3D-FLASH (n=20). Liver (LS) and spleen (SS) stiffness were 
determined from stiffness maps. DCE-MRI data were analysed using model-
free parameters and pharmacokinetic modeling (liver: dual-input single com-
partment model, spleen: Tofts model). MRI parameters were correlated with 
HVPG. ROC and sensitivity/specificity analysis for prediction of HVPG≥5 and 
≥10mmHg were performed for individual and combinations of parameters.
Results: Mean HVPG was 8.0±7.5 mmHg. There were significant positive cor-
relations between HVPG and liver time-to-peak (TTP; r=0.712,P<0.001), liver 
mean transit time (MTT; r=0.514,P=0.020) and LS (r=0.478,P=0.016), while 
liver upslope was negatively correlated with HVPG (r=-0.548,P=0.01). ROC 
analysis provided significant AUCs for HVPG≥5mmHg (LS:0.786/SS:0.752) 
and HVPG≥10mmHg (LS:0.833, SS:0.771, liver MTT:0.786, liver TTP:0.857, 
liver upslope:0.869, spleen TTP:0.845, spleen upslope:0.786). Sensitivity/
specificity of LS for detection of HVPG≥10mmHg were 67%/92%, while LS 
and spleen TTP in combination yielded the highest sensitivity/specificity 
(100%/92%).
Conclusion: Liver and spleen perfusion and stiffness metrics correlate with 
HVPG and can be combined into a multiparametric analysis to maximize diag-
nostic performance for the prediction of clinically significant portal hyperten-
sion.
SS 7.8 
Clinical validation of a novel method to measure total 
liver and hepatic arterial blood flow using phase-
contrast MRI in cirrhotic patients
M. Chouhan, A. Bainbridge, N. Davies, R. Jalan, 
S. Walker-Samuel, M. Lythgoe, S. Punwani, R. Mookerjee, 
S.A. Taylor; London/GB 
Purpose: Non-invasive measurements of total liver blood flow (TLBF) and he-
patic arterial flow (HAF) using phase contrast MRI (PCMRI) maybe valuable in 
evaluating portal hypertension. Direct HAF measurement is time consuming 
and technically challenging in patients with chronic liver disease, who often 
struggle to comply with MRI protocols. The purpose of this study was to vali-
date a novel PCMRI technique to estimate TLBF and HAF in cirrhotic patients 
using inferior vena cava (IVC) and portal vein (PV) measurements alone.
Material and methods: Histologically confirmed cirrhotic patients (n=11) un-
derwent PV, HA, proximal and distal IVC breath-hold, cardiac-gated 2D cine-
PCMRI (5 mm slice thickness, α=10˚, 256x256(FExPE)) at 3T, with velocity en-
coding settings of 40,60 and 80cm/s. TLBF was estimated by subtracting 
proximal IVC flow (above renal but below hepatic venous inlets) from distal IVC 
flow (above hepatic venous inlets, but below the IVC-right atrial junction). HAF 
was estimated by subtracting PV flow from estimated TLBF. Estimated flow 
measurements were compared with direct PCMRI measurements using Bland-
Altman limits-of-agreement and Pearson’s correlation coefficient.
Results: Estimated and directly measured Bland-Altman 95% limits-of-agree-
ment were ±29.1 ml/min/100g for TLBF and HAF; and ±14.9% for HA fraction. 
There were significant correlations between estimated TLBF (r=0.9924; 
p<0.0001), estimated HAF (r=0.8061; p=0.0027), estimated HA fraction 
(r=0.8102; p=0.0045) and their directly measured counterparts. There were no 
significant differences between mean estimated and directly measured TLBF 
(99.1±14.8 vs 106.4±18.8 ml/min/100g; p=0.1328), HAF (24.2±5.15 vs 
31.5±7.4ml/min/100g; p=0.1328) and HA fraction (22.±4.0 vs 25.2±3.7%; 
p=0.2486).
Conclusion: PCMRI IVC and PV flow measurements can successfully esti-
mate TLBF and HAF in cirrhotic patients.
SS 7.9 
Diagnosis of sinusoidal obstruction syndrome by 
contrast-enhanced US
L. Tarantino1, P. Ambrosino2, P. Gallo3, A. Sullo4; 1Pagani/IT, 
2Naples/IT, 3Rome/IT, 4Nocera/IT 
Purpose: Hepatic sinusoidal obstruction syndrome (SOS) is a rare cause of 
acute hepatic failure. In this case report, we emphasize the diagnostic value of 
CEUS in the diagnosis of SOS. 
Material and methods: A 62-year-old woman previously in good health condi-
tions was admitted to our hospital for fever, vomiting, hypertension and 
epistaxis, abdominal pain, abdominal swelling, jaundice. She had received oral 
antibiotics (ciprofloxacin) for 10 days. Laboratory tests showed the following 
results: aspartate aminotransferase (AST) 1685 IU/L; alanine aminotransferase 
(ALT) 404 IU/L; alkaline phosphatase level 1145 IU/L; gamma-glutamyl trans-
peptidase level 96 IU/L, total bilirubin level 5.08 mg/dL; prothrombin time 30.2 
%, platelets 31.000/mmcc; white blood cells 16.170/mmcc. The patient under-
went CEUS and CT.
Results: Enhanced CT imaging showed hepatomegaly, massive ascites, mul-
tiple parenchymal undefined areas and absence of clear space-occupying le-
sions. CEUS showed large and completely avascular, irregular areas in the 
liver, crossed from patent portal, arterial and hepatic vessels. These aspects 
were highly consistent with massive occlusion of sinusoids without any vascu-
lar damage to portal spaces. The patient died because of liver failure 4 days 
after admission. At autopsy microscopic examination showed markedly dilat-
ed sinusoids filled with thrombi and fibrin and hepatic venules lumen obstruc-
tion. 
Conclusion: Contrast material for CEUS, as blood-pool agent, allows a clear 
and well-defined detection of thrombosed sinusoids. CT and MR contrast ma-
terials could miss these aspects due to their interstitial diffusion.
SS 7.10 
Hepatic enhancement of gadolinium-ethoxybenzyl-
diethylenetriamine pentaacetic acid-enhanced 3-T MRI 
predicts the severity of liver cirrhosis
S. Lee; Seoul/KR 
Purpose: To evaluate the effectiveness of gadolinium-ethoxybenzyl-diethylen-
etriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MR in the assessment 
for the severity of liver cirrhosis and quantitative liver function.
Material and methods: This retrospective study consists of 120 patients who 
underwent Gd-EOB-DTPA-enhanced 3-T MR (normal liver, n=30; Child-Pugh 
class A, n=30; B, n=30; C, n=30), using matching method by underlying dis-
ease, age (±5 years), gender, and creatinine (±0.05 mg/dL). Contrast enhance-
ment index (CEI) was calculated and compared between normal liver and each 
cirrhotic group. We analyzed the correlation between hepatic function param-
eters and CEI on 20-min hepatobiliary phase (HP). The diagnostic performance 
of CEI on HP for the severity of cirrhosis was evaluated by area under curve 
analysis.
Results: The degree and time course of hepatic enhancement differed signifi-
cantly between normal and each cirrhotic group (P<0.001). The mean CEI on 
HP constantly and significantly decreased as severity of liver cirrhosis pro-
gressed (P<0.001). Total bilirubin (P=0.022), albumin (P<0.001), platelet count 
(P=0.04) and model for end stage liver disease (MELD) score (P=0.01) were 
independent predictors of hepatic enhancement on HP. The CEI on HP showed 
good discriminatory ability in the severity of cirrhosis (AUC ≥ 0.94).
Conclusion: The degree of hepatic enhancement with Gd-EOB-DTPA indi-
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11:00 - 12:30 Meeting Hall V
Scientific Session SS 8
Pancreas: solid and cystic tumours
SS 8.1 
What is the optimal interval between abdominal CT and 
surgery for pancreatic adenocarcinoma? A review using 
evidence-based medicine methods
G.M. Healy, A.G. Carroll, D. Malone, E.R. Ryan; Dublin/IE 
Purpose: Complete (R0) resection is the only curative therapy for pancreatic 
adenocarcinoma. Up to 21% of candidates may have unexpected disease 
progression found at surgery, not identified on pre-operative imaging.
Material and methods: A literature review was performed using evidence-
based medicine (Oxford/McMaster) methodology. An answerable question 
was created using the population, intervention, comparison and outcome 
(PICO) format and used to perform a systematic search of international guide-
lines, information systems, Cochrane and Trip databases and Pubmed from 
2005 to 2015. Reverse citation analysis was performed. Studies were ap-
praised using the Oxford centre for evidence-based medicine (CEBM) tools for 
diagnostic studies.
Results: There are no international guidelines or secondary literature address-
ing this topic. Two retrospective cohort studies were identified and appraised 
as CEBM level of evidence level 2B and 3B. Both articles focused on liver and 
peritoneal metastasis, excluding local progression. Negative predictive values 
were reported for the 2B study and derived from provided data for the 3B 
study. Each paper shows a deterioration in negative predictive values with an 
increasing interval between imaging and surgery, dropping below 80% at 25 
and 27 days, respectively.
Conclusion: Current best evidence (level 2B) directs that surgery for pancre-
atic adenocarcinoma should be performed within 25 days of the last CT scan.
SS 8.2 
Differentiation of mass-forming focal pancreatitis from 
pancreatic ductal adenocarcinoma: value of 
characterizing dynamic enhancement patterns on 
contrast-enhanced MR images with adding signal 
intensity color mapping
Y.A. Choi, K.M. Jang, D.I. Cha, M. Kim, J.H. Min; Seoul/KR 
Purpose: To evaluate the value of dynamic enhancement patterns on con-
trast-enhanced MR images with adding signal intensity color mapping (SICM) 
for the differentiation of mass-forming focal pancreatitis (MFFP) from pancre-
atic ductal adenocarcinoma (PDAC).
Material and methods: Clinicopathologically proven 41 MFFPs and surgically 
confirmed 144 PDACs were enrolled. Laboratory and MR imaging parameters 
were used to differentiate MFFP from PDAC. In particular, enhancement pat-
terns on MR images with adding SICM were evaluated. Using classification 
tree analysis (CTA), we determined the predictors for the differentiation of 
MFFP from PDAC.
Results: In the CTA with all parameters except enhancement pattern on SICM 
images, ductal obstruction grade and T1 hypointensity grade of the pancreatic 
lesion were the first and second splitting predictors for differentiation of MFFP 
from PDAC in order. With adding enhancement pattern on SICM images to 
CTA, enhancement pattern was the only splitting predictor for the differentia-
tion of MFFP from PDAC. The CTA model including enhancement pattern on 
SICM images has sensitivity at 78.1%, specificity at 99.3%, and accuracy at 
94.5% for the differentiation of MFFP from PDAC.
Conclusion: The characterization of enhancement pattern for pancreatic le-
sions on contrast-enhanced MR images with adding SICM would be helpful to 
differentiate MFFP from PDAC.
SS 8.3 
Pancreatic MRI for the surveillance of cystic neoplasms: 
comparison of a short with a comprehensive imaging 
protocol
R.M. Pozzi Mucelli1, I. Rinta-Kiikka2, K. Wünsche3, 
J. Laukkarinen2, K.J. Labori4, K. Ånonsen4, C. Verbeke1, 
M. Del Chiaro1, N. Kartalis1; 1Stockholm/SE, 2Tampere/FI, 
3Trondheim/NO, 4Oslo/NO 
Purpose: Pancreatic cystic neoplasms (PCN) are increasingly identified and 
multiple MRI controls are often recommended. This results to increased 
healthcare costs for the society. The study aims were, therefore, to evaluate: (i) 
whether a short-protocol (SP) MRI for the surveillance of PCN provides equiv-
alent clinical information as a comprehensive-protocol (CP) and (ii) the cost 
reduction from substituting CP with SP for patient surveillance.
Material and methods: This retrospective study included 154 consecutive 
patients (median age: 66, 52% men) with working diagnosis of PCN and avail-
able contrast-enhanced MRI/MRCP. Three radiologists evaluated indepen-
dently two imaging sets (SP/CP) per patient. The CP included: T2-weighted 
(HASTE/MRCP), DWI and T1-weighted (chemical-shift/pre-/post-contrast) im-
ages [acquisition time (AT)≈35 min], whereas the SP included: T2-weighted 
HASTE and T1-weighted pre-contrast images (AT≈8 min). Mean values of larg-
est cyst/main pancreatic duct diameter (DC/DMPD) were compared. Agree-
ment regarding presence/absence of cystic/MPD mural nodules (MNC/
MNMPD), inter-observer agreement and cost differences between SP/CP were 
calculated.
Results: For DC and DMPD, mean values with SP/CP were 21.4/21.7 mm and 
3.52/3.58 mm, while mean differences SP-CP were 0.3 mm (P=0.02) and 0.06 
mm (P=0.12), respectively. For presence/absence of MNC and MNMPD, SP/
CP coincided in 93% and 98% of cases, respectively. Inter-observer agree-
ment was strong for SP/CP. SP cost was 25% of CP cost.
Conclusion: For the surveillance of PCN, short-protocol MRI provides infor-
mation equivalent to the more time-consuming and costly comprehensive pro-
tocol.
SS 8.4 
Usefulness of DWI combined with MRCP in detection of 
pancreatic cancer and secondary liver lesions
E. Kasatkina1, T. Rieden2, H.U. Kauczor1, M. Klauß1, 
V. Sinitsyn2; 1Heidelberg/DE, 2Moscow/RU 
Purpose: To compare the performance of DWI combined with MRCP and 
contrast-enhanced (CE) MDCT with emphasis of isodense pancreatic cancer 
(PC) and liver metastases.
Material and methods: DWI (b values 0,50,400,800s/mm2) with MRCP and 
CEMDCT were performed in 64 patients with PC, the interval between studies 
did not exceed 10 days. All patients underwent surgery, in 38 patients carci-
noma was resected. Images were analyzed in consensus by two radiologists 
blinded to clinical data. Results were correlated with intraoperative surgical 
and pathologic analysis.
Results: In seven patients (11%) the tumor was isodense to pancreatic paren-
chyma in CEMDCT, in all cases DWI/MRCP showed a superior performance to 
CEMDCT with mass identifiability at DWI and duct interruption at MRCP. In 
detection of liver metastases, CEMDCT and MRI results were discrepant in 13 
patients (20%), in these cases lesions were smaller than 1-1.5cm. In two pa-
tients, metastases were missed both in CEMDCT and MRI. Sensitivity and 
specificity in detection of PC were 83% and 93% for CEMDCT and 81% and 
88% for DWI/MRCP; in detection of liver metastases 54% and 76% for CEM-
DCT and 87% and 96% for DWI/MRCP.
Conclusion: DWI combined with MCRP was useful and preferable to CEM-
DCT in cases of isodense PC, showed equivocal performance to CEMDCT in 
cases of typical PC without need of i.v. contrast agent. DWI showed superior-
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SS 8.5 
Pancreas serous cystadenoma operated on by mistake: 
how to avoid it?
M.-P. Vullierme, N. Bessaoud, M. Lagadec, M. Ronot, 
V. Vilgrain; Clichy/FR
Purpose: To study misdiagnosis of pancreas serous cystadenoma, comparing 
MRI and MDCT of two series of serous cystadenoma, patients with typical 
pattern and patients operated on for erroneous diagnosis of other diseases.
Material and methods: Monocentric study, by two radiologists, retrospective 
over 10 years, of 77 patients with MRI (n=64) and or MDCT (n=63) (out of 126 
patients), of n=85 serous cystadenoma diagnosed by resection (n=14), biopsy 
(n=8), endoscopic ultrasound (n=61). Criteria were: shape, presence of micro-
cysts, presence of central scare, enhancement of peripheral wall, enhance-
ment of internal cystic wall. Same criteria were studied upon n=14 patients 
operated on for erroneous diagnosis of NET n=6, and branch duct IPMN n=8.
Results: Microcysts were seen in 75% MRI and 45 % MDCT, and diagnosed 
with kappa=0.74 at MRI. Central scar had k=0.821. The 6 false NET were 
pseudo solid serous cystadenoma. This subtype contains microcyst at pathol-
ogy. It has liquid pattern with T2, but microcyst were less diagnosed (p=0.034). 
The 2/6 cases ADC available were high (2.9). No true solid serous cystadeno-
ma was present. The 8 false branch-duct-IPMN were of small size (mean 2 cm) 
and misdiagnosed with endoscopic US.
Conclusion: Pseudo solid serous cystadenomas could be diagnosed by mean 
of MRI with MRCP and DW-MRI. True solid serous cystadenoma is highly in-
frequent. Small branch-duct IPMN is difficult to differentiate from serous cys-
tadenoma.
SS 8.6 
Factors affecting transabdominal US detection rate of 
focal pancreatic lesion detected by endoscopic US
J.H. Kim1, S.-Y. Choi2, H.W. Eun1, J.K. Han1; 1Seoul/KR, 
2Bucheon/KR 
Purpose: To assess the factors affecting detection rate of transabdominal ul-
trasound (TAUS) for focal pancreatic lesion detected by endoscopic ultra-
sound (EUS).
Material and methods: 338 consecutive patients with focal pancreatic lesions 
(cyst, n=253; adenocarcinoma, n=54; PNET, n=24; SPN, n=4; IPAS, n=1; me-
tastasis, n=1; and lymphoma, n=1) detected by EUS and who underwent TAUS 
were included in our study. We reviewed formal report and assessed the pres-
ence or absence of focal lesion, single or multiple, size, and location on TAUS. 
We also assessed the same parameters for only cystic and solid lesions. Sta-
tistical analyses were performed using Chi-square tests, Student t test, and 
multivariable logistic regression analysis.
Results: The overall detection rate of TAUS was 61.5 % (208/338). Solid le-
sion, located in the body, and larger size (15.5+10.1mm vs 23.1+12.9mm) 
showed significantly higher detection rate than others (p<0.05). In multivaria-
ble analysis, body lesion (OR=2.337, 95% CI, 1.39- 3.92) and solid (OR=1.745, 
95% CI, 1.02- 2.99) were significant variables (p<0.05). For cystic lesion, de-
tection rate of TAUS was 58.5 % (148/253). In multivariable analysis, only body 
lesion (OR=2.435, 95% CI, 1.36- 4.36) was significant variable (p=0.003). On 
the contrary, for solid lesion, detection rate of TAUS was 70.6 % (60/85). How-
ever, in multivariable analysis, there was no significant variable.
Conclusion: Transabdominal US is useful for detection of focal pancreatic le-
sion detected by EUS, especially, located in body and solid lesion.
SS 8.7 
Diagnostic value of contrast-enhanced transabdominal 
US and contrast-enhanced endoscopic US in pancreatic 
cystic tumors
X. Yu, Y. Sun, F. Zhou, P. Liang, F. Liu, E. Linghu, Z. Wang; 
Beijing/CN 
Purpose: Pancreatic cystic tumors account for approximately 1-2% of pan-
creatic tumors. Contrast-enhanced US has now been used for the differential 
diagnosis of pancreatic cancer. This research aimed to investigate the diag-
nostic value of contrast-enhanced transabdominal ultrasound (CEUS) and 
contrast-enhanced endoscopic ultrasound (CE-EUS) in pancreatic cystic tu-
mors.
Material and methods: We prospectively reviewed database of patients diag-
nosed with pancreatic cystic tumors between April 2015 and October 2015 in 
our institute. The inclusion criteria were as follows: patients who underwent 
conventional ultrasonography, CEUS, CE-EUS, CT/MRI, endoscopic US guid-
ed-FNA and were pathologically diagnosed with pancreatic cystic tumor. One 
radiologist with more than 20 years’ experience in contrast-enhanced US read 
all the patients’ imaging and made diagnosis. We compared the diagnostic 
results from CEUS and CE-EUS with that of histopathology and made com-
parisons between the diagnostic efficacy of CEUS and CE-EUS.
Results: A total of 55 patients were enrolled in this study. Diagnosis included 
pancreatic cystadenoma (n=36), pancreatic pseudocyst (n=6), intraductal pap-
illary mucinous neoplasm of pancreas (n=5), solid-pseudopallary tumor of 
pancreas (n=3), pancreatic cyst (n=3), and pancreatic cystadenocarcinoma 
(n=2). The diagnostic accuracy of CE-EUS was significantly higher than that of 
CEUS (78.2% vs 85.5%, P =0.004). For 36 cases with pancreatic cystadeno-
ma, CEUS and CE-EUS showed comparable diagnostic accuracy of 80.6 % 
and 88.9% (P=0.25).
Conclusion: CE-EUS is more effective in the diagnosis of pancreatic cystic 
tumor than CEUS.
SS 8.8 
CT patterns of recurrence of pancreatic 
adenocarcinoma after surgery: is there a correlation 
with resection margin involvement?
F. Lombardo1, G.A. Zamboni1, M. Bonatti2, G. Marchegiani1, 
R.M. Pozzi Mucelli1; 1Verona/IT, 2Bolzano/IT 
Purpose: To correlate CT pattern of recurrence of pancreatic adenocarcinoma 
with surgical margins status.
Material and methods: We retrospectively reviewed the multiphasic MDCTs 
performed on 43 patients (22 M, 21 F; mean age 66,6 years) with pancreatic 
adenocarcinoma recurrence after major pancreatic resection. Presence of lo-
cal recurrence, metastatic disease or peritoneal carcinomatosis was noted and 
correlated with surgical margins status (R status) after resection. CT findings 
were confirmed by subsequent follow-up examinations, by increasing levels of 
CA 19-9 or by both.
Results: 31 patients underwent pancreaticoduodenectomy, 10 patients un-
derwent spleno-pancreatectomy and 2 patients underwent total pancreatec-
tomy. 31 patients had R0 resections and 12 patients had R1 or R2 resections. 
18 patients presented local recurrence with solid tissue formation along the 
surgical margins and/or surrounding the main splanchnic vessels; of these, 14 
had R0 resections and 4 had R1-2 resections. 26 patients had hepatic/pulmo-
nary metastases; of these, 17 had R0 resections and 9 had R1 or R2 resec-
tions. 7 patients presented peritoneal carcinomatosis; of these, 5 had R0 re-
sections and 2 had R1 or R2 resections. No association was observed between 
R+ status after resection and the presence of local recurrence and/or metasta-
ses (p=n.s.).
Conclusion: Metastatic disease is the most frequent pattern of recurrence of 
pancreatic adenocarcinoma after surgery, followed by local recurrence and 
peritoneal carcinomatosis. These patterns of recurrence do not appear to be 
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SS 8.9 
Low-dose CT perfusion in the evaluation of the 
pancreatic neuroendocrine tumors grading
Y. Nerestyuk, G.G. Karmazanovsky, A. Smirnov;  
Moscow/RU 
Purpose: To evaluate CT perfusion values for pancreatic neuroendocrine tu-
mors.
Material and methods: 8 patients with known pancreatic neuroendocrine tu-
mor (4 patients - well-differentiated tumors (G1) and 4 patients - moderately 
differentiated tumors (G2)) underwent whole pancreas perfusion by a 256-slice 
CT (Brilliance iCT; Philips). 80-kVp/100mAs (low-dose) image data were recon-
structed with iDose5 iterative reconstruction. Perfusion parameters were cal-
culated with maximum-slope and dual-input one-compartment model meth-
ods. The parameters generated included the blood flow (BF, ml/min/100 ml 
tissue), blood volume (BV, ml/100 ml tissue), arterial blood flow (AF, ml/min/100 
ml tissue), portal blood flow (PF, ml/min/100 ml tissue) and perfusion index (%) 
[PI = AF/(AF + PF) x 100].
Results: CT-perfusion characteristics of the healthy pancreatic parenchyma 
were: BF - 72±32.2 ml/min/100ml, BV - 26.2±10.7 ml/100ml, AF - 58.9±17.5 
ml/min/100ml, PF - 30.3±28.8 ml/min/100ml. There was a significant differ-
ence in neuroendocrine pancreatic tumors between G1 and G2 for PI (p<0.05). 
TTP for G1 tumor decreases, for G2 maybe not changed in comparison with 
the parenchyma. TTP for the healthy pancreatic parenchyma was 16±6.4 sec. 
The radiation dose was 7.4±0.4mZv.
Conclusion: Low-dose whole pancreas CT perfusion values can be used as 
an additional parameter to differentiate the neuroendocrine tumors grading.
SS 8.10 
Non-enhanced MRI versus contrast-enhanced MDCT in 
detection of pancreatic neuroendocrine tumors: does 
DWI add additional information?
K. Lomovtseva, D. Babaeva, N. Karel’Skaya, 
G.G. Karmazanovsky; Moscow/RU 
Purpose: To compare non-enhanced MRI with contrast-enhanced MDCT in 
detection of pancreatic neuroendocrine tumors (NET) and evaluate the role of 
diffusion-weighted imaging (DWI) in detection of NETs.
Material and methods: 18 patients with 19 histologically proved solid pancre-
atic NETs were included in this study. The three imaging sets (I – arterial and 
portal phases of MDCT, II - T1-weighted image (WI) + T2WI with fat suppres-
sion, III - T1WI +T2WI with fat suppression+DWI (b value 600 s/mm2)) were 
retrospectively evaluated. The presence of tumor on all three sets was graded 
on a three-point scale (1 – definitely present, 2 – probably present, 3 – absent) 
by consensus of two radiologists. Grade 1 and 2 were considered as the pres-
ence of a tumor and relative sensitivity value was calculated.
Results: Tumor size varied from 3 to 41mm (mean value 18.5mm+-10.4mm). 
The presence of tumor was graded with MDCT: (1)-13, (2)-4, (3)-2; T1WI+T2WI: 
(1)-13, (2)-4, (3)-2; T1WI+T2WI+DWI: (1)-15, (2)-3, (3)-1. Relative sensitivity for 
sets I and II was 89.5%, for set III 94.7%.
Conclusion: DWI improves MRI sensitivity in detection of pancreatic NETs. 
MRI sensitivity with added DWI may be even higher than MDCT sensitivity.
11:00 - 12:30 Chamber Hall
Scientific Session SS 9
Appendix, mesentery and peritoneum: 
what’s new?
SS 9.1 
The diagnostic performance of CT in detecting 
colorectal peritoneal metastases
W.J. Van Eden, M.J. Lahaye, D.M.J. Lambregts,  
N.F.M. Kok, G.L. Beets, R.G.H. Beets-Tan, A.G.J. Aalbers; 
Amsterdam/NL 
Purpose: Staging of tumor burden is essential in patients with colorectal peri-
toneal carcinomatosis (PC) who are eligible for cytoreductive surgery (CRS) 
and hyperthermic intraperitoneal chemotherapy (HIPEC). CRS-HIPEC is not 
advised in patients with more than 5 affected regions, according to 7-point 
Dutch region count. This study aims to compare the extent of PC on CT with 
the peroperative findings of PC and long-term survival.
Material and methods: Preoperative abdominal CT scans, for patients who 
underwent CRS-HIPEC, were performed between January 2005 and March 
2007. An experienced radiologist evaluated all scans and scored the extent of 
PC according to the Dutch region count. A region count up to 5 was used as 
cutoff value for a good prognosis. Peroperative region count was the reference 
standard. Diagnostic performance of CT imaging was calculated. Survival 
analyses were performed.
Results: Forty-nine patients were included. The accuracy for selecting PC pa-
tients with a good or bad prognosis with CT was 86%. Disease-free survival 
(median 21.9; 19.0-24.7 months) and overall survival (median 39.5; 25.8-53.2 
months) showed significant lower survival rates for patients with more affected 
abdominal regions on CT imaging (p=0.041 and p=0.014).
Conclusion: These results show that CT has a high accuracy in selecting pa-
tients who could benefit from CRS-HIPEC. Survival rates decreased when 
more abdominal regions on CT were affected.
SS 9.2 
Diagnostic value of imaging for the detection of 
peritoneal metastases: a meta-analysis
M.J. Lahaye1, D.M.J. Lambregts1, I. Bekkers2, 
A.G.J. Aalbers1, W. Van Driel1, R.G.H. Beets-Tan1; 
1Amsterdam/NL, 2Maastricht/NL 
Purpose: To determine the diagnostic value of pre-operative imaging in de-
tecting peritoneal carcinomatosis (PC) in staging cancer patients.
Material and methods: A literature search of Ovid, Embase and Pubmed was 
performed to identify studies reporting on the accuracy of imaging for the de-
tection of PC for colorectal, gastric and gynaecological cancers. Data extrac-
tion was performed by two observers in consensus. The sensitivity, specificity, 
and diagnostic odds ratio (DOR) were calculated using a bivariate random ef-
fects model and hierarchical summary operating curves (HSROC) were gener-
ated.
Results: The search resulted in 4165 articles. Thirty-five relevant studies ful-
filled all the required inclusion criteria of >15 patients and surgery/histology/
clinical follow-up as reference standard. From these articles 42 datasets could 
be extracted for analysis; 21 for CT, 5 for MRI, 5 for PET and 11 for CTPET. The 
pooled sensitivity, specificity, DOR for detection of PC were 73% (CI: 60-83%); 
90% (CI: 84-94%); 25.6 (CI: 13.3-49.1) for CT and for MRI 78% (CI: 69-85%); 
88% (CI: 83-92%); 26.6 (CI: 14.7-48.4). For PET these values were 53% (CI: 
32-75%); 98% (CI: 94-99%); 55.7 (CI: 19.4-159.9) and CTPET: 87% (CI: 74-
94%); 87% (CI: 69-95%); 46.0 (CI: 16.2-130.4).
Conclusion: This meta-analysis shows that CTPET is the most optimal imag-
ing modality for the detection of PC. CT and MRI demonstrate similar results 
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SS 9.3 
Prediction of complete resections after cytoreductive 
surgery based on the extent of colorectal peritoneal 
carcinomatosis
W.J. Van Eden, M.J. Lahaye, D.M.J. Lambregts,  
N.F.M. Kok, G.L. Beets, R.G.H. Beets-Tan, A.G.J. Aalbers; 
Amsterdam/NL 
Purpose: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal 
chemotherapy (HIPEC) are the treatments of choice for colorectal peritoneal 
carcinomatosis (PC). Prior to surgery abdominal CT was performed to gain 
insight into the extent of PC and the presence of distant metastases. Our ob-
jective was to evaluate the relation between the completeness of cytoreduc-
tion and the Dutch 7 region count evaluated with CT and during surgery.
Material and methods: Patients who underwent abdominal CT imaging for 
PC prior to CRS-HIPEC were eligible. The 7-point region count was assessed 
with CT by an experienced radiologist and peroperative by the operating sur-
geon, based on the Dutch region count. The completeness of cytoreduction 
was scored after CRS. Survival analyses were performed.
Results: Forty-nine patients were included. Patients who had an incomplete 
resection had more often PC in 5 to 7 regions during surgery (p=0.05). This 
result was not found using the CT assessment of the region score (p=0.60). 
Regarding disease-free and overall survival no differences were found be-
tween patients with complete and incomplete resections (p=0.39 and p=0.70).
Conclusion: Patients with four or less involved abdominal regions with PC 
peroperative were more likely to have a complete resection. CT assessment of 
the region score could not accurately predict a complete resection. No sur-
vival differences were seen between complete and incomplete resections.
SS 9.4 
Role of elastosonography and diffusion-weighted MRI 
for the assessment of mesentery in patients with 
Crohn’s Disease: preliminary results
D. Picone, R. Cannella, F. Vernuccio, C. Tudisca, 
M. Costanzo, A. Di Piazza, S. Serraino, G. La Tona, 
S. Salerno, A. Lo Casto, T.V. Bartolotta, G. Lo Re;  
Palermo/IT 
Purpose: To evaluate the diagnostic role of elastosonography (USE) and the 
apparent diffusion coefficient (ADC) in differentiating oedematous and fibrotic 
change of mesentery of patients affected by Crohn’s disease (CD).
Material and methods: In our department, twenty-five patients (mean age 
33,12 ± 7,32) with CD underwent MR enterography and in the same time a 
real-time USE from July 2014 to October 2015. ADC values were calculated in 
the mesentery of pathological ileum (study group) and of normal ileum (control 
group) and were compared with the USE colour images in the same location. 
These results were statistically analysed.
Results: In the study group, the USE colour-scale coding showed a colour 
change from blue to red in the fibrotic change of mesentery, and blue-green in 
the oedematous change, 10 and 15 patients, respectively. Moreover, there was 
a significant (p<0,05) restriction of the diffusion in 13 patients with CD in the 
active phase (mean ADC values for the fibrotic mesentery: 2,83 ± 0,21 x 10-3, 
mean ADC values for oedematous mesentery: 2,17 ± 0,33 x 10-3). However, 
there was a significant difference between the control and the study group.
Conclusion: Evaluation of CD through USE and DWI is a more and more grow-
ing field, and many tools are available. USE also gives a confirmation of the 
nonsolid nature of the mesenteric mass because the tumor appeared almost 
entirely green (soft) on hardness colorimetric scale.
SS 9.5 
withdrawn by the authors
SS 9.6 
A clinical scoring system to discriminate between 
infected and non-infected postoperative abdominal fluid 
collections
C.G. Radosa1, J.C. Radosa2, D. Seppelt1, A. Volk1, 
R.-T. Hoffmann1, V. Plodeck1, M. Laniado1; 1Dresden/DE, 
2Homburg/DE 
Purpose: The aim of this retrospective study was to introduce and validate a 
CT-scoring system to discriminate between infected and non-infected postop-
erative abdominal fluid collections.
Material and methods: Between May and November 2015, all patients with 
portal-venous CT within 24 hours before CT-guided intervention were includ-
ed. CTs were independently reviewed by two radiologists. Imaging signs 
(Hounsfield units - HU, wall enhancement, entrapped gas) and C-reactive pro-
tein ≤ 24h before CT were retrospectively correlated with results of microbiol-
ogy (CT-guided intervention).
Results: 50 patients were included. On binary logistic regression analysis, the 
four parameters were associated with the incidence of infected abdominal 
fluid collections. A scoring system consisting of nominal categorization of the 
four variables was selected to develop a clinical scoring from 0 to 11 (C-reac-
tive protein ≥ 150 mg/l: 4 points; HU ≥ 20: 2 points; wall enhancement: 2 
points; entrapped gas: 3 points). The model was well calibrated (Hosmer-
Lemeshow test). A cut-off of 5 points showed a 83% positive predictive value 
for the presence of infected fluid and a 74% negative predictive value. The 
sensitivity was 73% and the specificity was 83%.
Conclusion: This study provides a validation of a newly developed scoring 
system and cut-off values for the discrimination between infected and non-
infected postoperative abdominal fluid collections. These findings might help 
to prevent unnecessary interventions.
SS 9.7 
Abdominal fungal ball sign for invasive fungal infection 
in immunocompromised patients
S. Hur, M.H. Lee, S.-Y. Choi, B.H. Yi, H.K. Lee, S. Chin; 
Bucheon/KR 
Purpose: To retrospectively review abdominal CT findings of patients with leu-
kemia who suffered from suspected invasive fungal infections.
Material and methods: Medical records of 343 consecutive patients who 
were treated for leukemia in our hospital from March 2004 to February 2014 
were reviewed. Two abdominal radiologists reviewed medical records and CT 
images of all patients. A total 155 patients took abdominal CT scan and we 
excluded 124 patients who had only lymphadenopathy or organomegaly due 
to leukemic involvement, or didn’t have any abdominal lesion, who hadn’t un-
dergone any chemotherapy. Consequently, 31 leukemic patients who under-
went CT examination for their abdominal symptoms were included in this 
study and they were divided into two groups. The first group was the fungal 
ball group consisting of 8 patients who had poorly enhancing ball-shaped le-
sion involving bowel or liver and the second group consisted of other patients. 
We compared ANC, duration between chemotherapy induction and CT scan, 
and clinical diagnosis for two groups.
Results: The result showed ANC was significantly low and the duration was 
significantly short for the fungal ball group. Clinical diagnosis of invasive fungal 
infection was significantly high for the fungal ball group.
Conclusion: Poorly enhancing ball-shaped lesion involving the liver or intes-
tine of immunocompromised patients may suggest invasive fungal infection. 
The CT findings are not pathognomonic but are helpful in narrowing the dif-
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SS 9.8 
Suspected acute appendicitis (AA) in adults: influence of 
experience and intravenous (IV) contrast on diagnostic 
accuracy of multidetector computed tomography (CT)
Q. Monzani, S. Beranger-Gibert, M. Gavrel, L. Corno, 
S. Gerber, J. Gregory, H. Beaussier, M. Zins; Paris/FR 
Purpose: To assess the influence of IV enhancement at CT for suspected AA 
depending on the reader’s experience.
Material and methods: Over 14 months, patients from our emergency depart-
ment who underwent CT for suspected AA were retrospectively included. The 
CT protocol included both unenhanced (UCT) and IV-enhanced CT (IVCT) 
scans. Four readers (two residents, one senior abdominal radiologist, one sen-
ior non abdominal radiologist (SNAR)) read each patient scans: UCT first then 
IVCT. At each reading, they were asked to confirm or rule out AA, to record 
their level of confidence and to propose an alternative diagnosis. The reference 
standard was pathologic specimen when available or a composite reference 
standard with other tests and follow-up when the patient did not undergo sur-
gery.
Results: 62/175 patients included were finally diagnosed as AA. Diagnostic 
performances were not significantly superior with IVCT. Sensitivities for the 
four readers were, respectively, 95.6, 92.9, 91.1 and 93.8 with UCT and 98.2, 
95.6, 97.3 and 97.3 with IVCT. Specificities were, respectively, 91.9, 96.8, 96.8, 
80.7 and 95.2, 100, 96.8, 90.3. The SNAR had lower diagnostic performances. 
For the 113 non-AA remaining patients, an accurate alternative diagnosis was 
more frequently proposed with IVCT for all readers (p<0.001).
Conclusion: Regardless of the reader’s experience, diagnostic performances 
of IVCT for the diagnosis of AA were not significantly superior to UCT. IV con-
trast administration improves CT performances in establishing an accurate 
alternative diagnosis.
SS 9.9 
Contribution of diffusion-weighted MR imaging in 
follow-up of inflammatory appendiceal mass
Y. Metin, N. Orhan Metin, O. Özdemir, E. Özer; Rize/TR 
Purpose: The main goal of this prospective study was to assess the added 
value of DWI in patients with inflammatory appendicial mass, who were de-
cided a conservative treatment rather than immediate surgery. We also aimed 
to reveal alternative diagnoses such as tumors of cecum and appendix. This 
paper hypothesizes that DWI has the ability show the morphological and in-
flammatory changes of IAM to monitor the treatment response and show alter-
native diagnoses.
Material and methods: A total of 19 consecutive patients (mean age, 37+-
13.1; range, 19-69; F/M: 9/10) with a clinical diagnosis of IAM followed-up with 
conservative treatment with or without interval appendectomy, were enrolled in 
this prospective study during a period of 19 months. All the diagnoses of IAM 
were made with contrast enhanced CT. After the CT diagnosis of IAM, only 
those patients who were decided a follow-up period of conservative treatment 
were included to our study. For follow-up period, DWI was chosen as the mo-
dality of imaging.
Results: It provided statistical confirmation that ADC values increase as CRP 
and WBC drop towards their normal level. Additionally, we assessed the size 
of IAM that the decrement also corresponded to increase of ADC value.
Conclusion: The study revealed that DWI has the ability to show the morpho-
logical and inflammatory changes of IAM to monitor the treatment response 
and show alternative diagnoses.
SS 9.10 
Reliability of Alvarado score in acute appendicitis and 
establishment of a compound sonographic score
M. Mannil, C. Polysopoulos, D. Weishaupt, A. Hansmann; 
Zurich/CH 
Purpose: The purpose of this clinical retrospective study is to improve the di-
agnosis of acute appendicitis using the established Alvardo score in its modi-
fied version [1.2] combined with sonographic criteria.
Material and methods: 132 patients with clinical suspicion of acute appendi-
citis received an abdominal US between 2012 and 2014. Sonographic criteria 
included appendix found, appendix diameter, appendix stone, compressibility, 
free fluid, mesenteric lymph nodes, inflamed mesenteric fatty tissue, perfora-
tion, abscess formation, small/large bowel affection and gynecological/uro-
logical pathologies. 100 patients had a surgically and pathologically confirmed 
acute appendicitis. The remaining 32 patients served as controls. Two models 
were computed in case the appendix was found (n=93) and when it was not 
(n=39) using logistic regression.
Results: The modified Alvarado score shows already excellent correlation with 
acute appendicitis with a cutoff value of 8. However, the diameter of the ap-
pendix adds significant information to this already strong predictor (p = 0.003). 
Adding the appendix diameter to the Alvarado score improves its sensitivity 
(~100%) and specificity (91.4%), resulting in the formula: modified Alvarado 
score + appendix diameter [mm] ≥13 is highly suggestive of an acute appendi-
citis, while 1 point/per mm is subtracted in case the appendix shows a diam-
eter of <8 mm and 1 point/per mm is added if the diameter is >8 mm.
Conclusion: The modified Alvarado score shows excellent correlation with 
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11:00 - 12:30 Meeting Hall IV
Scientific Session SS 10
Small bowel: technical update
SS 10.1 
Early changes in MRI-measured segmental small bowel 
motility after initial anti-TNF treatment may predict 
longer term outcome
M. Almarashi, A. Plumb, A. Menys, E. Russo, T. Orchard, 
S. Halligan, S.A. Taylor; London/GB
Purpose: To determine if early changes in MRI-measured small bowel (SB) 
motility, occurring after initiation of anti-TNF treatment, are associated with 
longer-term response to therapy.
Material and methods: 11 patients were recruited prospectively; 20 patients 
were identified retrospectively. All completed a standard SB-MRI protocol pre- 
and post- initiation of anti-TNF therapy. Patients ingested mannitol orally and 
underwent 8-12 breath-hold coronal TruFISP/BTFE imaging at a frame rate of 
1/second, encompassing the entire SB. Two radiologists independently seg-
mented diseased ileum and motility was measured using a validated optic-
flow algorithm. Subsequently, patients were followed-up for a mean of 10.3 
months, with response to therapy being judged via a physician global assess-
ment (PGA). Motility changes in responders vs. non-responders were com-
pared via the Wilcoxon rank sum test. The sensitivity and specificity of im-
proved motility for response to therapy was calculated.
Results: Mean time between initiation of anti-TNF therapy and follow-up SB-
MRI was 16 weeks (range = 8-28 weeks). Patients who were durable respond-
ers (i.e. sustained response to anti-TNF therapy at a mean of 10.3 months) had 
significantly greater motility changes (median=83.3% rise from baseline) than 
non-responders (median=22.7% reduction from baseline, p<0.001). Improved 
motility at mean 16 weeks had 93% Sn and 83% Sp for predicting longer term 
response.
Conclusion: Early changes in segmental SB motility measured by MRI may be 
able to predict longer-term durable response to anti-TNF therapy.
SS 10.2 
Elevated fecal calprotectin (FCP) is associated with 
correlation between restricted diffusion (RD) and 
mucosal inflammation (MI) in patients with quiescent 
Crohn’s disease (CD)
E. Klang, U. Kopylov, S. Ben-Horin, A. Eliakim, M.-M. Amitai; 
Ramat Gan/IL 
Purpose: Elevated fecal calprotectin (FCP) is associated with correlation be-
tween restricted diffusion (RD) and mucosal inflammation (MI) in patients with 
quiescent Crohn’s disease (CD).
Material and methods: The study was partially sponsored by a generous 
grant from the Helmsley Charitable Trust. 52 quiescent CD patients prospec-
tively underwent MRE, video capsule endoscopy (VCE), FCP and CRP. RD was 
assessed in the terminal ileum qualitatively (absence/presence) and quantita-
tively (ADC). The VCE Lewis score (LS) was calculated for the distal small 
bowel. MI was defined as LS>135. ADC’s correlation to biomarkers was calcu-
lated. RD’s sensitivity and specificity for MI and ADC’s correlation to LS were 
assessed for elevated FCP (>100 μg/g) and normal FCP patients. ROC curve 
assessed ADC’s prediction of patients that had both MI and elevated FCP.
Results: 26/52 (50%) patients had elevated FCP. ADC correlated with FCP 
(r=-0.527, p<0.0001), but not CRP. RD’s sensitivity and specificity for MI and 
ADC’s correlation to LS were high in elevated FCP patients (76.1%,100%; r=-
0.5, p=0.009, respectively) but insignificant in normal FCP patients (15.4%, 
76.9%; r=0.146, p=0.496, respectively). ADC’s prediction in patients with both 
MI and elevated FCP was high (AUC=0.832). ADC of 1.92X103 mm2/s had 
89.7% sensitivity and 71.4% specificity for these patients.
Conclusion: In quiescent CD patients, RD significantly associates with MI in 
elevated FCP patients, but not in normal FCP patients. RD represents a more 
severe inflammation and shows low sensitivity for MI in normal FCP patients.
SS 10.3 
Diffusion-weighted imaging in the assessment of the 
small bowel in patients with inflammatory bowel 
disease: a comparative study using standard magnetic 
resonance imaging, diffusion-weighted imaging and 
capsule endoscopy
M.L. Hahnemann1, A. Dechene2, S. Kathemann2, S. Sirin2, 
G. Gerken2, T. Lauenstein2, S. Kinner2; 1Muenster/DE, 
2Essen/DE 
Purpose: To investigate diffusion-weighted imaging (DWI) compared to stand-
ard MRI (sMRI) in the assessment of inflammatory lesions of the small bowel 
using small bowel capsule endoscopy (CE) and ileocolonoscopy (ICS) as 
standard of reference.
Material and methods: MRI of the small bowel including DWI followed by CE 
and ICS were retrospectively analyzed in thirty consecutive patients with sus-
pected or established diagnosis of IBD. Inflammatory lesions of the small 
bowel detected in endoscopy (CE and ICS) were compared with findings in 1.) 
standard MRI alone (sMRI = MRI without DWI), 2.) DWI alone and 3.) sMRI in 
combination with DWI (sMRI + DWI). Sensitivity, specificity and accuracy were 
calculated.
Results: DWI alone showed slightly superior results in sensitivity compared to 
sMRI alone (60.0% vs. 55.2%). DWI alone and sMRI alone revealed lower re-
sults in sensitivity than sMRI + DWI in combination (60.0% and 55.2% vs. 
70%). Specificity and accuracy of different readouts showed no differences 
(specificity/accuracy; sMRI alone 99.5%/94.2%, DWI alone 99.0%/94.2%, 
sMRI + DWI 99.0%/95.4%). Missed lesions in sMRI and DWI were located in 
the proximal bowel segments.
Conclusion: DWI can be recommended as additional sequence for the detec-
tion of inflammatory small bowel lesions.
SS 10.4 
Prelesionary bowel dilatation and morphological signs 
of inflammatory bowel disease correlation in children 
with Crohn’s disease
J. Podgorska, R. Pacho, P. Albrecht, I. Lazowska;  
Warsaw/PL 
Purpose: To determine if prelesionary bowel dilatation correlates with mor-
phological signs of inflammatory bowel disease in children with Crohn’s dis-
ease.
Material and methods: MRE examinations of 77 consecutive paediatric pa-
tients (36 female, mean age 14, range 7-17), with confirmed Crohn’s disease 
were retrospectively reviewed. The ‘cine’ imaging (coronal, Fiesta sequence, 
TR 3.5 ms, TE 1.5ms, slice thickness 5mm, 22 sec. breath hold) was per-
formed through the small bowel. The bowel segment proximal to the terminal 
ileum (TI) was identified, and its maximal diameter measured. Other MRE se-
quences were used to evaluate Crohn’s disease activity characteristics in TI: 
bowel wall thickening, T2 hyperintensity, relative contrast enhancement (RCE), 
deep ulcerations and mesenteric hyperaemia. ROC curve analysis was per-
formed.
Results: Strongest correlation was found between the dilatation and presence 
of bowel wall thickening (OR=1.17, p<0.02, area under ROC curve (AUC) 0.72), 
RCE (OR=1,1, p<0.006, AUC=0,72), T2 hyperintensity (OR=1,05, p<0,125, 
AUC=0,72) and mesenteric hyperaemia (OR=1,09, p<0.03, AUC=0.76). Strong 
correlation was found between these inflammatory signs and prelesionary dila-
tation greater than 22,5mm. There was no correlation between the length of 
inflammatory segment nor presence of deep ulcerations and prelesionary dila-
tation.
Conclusion: This retrospective study showed that prelesionary dilatation is 
related to signs of inflammatory activity and is not related to the length of the 
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SS 10.5 
The assessment of usability of the ADC as a biomarker 
of the inflammatory process activity in the Les´ niowski-
Crohn’s disease
O. Kozak, A.M. Szymańska-Dubowik, D. Gałąska, 
K. Markiet, E. Szurowska; Gdan´sk/PL
Purpose: The aim of the study is to assess the usability of the ADC as a bio-
marker of the inflammatory process activity in the CLC disease.
Material and methods: We analyzed the MRI scans of 43 patients, performed 
on 1.5T scanner. A standard protocol of MR enterography was performed in-
cluding the DWI sequence and the following values b (0, 100, 300, 500, 800 s/
mm2), the ADC maps were generated. The ADC value was obtained by way of 
a 5-fold measurement and marking a region of interest (ROI) for each of the 
affected bowel area. The results were averaged and compared with the value 
of CRP and colonoscopy results and histo-pathological examination.
Results: Based on the colonoscopy and histopathological examination, in 32 
of 43 examined patients an active stage of CLC was ascertained, and in 11 
people – a chronic stage. The average value of the ADC for the active stage of 
disease was ~1.411x10-3 mm2/s, and for the chronic stage ~1.750x10-3 
mm2/s. 27 patients’ CRP was accordant with the clinical stage of the disease 
activity and the ADC value, low in active stage and high in chronic stage. In 6 
cases of the active process, the value of the ADC correlated with disease ac-
tivity better than the CRP.
Conclusion: The apparent diffusion coefficient (ADC) can be used as a bio-
marker of active inflammation in Les´ niowski-Crohn’s disease.
SS 10.6 
Role of DWI in MR enterography evaluation of tumoral 
and inflammatory lesions of small bowel
V. Sobko, A. Karpenko, O. Shchukina, E. Bogdanova, 
A. Dmitriev; Saint Petersburg/RU 
Purpose: DWI analysis of small bowel lesions in the differential diagnosis of 
neoplasms and inflammation in Crohn’s disease at performance of magnetic 
resonance enterography (MRE).
Material and methods: 49 patients (23 men and 26 women) with long painful 
syndrome in an abdominal cavity were included in this study. MRE was per-
formed after oral administration of 1000 ml Mannitol-solution (2.5%). The 
study protocol included sagittal, axial, coronal true-FISP, T2 HASTE sequenc-
es and contrast-enhanced T1 VIBE. DWI with b-values 50, 400, 800 s/mm2 
and intravenous injections of contrast agent was performed in all cases.
Results: 8 patients (16.3 %) were identified malignant tumors (adenocarcino-
ma, lymphomas, carcinoid tumors, GIST, metastasis). In all cases the high sig-
nal on DWI b=800 s/mm2 with diffusion restriction ranged from 0.45 ±0.1 
mm2/s to 0.91 ±0.1 mm2/s . 2 patients (4.1 %) in ileocecal valve benign tumors 
(lipoma) were found, that characterized by high signal on T1 and T2-weighted 
images and low signal on T1 and T2. Tumors characterized by low signal on 
DWI b=800 s/mm2 and ADC ranged from 1.34 ±0.1 mm2/s to 1.45 ±0.1 
mm2/s. Wall of small intestine in Crohn’s disease show ADC value from 0.90 
±0.1 mm2/s to 1.25 ±0.1 mm2/s.
Conclusion: DWI is good additional tool for performing MRE in differential di-
agnosis Crohn’s disease and neoplasms of small bowel.
SS 10.7 
CT characteristics and clinical relevance of the small-
bowel faeces sign in patients with small-bowel 
obstruction: are there different faeces signs?
W. Khaled1, L. Corno1, I. Millet2, A.-M. Chuong1, 
M.A. Benadjaoud3, I. Boulay-Coletta1, M. Zins1; 1Paris/FR, 
2Montpellier/FR, 3Villejuif/FR 
Purpose: To study CT characteristics of the small-bowel faeces sign (SBFS) 
and its clinical relevance to predict medical management success and the di-
agnostic of ischaemia in small-bowel obstruction (SBO) due to matted adhe-
sions or adhesive bands.
Material and methods: Two senior radiologists retrospectively performed 
blinded and independent review of 237 consecutive CT scans amongst 216 
patients with SBO due to matted adhesions or adhesive bands for assessment 
of the transition zone (TZ) (number, location) and the SBFS characteristics 
(presence, location related to the TZ, length, density, morphology) between 
two groups: surgical (n = 108) or medical (n = 129) treatment.
Results: The prevalence of SBFS was 41.4%. SBFS was proximal to the TZ in 
82 of 98 CT scans (83.7%). A unique TZ (OR = 0.25; IC95% 0.13-0.46, p < 
0.001), an anterior location of the TZ (OR = 0.39; IC95% 0.18-0.86, p = 0.019) 
or an SBFS >5 cm proximal to the TZ (OR = 0.43; IC95% 0.21-0.89, p = 0.022) 
were inversely predictive of surgery. More than two TZ (OR = 6.54, IC95% 
2.96-14.41, p < 0.001) or an SBFS >5 cm located in a closed loop (OR = 4.00; 
IC95% 1.11-14.42, p = 0.034) were predictive of ischaemia.
Conclusion: The SBFS is a common and useful sign to locate the TZ. There 
are multiple types of SBFS and their clinical relevance depends on their length 
and location.
SS 10.8 
The incidence and risk factors of transient bowel 
angioedema induced by iodinated contrast media
N. Seo, Y.E. Chung, J. Lim, M.-J. Kim, K.W. Kim; Seoul/KR 
Purpose: To investigate the incidence and risk factors of iodinated contrast 
medium (CM)-induced bowel angioedema during CT.
Material and methods: From July 2013 to July 2015, 427 patients with a his-
tory of adverse reactions to iodinated CM during CT (group A) and propensity 
score-matched control group (group B, n=427) without adverse reactions were 
studied. Age, sex, CM types, CM injection protocols including velocity, total 
amount and duration, the presence or absence of prophylaxis and accompa-
nying allergic symptoms were compared between patients with angioedema 
and those without angioedema in group A. In addition, the incidence of bowel 
angioedema was compared between group A and B using a clustered logistic 
regression method.
Results: The incidences of CM-induced bowel angioedema in group A were 
3.3 % (14/427) in per-patient analysis and 2.6 % (15/578) in per-exam analysis. 
Angioedema was found in 1 of 14 patients in consecutive CT examinations. 
None of the patient demographics or CM related factors were different be-
tween the patients with and without bowel angioedema (P > 0.05). The inci-
dences of CM-induced bowel angioedema in group B were 1.7 % (8/458) and 
1.9 % (8/427) in per-patient and per-exam analyses, and these rates were not 
significantly different between group A and B (P=0.35 and P=0.37, respec-
tively).
Conclusion: The incidence of CM-induced bowel angioedema during CT was 
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SS 10.9 
CT enteroclysis imaging features for diagnosis, 
treatment and follow-up of small bowel neuroendocrine 
tumors
D. Maiettini, C. Valloncelli, P. Ferolla, A. Rebonato, 
M.C. Bellucci; Perugia/IT 
Purpose: To analyse the role of CT-enteroclysis (CT-E) in the identification and 
diagnosis of small-bowel neuroendocrine tumors (SBNET) defining CT-E find-
ings and SBNET features useful in the management of SBNET.
Material and methods: We selected for this retrospective study 75 patients 
suspected of primary or recurrence SBNET, who underwent to CT-E from 2009 
through 2015. Written informed consent was obtained. After the positioning of 
an 8-French naso-jejunal tube, CT-E acquisition was performed with a double 
continuous bolus (DCBT) or a single-bolus technique (SBT). SBNET diagnosis 
was immune-histochemical confirmed after surgery. Imaging features were 
gathered to evaluate sensitivity and prevalence of each one. Primary tumor 
densitometric values and the radiation dose were analyzed comparing the two 
contrast techniques.
Results: Fifty-one cases of primary SBNET were detected and 29 (57%) were 
multifocal. Tumor densitometry showed a statistical non-significant difference 
between phases (p>0.05). DCBT did not allow a significant radiation dose re-
duction (p>0.05). Among all the 75 CT-E in patients with SBNET, 53% had liver 
metastasis. Desmoplastic reaction was present in 38 (51%) cases, but only in 
9 (12%) figured out as “Sun Burst Sign”. In the 57% (43 patients) of cases 
mesenteric lymph nodes were noticed and a mesenteric mass was present in 
41 cases (33 cases presented vascular encasement).
Conclusion: CT-E might be proposed as the main imaging technique in the 
diagnosis and planning the management of SBNETs.
SS 10.10 
Contrast-enhanced computed tomography (CT) 
assessment of the positioning of a novel intestinal 
bypass liner device (Endobarrier) for type 2 diabetes: 
correlation of the degree of metabolic response with the 
extent of intestinal exclusion
V. Hedayati1, P. Sen Gupta1, B.M. Mcgowan1, R.E. Ryder2, 
F. Rubino1, S.A. Amiel1, S.M. Ryan1; 1London/GB, 
2Birmingham/GB 
Purpose: The Endobarrier is a 60cm duodenal bypass liner placed endoscop-
ically for up to 1-year, improving glucose control and weight in obesity-related 
diabetes. The aim of this study was to evaluate whether failure of response to 
Endobarrier relates to chyme leakage around the device’s proximal anchor.
Material and methods: Adults with suboptimally controlled type-2 diabetes 
and obesity who had undergone minimum 6 months’ treatment were classified 
as responders (≥3% initial body weight loss; ≥1% HbA1c reduction) and non-
responders. They underwent limited CT post oral contrast. Leakage was eval-
uated (none, mild, moderate, severe) by an independent experienced radiolo-
gist, blinded to responder status, and correlated with metabolic response. 
Anteroposterior, craniocaudal dimensions of the anchor, wall thickness, liver 
HU were measured.
Results: Twelve patients (53.7±8.7years, 33.3% male, 75% Caucasian, BMI, 
115.5±13.8kg, HbA1c 8.9±2.2%) underwent scanning at 8.5 (6.0-11.7) 
months. There were 6 responders [mean weight loss 15.8±8.9kg (13.4±7.4%) 
and HbA1c fell 2.0±0.6%] and 6 non-responders [weight fell 10.6±6.2kg 
(9.7±5.5%) and HbA1c fell 0.4±1.1%], P=NS and P=0.02 respectively, with no 
baseline differences between groups. One (16.7%) moderate leak was found 
in non-responders vs none in responders, with no correlation between leakage 
and responder status (P=0.27). Anteroposterior, craniocaudal dimensions of 
the anchor, wall thickness and fatty liver status were not significant.
Conclusion: Endobarrier was successful at providing duodenal exclusion with 
associated weight loss but variable diabetes improvement. Reasons other 
than peri-Endobarrier leakage must account for failure of glycaemic response.
11:00 - 12:30 Panorama Hall
Scientific Session SS 11
Rectum: advances in tumour assessment
SS 11.1 
Dynamic contrast enhanced MRI in rectal cancer: 
tumours with poor prognosis show low vascularity
M. Maas1, G. Shakirin2, D.M.J. Lambregts3, M. Weibrecht2, 
M. Perkuhn2, M.H. Martens1, R. Dijkhoff1, G.L. Beets3, 
R.G.H. Beets-Tan3; 1Maastricht/NL, 2Aachen/DE, 
3Amsterdam/NL 
Purpose: Dynamic contrast-enhanced (DCE) MRI has shown promise for re-
sponse evaluation after chemoradiation for rectal cancer. Conflicting results 
have been reported regarding predictive value of DCE-MRI for tumour aggres-
siveness. Aim was to explore the value of DCE-MRI with gadofosveset triso-
dium for the distinction between patients with and without poor prognostic 
factors.
Material and methods: 19 patients with primary rectal cancer underwent 
DCE-MRI with gadofosveset trisodium. DCE-MRI was processed using the 
Intellispace Discovery research platform (Philips Healthcare). One reader delin-
eated whole-tumour volumes. Semi-quantitative DCE-parameters based on 
the enhancement curve (initial slope, wash-in, wash-out, initial signal excess, 
wash-in time to peak(TTP), final slope, TTP, maximum enhancement, mean 
transit time, AUC) were compared between patients with and without prognos-
tic unfavourable factors (primary metastasis, lymphangio-invasion, CEA, 
cT&cN-stage, cMRF-stage and differentiation grade). P<0.05 was statistically 
significant.
Results: Patients with metastasis (n=2) had significantly lower peak enhance-
ment, washin-time and AUC60. Patients with high CEA (> 5,n=9) had signifi-
cantly lower peak enhancement and total AUC. Patients with lymphatic inva-
sion (n=3) had significantly higher maximum slope. A trend to higher 
washin-time was found in patients with unfavourable characteristics at histo-
pathology (n=12,p=0.076).
Conclusion: Low vascularity at DCE-MRI indicates a risk of poor prognosis. 
This might reflect a poor vascular organisation/efficiency in patients with me-
tastasis, angio-invasion and high CEA. Possibly this is due to rapid tumour 
growth. Poor vascularity can be important for treatment decisions with regard 
to chemotherapy and/or radiotherapy.
SS 11.2 
Multiparametric functional MR imaging assessment of 
primary rectal cancer: correlation between diffusion, 
perfusion, magnetization transfer and signal intensity 
measurements
D.M.J. Lambregts1, J.J.M. Van Griethuysen1, G. Shakirin2, 
M. Maas3, M. Weibrecht2, M.J. Lahaye1, M.M. Van 
Heeswijk3, G.L. Beets1, M. Perkuhn2, R.G.H. Beets-Tan1; 
1Amsterdam/NL, 2Aachen/DE, 3Maastricht/NL
Purpose: Different functional MRI-techniques have shown promise in rectal 
cancer assessment, but limited data exist on how various quantitative meas-
urements correlate. Aim was to evaluate how different components of mul-
tiparametric-MRI are related to each other in primary rectal tumours.
Material and methods: 19 primary rectal cancer patients underwent multipar-
ametric-MRI including diffusion-weighted (DWI), dynamic contrast-enhanced 
(DCE), magnetisation transfer (MT), T2-weighted, and contrast-enhanced 
3DT1-weighted imaging (with gadofosveset-trisodium). Sequences were pro-
cessed using the Intellispace Discovery research platform (Philips Healthcare). 
One reader delineated whole-tumour volumes on b1000-DWI, which were 
subdivided into three equal subvolumes (high, intermediate and low DWI-sig-
nal). The following parameters were compared between these 3 DWI-signal 
groups: ADC, MT-ratio, signal intensity on T2W and contrast-enhanced MRI, 
and various DCE parameters (initial slope, wash-in/wash-out, initial signal ex-
cess, wash-in time to peak (TTP), final slope, TTP, max enhancement, mean 
transit time, AUC).
Results: Significant differences between the 3 DWI-signal groups were found 
for the DCE-parameters initial slope and initial signal excess (both higher with 
increasing DWI-signal; P=0.008/0.026). ADC, wash-in TTP, TTP and AUC60 
were significantly different for the high vs. low DWI-signal groups with lower 
ADC and TTP, and higher wash-in TTP and AUC60 in the high DWI-signal 
group.
Conclusion: Differences in perfusion correlate with differences in DWI signal 
intensities within rectal tumours. DCE and DWI measurements may thus be of 
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SS 11.3 
Comparison of the effectiveness of computed 
tomography and magnetic resonance imaging in the 
preoperative staging of rectal cancer
D. Oncel; Izmir/TR 
Purpose: To compare the effectiveness of computed tomography and mag-
netic resonance imaging in the preoperative staging of rectal cancer.
Material and methods: The study includes 105 patients who have been oper-
ated with the diagnosis of rectal cancer between October 2011 and December 
2015. The patients were graded with CT and MRI examinations and the results 
were compared with the pathologic grading.
Results: Pathologically, 86 patients were graded as T1-2 and 19 patients as 
T3. With CT 80 patients with in T1-2 grade were correctly graded, 6 patients 
were graded as T3. Among 19 patients in grade T3, 17 were correctly graded 
and 2 patients were misgraded as T2. With MRI, 82 patients with in T1-2 grade 
were correctly graded, 4 patients were graded as T3. 18 was correctly graded 
as T3 and only one was misgraded as T2. According to those results, the sen-
sitivity and specificity of CT in the preoperative staging of rectal cancer was 
86% and 93% and for MRI 94% and 95%, respectively.
Conclusion: According to our study, although MRI has higher sensitivity and 
specificity values than CT in the preoperative staging of rectal cancer, no sta-
tistically significant difference was found between the two methods. The rea-
son for the relatively high sensitivity and specificity of CT compared to the lit-
erature data is the thin slice collimation and multiplanar imaging capability of 
multislice CT imaging.
SS 11.4 
Quantifying treatments based on CT versus mandated 
MRI-based policy for rectal cancer staging: implications 
for patient care and outcomes
A. Wale, M. Chand, M. Usher, M. Capucci, G. Brown; 
Surrey/GB 
Purpose: MRI is mandatory for staging rectal cancer in the UK due to its abil-
ity to identify validated poor prognostic features. However globally MRI has 
not replaced the CT/EUS staging method. Consequent implications for patient 
care according to preoperative treatment strategies have not previously been 
assessed or quantified. This study aims to compare the impact on treatment 
when rectal cancer is staged by CT compared with MRI within three recog-
nised preoperative strategies; current and future planned USA/global guide-
lines and local treatment guidelines.
Material and methods: Retrospective case-controlled study of rectal adeno-
carcinoma patients. MRI is used as the reference. Concordant treatment deci-
sions are those when CT and MRI based treatments are identical, discordant 
decisions are when treatments differ.
Results: 85 patients were included. When preoperative treatment is decided 
by CT alone 20-31% of patients receive discordant treatment depending on 
the treatment strategy followed. More patients are over-treated (12-20%) than 
under-treated (5-15%). For treatment strategies based on T and N staging, CT 
T overstaging (13/20, 65%) and N overstaging (12/20, 60%) account for the 
majority of discordant decisions. When treatment strategy also considers 
EMVI & CRM status, CT EMVI understaging (36/38, 95%) accounts for most 
discordant decisions.
Conclusion: Irrespective of treatment strategy local staging of rectal cancer 
with CT alone is unsafe; up to 31% of patients receive discordant treatment, 
with both under and over-treatment likely to impact negatively upon morbidity 
and mortality. 
SS 11.5 
Limited accuracy of DCE-MRI in identification of 
pathological complete responders after 
chemoradiotherapy treatment for rectal cancer
T. Tong1, M.J. Gollub2, K. Zakian2, J. Zheng2, M. Gonen2, 
M. Weiser2; 1Shanghai/CN, 2New York, NY/US 
Purpose: To determine if DCE-MRI can accurately detect patients with patho-
logic complete response (pCR) to treatment for rectal cancer
Material and methods: From a surgical database between 2007-2014, con-
secutive patients with stage II/III primary rectal adenocarcinoma; received 
chemoradiotherapy which terminated within 8 weeks of the index 
MR;underwent curative intent total mesorectal excision surgery within 6 weeks 
of the index MRI and had a diagnostic quality rectal MRI with dynamic contrast 
enhanced (DCE) imaging were included. Two experienced radiologists, in con-
sensus, used image J to draw regions of interest (ROI) on the sagittal DCE 
image. Data were exported to Matlab for analysis of Ktrans, Kep, vp and ve. 
Mean values and decile and quartile histogram analysis of Ktrans, Kep, vp and 
ve were derived to see if post-CRT DCE-MRI could distinguish between pa-
tients with and without pCR.
Results: In 49 patients (19 males and 30 females; mean age 53 yrs); using 
histogram analysis, the 90th percentile Ktrans and Kep values (p=0.025 and 
0.048 respectively), were statistically significantly different between patients 
with and without pCR. Using a cutoff value of Ktrans90 = 0.16 min-1 , the 
sensitivity, specificity, PPV and NPV were: 0.69, 0.55, 0.42, and 0.78 respec-
tively. The area under the receiver operating characteristic curve (AUC) was 
0.73.
Conclusion: The DCE-MRI parameter Ktrans90 could identify patients with 
complete pathological response to chemoradiotherapy for rectal cancer with 
an AUC of 0.73.
SS 11.6 
Significance of mesorectal vascular lesion on rectal MRI 
for assessment of metastasis among indeterminate 
hepatic lesions on CT in patients with rectal cancer
K.A. Kang1, K.M. Jang1, S.H. Kim1, T.W. Kang2, D.I. Cha1, 
S.Y. Heo1; 1Goyang si/KR, 2Seoul/KR 
Purpose: To assess the significance of mesorectal vascular lesion (MVL) on 
rectal magnetic resonance imaging (MRI) for evaluating metastasis among in-
determinate hepatic lesions on CT in patients with rectal cancer.
Material and methods: A total of 210 patients with rectal cancer who under-
went preoperative contrast-enhanced abdominopelvic computed tomography 
(CT), and rectal and liver MRI were included. Univariate analysis and multivari-
ate logistic regression were used to evaluate determining factor for the signifi-
cance of indeterminate hepatic lesions on CT in patients with rectal cancer.
Results: Hepatic metastases were diagnosed in 29 (20.6%) of 141 patients 
who had indeterminate hepatic lesions on preoperative CT obtained for rectal 
cancer. On univariate analysis, carcinoembryonic antigen level, N stage and 
MVL grade on rectal MRI (p< 0.05) were associated with the possibility of me-
tastasis for indeterminate hepatic lesions on CT. On multivariate analysis, MVL 
grade on rectal MRI was the only independent factor associated with the pos-
sibility of metastasis for indeterminate hepatic lesions on CT (p=0.0002).
Conclusion: MVL grade on rectal MRI is an independent factor for estimating 
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SS 11.7 
Organ-preservation for clinical complete responders 
after chemoradiation for rectal cancer: does timing of 
selection matter?
M. Maas1, M.H. Martens2, B. Hupkens1, M. Van Der Sande3, 
M.M. Van Heeswijk1, R. Beckers1, D.M.J. Lambregts3, 
J. Leijtens4, C. Hoff5, L. Heijnen1, G.L. Beets3, 
R.G.H. Beets-Tan3; 1Maastricht/NL, 2Sittard/NL, 
3Amsterdam/NL, 4Roermond/NL, 5Leeuwarden/NL 
Purpose: Wait-and-see policy can be offered to clinical complete responders 
(cCR) after neoadjuvant chemoradiation. Aim was to evaluate whether the tim-
ing of selection influences outcome, by comparing patients included for wait-
and-see at initial assessment with patients who were selected after a second 
assessment 3 months later.
Material and methods: 114 eligible patients underwent initial assessment 
with endoscopy and MRI+DWI ±8 weeks post-CRT. 61 had a typical cCR and 
were selected for wait-and-see immediately(W&S-1). 24 had residual tumour 
and underwent TME. The other 29 patients had a near cCR (not meeting 1 or 
2 criteria for cCR) and underwent a second assessment after 3 months, after 
which 24 were included for wait-and-see(W&S-2) and 5 for TME. 3-6 monthly 
follow-up (with MRI+DWI and endoscopy) was performed.
Results: 2/24 patients that underwent TME after first assessment had a path-
ologic complete response(pCR). 1/5 that underwent TME after second assess-
ment had pCR. In total 85/114 (75%) were in wait-and-see with 25 months 
median follow-up. 3-year LRFS was 88% for W&S-1 compared to 77% for 
W&S-2 (p=0.22), 3-year overall survival was 96% and 96%, respectively 
(p=0.95). All local regrowths could be easily salvaged with standard TME.
Conclusion: A second response assessment after 3 months can offer wait-
and-see to more patients. However, there is a trend towards lower 3-year 
LRFS in patients included after second assessment, although overall survival 
is not influenced by the lower LRFS.
SS 11.8 
MRI can accurately predict sphincter preservation after 
CRT
J. Krdzalic1, M. Maas2, S. Engelen2, J.J.M. Van Griethuysen3, 
D.M.J. Lambregts3, G.L. Beets3, R.G.H. Beets-Tan3; 
1Heerlen/NL, 2Maastricht/NL, 3Amsterdam/NL 
Purpose: It is believed that chemoradiation for low rectal cancer increases 
sphincter preservation. Aim was to evaluate with MRI whether sphincter pres-
ervation is increased by chemoradiation and whether MRI can predict sphinc-
ter preservation after chemoradiation.
Material and methods: A radiologist independently evaluated the T2-weight-
ed MRIs (in 3 directions) in 47 patients before and after CRT with tumours <5 
cm from the anorectal junction (ARJ) and measured distance of the lower tu-
mour pole to the ARJ. Also, a confidence level score for feasibility of sphincter 
preservation was scored (CL=0 definitely no sphincter preservation, 
CL4=sphincter preservation definitely possible). Likelihood for sphincter pres-
ervation before and after CRT was compared and receiver operator 
characteristics(ROC) curves with area under the curve (AUC) were calculated.
Results: Mean distance from ARJ increased significantly during CRT from 
21±16mm pre-CRT to and 31±18mm post-CRT (P<0.001). In 42% sphincter 
preservation was deemed not feasible pre-CRT, which decreased to 23% after 
CRT. AUC for sphincter preservation based on confidence level score was 
0.84(0.72-0.96), with sensitivity of 100% and specificity of 44%. Based on 
post-CRT height measurement AUC was 0.87(0.76-0.98), with optimal size 
cut-off at 26 mm (sens: 86%, spec: 71%).
Conclusion: This is the first study to show that CRT increases the distance to 
the ARJ and thus leads to a higher rate of sphincter preservation. MRI can ac-
curately predict sphincter preservation after CRT.
SS 11.9 
Artefacts on diffusion-weighted MRI of the rectum: how 
often do they hamper our clinical interpretation?
D.M.J. Lambregts, M.J. Lahaye, J.J.M. Van Griethuysen, 
M. Maas, G.L. Beets, R.G.H. Beets-Tan; Amsterdam/NL
Purpose: Single-shot echo planar imaging (EPI) diffusion-weighted imaging 
(DWI) is the most commonly used DWI method in the abdomen. DWI-EPI se-
quences are prone to susceptibility artefacts, which may pose a particular 
challenge when performing DWI of the bowel. Aim was to quantify in which 
percentage of rectal DWI-examinations (without bowel preparation) clinical in-
terpretation is hampered by artefacts.
Material and methods: 360 rectal MRI-examinations (at 1.5T) including T2-
weighted MRI (in 3 directions) and an axial EPI-DWI (highest b-value b1000) 
were analyzed. MRIs were obtained in 127 patients undergoing (sequential) 
follow-up after primary rectal cancer treatment. Two readers visually assessed 
image quality of each MRI (T2W and DWI) and scored it as [1] sufficient for 
clinical interpretation or [2] uninterpretable due to artefacts. DW-imaging as-
sessment was performed using the high b-value (b1000) images.
Results: On T2W-MRI, 2/360 (1%) examinations were uninterpretable due to 
artefacts, the other 358/360 (99%) were of sufficient quality for clinical inter-
pretation. On DWI, 299/360 (83%) examinations were of sufficient quality, the 
other 61/360 (17%) were uninterpretable due to artefacts. Artefacts were 
mainly caused by air in the rectal lumen or suboptimal fat-suppression causing 
band-like artefacts.
Conclusion: In a substantial percentage of rectal EPI-DWI examinations (with-
out bowel preparation), image quality is hampered by artefacts. As such, we 
need to look for ways to improve image quality, e.g. by means of bowel prepa-
ration (rectal filling/enema) or by further optimizing image acquisition.
SS 11.10 
Prediction of sphincter preserving by MRI: accuracy and 
reproducibility between a radiologist and a surgeon
J. Krdzalic1, M. Maas2, S. Engelen2, J.J.M. Van Griethuysen3, 
D.M.J. Lambregts3, G.L. Beets3, R.G.H. Beets-Tan3; 
1Heerlen/NL, 2Maastricht/NL, 3Amsterdam/NL 
Purpose: Feasibility of sphincter-preserving surgery in low rectal tumours (<5 
cm from anorectal junction) is based on the exact distance from the anorectal 
junction (ARJ), rigidity upon digital rectal examination and presence of sphinc-
ter invasion. Aim was to evaluate whether a radiologist and a surgeon can 
predict feasibility of sphincter-preserving surgery at T2W-MRI.
Material and methods: 44 patients with a rectal tumour <5 cm from the ARJ 
that did not undergo CRT were included. T2W-MRI in 3 directions was evalu-
ated by a specialized radiologist and a specialized surgeon for feasibility of 
sphincter-preservation. Distance from ARJ (mm) and confidence level scores 
for sphincter-preserving surgery and sphincter invasion were scored. Refer-
ence standard was type of surgery combined radicality of the resection.
Results: Both the radiologist and surgeon could predict sphincter preservation 
accurately with AUC 0.81 (radiologist) and 0.82 (surgeon). Sensitivity and 
specificity are 75% and 83% (radiologist) and 50% and 87% (surgeon), re-
spectively. Height was predictive of sphincter preservation for both readers 
with AUC of 0.90 (radiologist) and 0.88 (surgeon), with optimal cut-off at 18 
and 26 mm, respectively. Interobserver reproducibility of height was ICC 0.70 
(0.51-0.82) and of confidence level scores for sphincter preservation was 
k0.53 (0.31-0.76).
Conclusion: Sphincter preservation can accurately be predicted with T2W-
MRI by both specialized radiologists as well as specialized surgeons. Height is 
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Rectum: new paradigms for evaluating 
tumour response
SS 12.1 
Assessment of the IMV diameter and IMV:CIV ratio on 
computed tomography in response to adjuvant 
radiotherapy for locally advanced rectal 
adenocarcinoma
J.A. Stephenson, C. Ivan, J. Mullineux, B. Billimoria, 
R. Verma, V. Shah, A. Rajesh, M. Elabassy; Leicester/GB 
Purpose: Neoadjuvent chemo-radiotherapy for locally advanced rectal cancer 
(LARC) aims to downstage prior to definitive management. Radiological reas-
sessment of the tumour post-therapy has implications for treatment. Various 
methods of assessing tumour response exist including TNM stage, RECIST 
and TRG-score.
Material and methods: We assessed the inferior mesenteric vein diameter 
(IMV) and the IMV:common iliac vein ratio (IMV:CIV) pre and post-radiotherapy 
of 100 patients with LARC to ascertain if these are surrogate markers of tu-
mour response. IMV measurements were performed by two radiologists and 
MRI response assessed by two radiologists blinded to CT measurements.
Results: At baseline IMV diameter was significantly higher for cases with local 
lymphadenopathy - N0 = 5.2 mm vs N1/2 =6 mm (p=0.0059) - and lymphovas-
cular invasion (LVI) – –ve 5.4 mm vs +ve 6.4 mm (p=0.0001). Post radiotherapy 
there was a significant decrease in the IMV diameter and IMV:CIV in cases with 
treatment response compared to non-responders - percentage change 
IMV:CIV = -16.46% vs +1.18% (p=0.0002). These results were reproduced be-
tween TRG groups using ANOVA (p=0.0001). There was also a significant de-
crease in IMV when assessing lymph-node and LVI response versus non-re-
sponders (p=0.0001 and 0.0001 respectively).
Conclusion: We confirm that IMV diameter and IMV:CIV are surrogate markers 
of lymph-node status and LVI at baseline. IMV diameter and IMV:CIV are also 
a markers of tumour , LN and LVI response to chemo-radiotherapy.
SS 12.2 
withdrawn by the authors
SS 12.3 
Dynamic contrast-enhanced MRI: use in predicting 
pathological complete response to neoadjuvant 
chemoradiation in locally advanced rectal cancer
T. Tong, Y. Sun, Y. Gu; Shanghai/CN 
Purpose: To determine the ability of dynamic contrast enhanced (DCE-MRI) to 
predict pathological complete response (pCR) before preoperative chemora-
diotherapy (CRT), in locally advanced rectal cancer.
Material and methods: In a prospective clinical trial, 38 enrolled patients un-
derwent pre- and post-CRT DCE-MRI at 3.0T. The tumor length and the follow-
ing perfusion parameters (Ktrans, kep, ve) were measured for the tumor and 
compared between the pCR group and the non-pCR group, as well as before 
and after CRT. For categorical variable comparison, the Kruskal–Wallis test 
was used. P<0.05 was considered significant.
Results: No difference in tumor length was found between pCR and non-pCR 
group pre-and post-CRT (P=0.26, 0.35, respectively). Before CRT, the mean 
tumor Ktrans in the pCR group was significantly higher than in the non-pCR 
group (P=0.01). A Ktrans of 0.66 emerged as the best cut-off for distinguishing 
pCR from non-pCR. Regarding kep and ve, significant differences were also 
observed between pCR and non-pCR groups (P=0.02, 0.01, respectively). The 
mean Ktrans, kep and ve values post-CRT were not significantly different be-
tween pCR and non-pCR groups (P=0.10, 0.12, 0.08, respectively).
Conclusion: Before neoadjuvant chemoradiotherapy in rectal cancer, DCE-
MRI can distinguish between complete and incomplete response using a 
Ktrans threshold of 0.66 with a sensitivity of 100%.
SS 12.4 
Standardized index of shape (DCE-MRI) and 
standardized uptake values (PET): two quantitative 
approaches to discriminate chemo-radiotherapy locally 
advanced rectal cancer responders under a functional 
profile. Two biological sides of the same coin?
A. Petrillo, M. Petrillo, R. Fusco, A. Avallone, S. Lastoria; 
Naples/IT 
Purpose: We investigated the potential use of dynamic contrast-enhanced 
MRI (DCE-MRI) to discriminate responder from non-responder patients after 
neoadjuvant chemo-radiotherapy (CRT) for locally-advanced rectal cancer 
(LARC) in comparison with [18F]2-fluoro-2-deoxy-D-glucose positron emis-
sion tomography (FDG-PET/CT).
Material and methods: 75 consecutive patients with LARC were enrolled in a 
prospective study. Each patient gave written informed consent to participate in 
the trial. Pathological TNM and tumor regression grade (TRG) were estimated. 
DCE-MRI analysis was performed by measuring SIS value before start and at 
the end of therapy as well as maximum SUV (SUVmax) by FDG-PET/CT. Non-
parametric sample tests, ROC analysis and diagnostic performance were per-
formed.
Results: Fifty-five patients (73.3%) with TRG 1-2 were classified as respond-
ers, while 20 subjects (26.7%) with TRG 3-4 were considered non responders. 
Assessment via ΔSIS reached a sensitivity of 92.7%, a specificity of 80.0% 
and an accuracy of 89.3% using a cut-off of 6.0% while ΔSUVmax reached a 
sensitivity of 67.3%, a specificity of 75.0% and an accuracy of 69.7% using a 
cut-off of 59.7%.
Conclusion: Pre-surgery assessment of CRT response by ΔSIS showed a 
higher predictive ability than ΔSUVmax in LARC, increasing sensitivity and 
negative predictive value. SIS percentage change could play a relevant role in 
LARC management improving the ability to identify complete pathological re-
sponse, allowing for conservative strategy or for a “wait and see” policy, re-
ducing significant morbidity and functional complications related to total mes-
orectal excision.
SS 12.5 
Diagnostic accuracy of magnetic resonance imaging in 
predicting response to neoadjuvant therapy in patients 
with locally advanced rectal cancer
J. Munir, I. Niazi, R. Sayyed, S. Hasan Raza, M. Hussain, 
S. Khattak, A. Syed; Lahore/PK 
Purpose: Magnetic Resonance Imaging of pelvis is the imaging modality of 
choice for preoperative staging in rectal cancer. We aim to look at the accuracy 
of MRI in evaluating response to neoadjuvant therapy.
Material and methods: Medical records of patients undergoing surgery for 
rectal cancer following neoadjuvant therapy at our institution in year 2014 were 
reviewed. Data was collected regarding T, N stage on MRI at presentation, af-
ter neoadjuvant therapy and on histopathology of resected specimen. Con-
cordance of post-treatment MRI and histopathology was evaluated. Factors 
that might affect this concordance were assessed in univariate analysis.
Results: A total of 108 patients underwent surgery for rectal cancer after neo-
adjuvant therapy in 2013-14. Most of these had T3 or above tumor (97%) or 
nodal involvement (95%) on MRI at presentation. Post neoadjuvant therapy 
MRI scan was able to predict a negative circumferential resection margin, 
however it was not able to predict complete pathological response. The post 
treatment MRI scan couldn’t accurately differentiate T3-T4 tumors from T1-T2 
tumors or node positive from node negative tumors. No specific factor could 
be identified to be significantly associated with this concordance. The diag-
nostic accuracy of MRI for predicting a negative CRM was 84.54%.
Conclusion: Although post treatment changes result in limitation of MRI to 
evaluate response to treatment, MRI shows acceptable diagnostic accuracy in 
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Non-cirrhotic liver: focal lesions
SS 13.1 
Liver MRI for colorectal cancer liver metastasis: 
comparative effectiveness research for the choice of 
contrast agents
N. Seo, M.-S. Park, K. Han, Y.E. Chung, J.-Y. Choi, J. Lim, 
M.-J. Kim, K.W. Kim; Seoul/KR 
Purpose: To compare the diagnostic performance for evaluating hepatic le-
sions between gadoxetic acid-enhanced MRI (Gd-EOB-MRI) and MRI using 
extracellular contrast agent (ECA-MRI), and to determine whether the type of 
contrast agent affects early intrahepatic recurrence.
Material and methods: Between January 2005 and December 2010, 418 
colorectal cancer patients who underwent both preoperative CT and liver MRI 
were retrospectively reviewed. Image interpretation was based on initial radio-
logic reports and all focal hepatic lesions were confirmed by pathology or fol-
low-up imaging. The diagnostic performance was assessed by the area under 
the receiver operating characteristic curve (AUROC) and the rate of indetermi-
nate lesions on each MRI. For patients who underwent curative liver surgery, 
early intrahepatic recurrence rate within 6 months were evaluated.
Results: Total 291 and 127 patients underwent Gd-EOB-MRI and ECA-MRI, 
respectively. In per-patient analysis, AUROCs of both MRI groups were not 
significantly different between Gd-EOB-MRI (0.990; 95 % confidence interval, 
0.980-0.999) and ECA-MRI (0.985, 0.968-1.000) (P=0.836). The rates of inde-
terminate lesions on MRI were 6.98 % (30/430) for Gd-EOB-MRI and 4.88 % 
(10/205) for ECA-MRI, which did not reach significant difference (P=0.309). 
Early recurrence rate in ECA-MRI group (28.6 %) was significantly higher than 
that in Gd-EOB-MRI group (11. 6%) (P=0.031).
Conclusion: Gd-EOB-MRI and ECA-MRI showed comparable excellent diag-
nostic performance in colorectal cancer patients. Further study comparing 
survival outcome between Gd-EOB-MRI and ECA-MRI should be followed.
SS 13.2 
Gd-EOB-DTPA-enhanced magnetic resonance imaging 
(MRI) for detecting colorectal hepatic metastases in 
patients who have not previously undergone treatment: 
a meta-analysis
Y. Liu1, L. Li2, Z. Huang2, H. Tang2, B. Song2;  
1Chongqing/CN, 2Chengdu/CN 
Purpose: To perform a meta-analysis to obtain the diagnostic value of gadox-
etic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) for 
detecting colorectal hepatic metastases (CRLM) in patients who have not pre-
viously undergone treatment.
Material and methods: A comprehensive search was performed in databases 
including MEDLINE, EMBASE, and Cochrane Library for studies, published 
from January 2000 to December 2015, evaluating the diagnostic performance 
of Gd-EOB-DTPA-enhanced MRI in detecting CRLM. We determined sensi-
tivities and specificities across studies, calculated positive and negative likeli-
hood ratios, and constructed summary receiver operating characteristic 
curves.
Results: Across 7 studies (410 patients, 1809 hepatic metastases), the pooled 
sensitivity of Gd-EOB-DTPA-enhanced MRI for detecting CRLM was 0.94 
(95% CI, 0.92-0.95), and the pooled specificity was 0.88 (95% CI, 0.86-0.91). 
Overall, the positive likelihood ratio was 8.22 (95% CI, 4.09-16.51), and the 
negative likelihood ratio was 0.07 (95% CI, 0.04-0.13). The area under the 
curve was 0.971. Also, among these studies, six of them combined Gd-EOB-
DTPA-enhanced MRI with diffusion weighted imaging (DWI). The sensitivity 
and specificity of Gd-EOB-DTPA-enhanced MRI combined with DWI were 
0.94 (95% CI, 0.92-0.95) and 0.91 (95% CI, 0.88-0.93).
Conclusion: Gd-EOB-DTPA-enhanced MRI has good diagnostic performance 
in the detection of CRLM. Moreover, DWI sequence combined with Gd-EOB-
DTPA-enhanced MRI may improve the diagnostic accuracy of CRLM com-
pared with Gd-EOB-DTPA-enhanced MRI alone.
SS 13.3 
CAIPIRINHA-VIBE in contrast-enhanced MRI of focal 
liver lesions: impact on interobserver agreement in 
comparison with conventional VIBE sequences
D. Leithner, J.L. Wichmann, S.S. Martin, B. Bodelle, 
P. Dewes, A.M. Bucher, R.W. Bauer, S. Zangos, T. Vogl, 
M.H. Albrecht; Frankfurt am Main/DE
Purpose: To evaluate the effect of controlled aliasing in parallel imaging results 
in higher acceleration (CAIPIRINHA) sequences on image quality and interob-
server agreement in contrast-enhanced volumetric interpolated breath-hold 
examination (VIBE) MRI of liver lesions in comparison with standard VIBE se-
quences.
Material and methods: Twenty-three patients underwent abdominal contrast-
enhanced MRI on a 3-T system and were included in this intra-individual com-
parison study. Each patient underwent both CAIPIRINHA-VIBE and conven-
tional VIBE within 3 months showing stable disease. The sequences were 
reviewed by two blinded radiologists (A+B) using a 5-point rating scale for liver 
lesions and affected segments and with regard to overall image quality and 
sharpness of intrahepatic vessels. Cohen’s analysis and Wilcoxon matched 
pairs tests were performed.
Results: Superior interobserver agreement was observed for CAIPIRINHA-
VIBE for both per-lesion and per-segment analysis (per-lesion, κ=0.18, p<0.04; 
per-segment κ=0.47, p<0.01) compared to conventional VIBE (per-lesion, 
κ=0.16, p<0.03; per-segment, κ=0.38; p<0.001). CAIPIRINHA-VIBE series re-
ceived better scores (image quality: A=4.8, B=3.7; sharpness of intrahepatic 
vessels: A=4.2, B=3.7) compared to standard VIBE (image quality: A=4.0, 
B=3.0; sharpness of intrahepatic vessels A=3.5, B=3.0) from both reviewers 
(p<0.01).
Conclusion: CAIPIRINHA-VIBE sequences facilitate superior image quality 
and consequently improved inter-observer agreement regarding dignity and 
allocation of focal liver lesions compared to standard VIBE sequences.
SS 13.4 
Liver metastases detection using sparsity-based 
learned dictionaries
E. Klang1, A. Ben-Cohen2, I. Diamant2, E. Konen1, 
H. Greenspan2, M.-M. Amitai1; 1Ramat Gan/IL, 2Tel Aviv/IL 
Purpose: Automatic liver lesions detection in CT examinations is an ongoing 
task for the computer vision community. Sparse classification has lately been 
proved to be powerful algorithms for data analysis. We evaluated sparse 
based learned dictionaries approach for the liver detection task.
Material and methods: This study included CT examinations of twenty pa-
tients with 68 metastases, segmented in 2D. The published SLIC algorithm 
was used to divide 2D liver images into 500 “super pixels”. Each “super pixel” 
is a homogeneous region that includes neighboring pixels with similar Houns-
field units. Several features sets were extracted from each “super pixel” (grey 
level histogram, acutance and others), and using this features a dictionary of 
“super pixels” was created. Sparsisty classification was used to optimize the 
dictionary, limiting its number of words, creating “super pixels” groups of me-
tastases, normal parenchyma, blood vessels and others, thus, effectively de-
tecting the “super pixels” of metastases. The sensitivity and specificity of the 
sparse based approach were compared to that of the state of the art “random 
forests” classification algorithm.
Results: The sensitivity and specificity to detect liver metastases were 71% 
and 98% for the sparse based algorithm and 66% and 99% for the “random 
forests” algorithm.
Conclusion: Sparse based approach to detect liver metastases showed 
promising results in comparison to “random forests” algorithm, with better 
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SS 13.5 
Preoperative staging of colorectal liver metastases after 
chemotherapy: assessment with diffusion-weighted MR 
imaging and Gd-EOB-DTPA-enhanced MRI at 3T
P. Boraschi, F. Donati, L. Urbani, M. Castagna, F. Pacciardi, 
R. Gigoni, M.C. Della Pina, S. Salemi, D. Caramella, 
F. Falaschi; Pisa/IT 
Purpose: To evaluate the diagnostic performance of diffusion-weighted MR 
imaging (DW-MRI) and Gd-EOB-DTPA-enhanced MRI at 3T-device in the pre-
operative staging of colorectal liver metastases in patients previously under-
gone chemotherapy.
Material and methods: Fifty patients with colorectal cancer and focal liver 
lesions underwent MR imaging at 3T-device (GE DISCOVERY MR750;GE 
Healthcare) after preoperative chemotherapy. After preliminary acquisition of 
axial T1w (in/out of phase) and T2w (propeller and SS-FSE) images, DW-MRI 
was performed using an axial spin-echo echo-planar sequence with multiple 
b-values (150,500,1000,1500 sec/mm²) in all diffusion directions. Gd-EOB-
DTPA-enhanced MRI was performed using a 3D breath-hold fat-suppressed 
T1w LAVA-flex sequence including both dynamic and hepato-biliary phase. 
MR images were reviewed by two observers in conference in order to detect 
and characterize (benign/malignant) focal liver lesions. MRI findings were cor-
related with surgery and histopathology, which was our gold standard. Only 
clear benign lesions at intraoperative ultrasound remained unresected. Statis-
tical analysis was performed on a per-lesion basis.
Results: A total of 306 hepatic lesions were detected; of these, 220 were me-
tastases (72%), whereas the remaining 86 (28%) were characterized as benign 
lesions (hemangiomas, cysts and nodular regenerative hyperplasia). The sen-
sitivity, specificity, PPV, NPV and diagnostic accuracy of the reviewers for the 
detection and characterization of focal liver lesions were 98%,93%,97%,95% 
and 97%, respectively.
Conclusion: The combination of DW-MRI with Gd-EOB-DTPA-enhanced MRI 
at 3T-device is particularly effective in preoperative staging of colorectal liver 
metastases after chemotherapy.
SS 13.6 
Hepatocellular carcinoma in non-fibrotic liver
M. Wagner1, P.-A. Lampson1, M. Ronot2, G. Hayek1, 
A. Bardier1, V. Paradis2, V. Vilgrain2, O. Lucidarme1;  
1Paris/FR, 2Clichy/FR 
Purpose: To assess clinical and radiological patterns of hepatocellular carci-
noma (HCC) in non-fibrotic liver.
Material and methods: Between 2007 and 2014, all resected HCC, in a non-
fibrotic liver (METAVIR F<2), with preoperative CT/MRI, were retrospectively 
included. Demographics, clinico-biological and pathological data, including 
alpha-fetoprotein level, differentiation, and presence of steatosis/NASH were 
recorded. Images were analysed by 2 radiologists in consensus. Presence of 
an arterial enhancement, a portal or delayed washout, and a capsule were as-
sessed.
Results: Forty-five patients (30 males, mean 60 yo), with 46 HCC (mean 10cm 
[1-30]) were included. Fourteen patients (31%) had abdominal pain, 3 (8%) a 
palpable mass and 3 (7%) a haemorrhagic syndrome. Alpha-fetoprotein was 
increased in 14 patients (31%). The liver was classified F0 and F1 in 24 (53%) 
and 21 (47%) patients. Significant steatosis and NASH were observed in 13 
(29%) and 6 patients (13%). Eleven (24%), 32 (71%) and 2 (4%) tumors were 
well-, moderately, and poorly differentiated. One was completely necrotic. 
Forty-five HCC (98%) showed arterial enhancement, 40/46 (87%) showed a 
washout either on the portal venous or the delayed phases. A capsule was 
present in 61% (28/46). 40 HCC met the AALSD criteria and 39 were classified 
as LI-RADS 5.
Conclusion: At the time of diagnosis, HCC in non-fibrotic liver are large and 
show typical enhancement pattern in most cases.
SS 13.7 
DWI in paediatric liver MRI
E. Petrash, E. Mikhaylova, D. Sevrjukov; Moscow/RU 
Purpose: The purpose of this study was to find out whether apparent diffusion 
coefficient (ADC) can enable differentiation of benign and malignant focal liver 
lesions (FLL) in children.
Material and methods: 39 patients (male-22, female-17) with 66 FLL in total 
underwent MRI of the liver including DWI. The age of patients ranged from 5 
months to 17 years. Inclusion criteria: the presence of newly diagnosed FLL, 
size of lesions more than 1 cm. Liver lesions were divided into benign (28) and 
malignant (38). Benign: focal nodular hyperplasia (7), regenerating nodules 
(11), haemangiomas (9), malignant-hepatoblastoma (15), hepatocellular carci-
noma (4), cholangiocarcinoma (3), metastases (17). Diagnosis was confirmed 
histologically, by contrast-enhanced MRI (including hepatobilliary MRIcontrast 
agents) and using dynamic control (for benignFLL).
Results: It was found that malignant tumors in the liver have a lower ADC 
(1.038±0.185*10-3 mm2/sec) than benign (1.372±0.383*10-3 mm2/sec) 
(р=0.0000136). ADC of malignant FLL was in the range 0.838 – 1.223 * 10-3 
mm2/sec, benign - 0.989-1.755 * 10-3 mm2/sec. It was suggested that FLL 
with ADC 0.989 * 10-3 mm2/sec and lower can be attributed to malignant, 
above 1.223 * 10-3 mm2/sec - benign. Neoplasms with ADC in the range of 
0.989- 1.223 *10-3 mm2/sec should be additionally examined and needs mor-
phological verification.
Conclusion: Though differences in mean ADC values of benign and malignant 
FLL were significant, confidence intervals indicate their large overlap, so ADC 
can’t be the main differential diagnostic criterion. Analysis of DWI images can 
help in difficult diagnostic cases, but should only be used in conjunction with 
standard MRI, including contrast-enhanced MRI.
SS 13.8 
Therapy response assessment of colorectal liver 
metastases after preoperative chemotherapy: 
diagnostic performance of diffusion-weighted MR 
imaging at 3T device
F. Pacciardi, F. Donati, P. Boraschi, M. Castagna, L. Urbani, 
R. Gigoni, D. Caramella, F. Falaschi; Pisa/IT 
Purpose: To assess the value of diffusion-weighted MR imaging (DW-MRI) at 
3T-device in evaluating therapy response of colorectal liver metastases after 
preoperative chemotherapy.
Material and methods: Our study group included thirty-two patients with 
colorectal liver metastases undergone MR imaging at 3T-device (GE DISCOV-
ERY MR750; GE Healthcare) after preoperative chemotherapy. DW-MRI was 
performed using a spin-echo echo-planar sequence with multiple b-values 
(150,500,1000,1500 sec/mm²), obtaining an ADC map. Fitted ADC values were 
calculated by two observers in conference for each liver lesion (more than 1 
cm of diameter) drawing a ROI around the entire tumor and another one at the 
tumor periphery. All MRI findings were correlated with histopathology after sur-
gery. Hepatic metastases were pathologically classified into three groups on 
the basis of tumor regression grading (TRG): MHR (major histological 
response,TRG 1-2), PHR (partial histological response,TRG 3), and NHR (no 
histological response,TRG 4-5). Statistical analysis was performed on a per-
lesion basis.
Results: A total of 104 colorectal liver metastases were analyzed. MHR, PHR 
and NHR were observed in 18%, 38% and 44% of lesions, respectively. Pe-
riphery ADC value was significantly different in the three groups (p<0.01) and 
was significantly higher in MHR than in NHR (p<0.01). However, ADC value of 
the entire tumor was not significantly different in the three groups.
Conclusion: DW-MRI, using ADC map and value, can be useful to assess the 
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SS 13.9 
Entropy from preoperative CT texture analysis: a 
potential imaging biomarker of early recurrence after 
resection of colorectal liver metastases
M. Kudzmaite1, K.W. Brudvik1, K. Skogen1, A. Bethke1, 
K.J. Labori1, B. Ganeshan2, J.B. Dormagen1, A. Schulz1; 
1Oslo/NO, 2London/GB 
Purpose: To determine the value of entropy, a CT texture analysis (CTTA) pa-
rameter, for preoperative prediction of recurrence after resection of colorectal 
liver metastases (CRLM).
Material and methods: Forty-four patients who underwent resection of CRLM 
between 2007-2009 were retrospectively included and followed-up until De-
cember 2015. CTTA was performed of the largest CRLM on contrast-enhanced 
CT using a research software TexRAD. Entropy was evaluated with different 
spatial scale filters (ssf2-6) corresponding to fine to coarse textures. A chemo-
naïve group (n=41) and a chemo-exposed group (n=20) were evaluated. 
TexRAD identified optimal threshold-values for entropy to divide the groups 
into poor/good prognosis. ROC and Kaplan-Meier/multivariate Cox analyses 
were performed.
Results: In the chemo-naïve group, the overall time-to-recurrence was 37.3 
months and the threshold-value 4.9 (filter ssf2). Below the threshold-value the 
overall time-to-recurrence was 46.7 months and above 21.7 months (p=0.008). 
Sensitivity and specificity for recurrence was 54.2% and 82.4%, respectively 
(p=0.447). In the chemo-exposed group, the overall time-to-recurrence was 
19.2 months and the threshold-value was 4.7 (filter ssf3). Below the threshold-
value the overall time-to-recurrence was 33.1 months and above 5.2 months 
(p=0.007). Sensitivity and specificity for recurrence was 62.5% and 100%, re-
spectively (p=0.001).
Conclusion: Entropy derived from preoperative CTTA may have the potential 
to predict early recurrence, especially in patients treated with preoperative 
chemotherapy. In practice, this may allow improved selection for resection or 
focused postoperative follow-up in high-risk patients.
SS 13.10 
Assessment of portal venous phase in dual-energy CT 
of the liver: initial experience with multiple 
monoenergetic levels and advanced monoenergetic 
reconstructions
D. Caruso1, C.N.N. De Cecco1, A. Laghi2, A. Schaefer3, 
D. Sheafor3, A.D. Hardie3; 1Rome/IT, 2Latina/IT, 3Charleston, 
SC/US 
Purpose: To assess Dual Source Dual-Energy CT (DECT) of the liver for image 
quality and diagnostic performance for liver lesions following intravenous con-
trast on the portal venous phase (PVP).
Material and methods: This prospective study included subjects who under-
went PVP DECT for assessment of liver lesions. From this data, linear-blended 
(LB) poly-energetic equivalent datasets and multiple monoenergetic recon-
structions from 40-190 keV were performed. Standard virtual monoenergetic 
images (VMI) and advanced image-based virtual monoenergetic images 
(VMI+) were performed. Quantitative and qualitative image quality were as-
sessed. An assessment of diagnostic accuracy was performed against Mag-
netic Resonance, as a reference standard. Direct comparisons were assessed 
by using repeated measure of variance.
Results: In 29 subjects with 49 liver lesions, the highest peak CNR for liver 
parenchyma and hyper-vascular liver lesions was achieved for VMI+, although 
for hypo-vascular liver lesions both VMI+ and VMI had lower CNR than LB. 
However, qualitative image quality assessments revealed a higher diagnostic 
quality and also reader preference for VMI+ over LB or VMI. There was also a 
trend toward higher diagnostic performance and confidence with VMI+ over 
the other two reconstructions: 83.7 % on LB, 75.5 % on the best VMI keV 
level (75 keV), and 95.9% on the best VMI+ keV level (50 keV)
Conclusion: Low keV VMI+ may improve detection of liver lesions on PVP 
despite a lack of clear improvement in measured CNR for hypo-dense lesions.
11:00 - 12:30 Meeting Hall V
Scientific Session SS 14
Pancreas and biliary tree: imaging and 
intervention
SS 14.1 
Autoimmune pancreatitis: MRI-MRCP characteristics
G. Avesani, R. Negrelli, E. Boninsegna, L. Frulloni, 
R. Manfredi, R.M. Pozzi Mucelli; Verona/IT 
Purpose: To better delineate the MRI-MRCP findings in a large group of pa-
tients with AIP, as up to now the characteristics of autoimmune pancreatitis 
(AIP) have been evaluated on a restricted population.
Material and methods: We retrospectively evaluated the MR-MRCP per-
formed before therapy in 112 patients diagnosed with AIP between 2001 and 
2014. Image analysis included T1- and T2- signal intensity, DWI, pattern of 
enhancement, extra-pancreatic involvement and main pancreatic duct (MPD) 
characteristics.
Results: 61 patients showed a diffuse enlargement of pancreas and 51 pa-
tients demonstrated a focal pancreatic involvement. The affected parenchyma 
was hypointense on T1-WI in 110/112 (98.2%) patients, hyperintense on T2-
WI in 77/112 (68.8%) and isointense in 30/112 (26,8%). DWI was available in 
52 patients and showed restricted diffusion in 36/52 (69.2%). After contrast 
injection, during the pancreatic phase it appeared hypointense in 104/112 
(92.9%). During the delayed phases, 95/112 (84.8%) patients showed delayed 
enhancement. The MPD was normal in 7/112 (6.3%) patients, while ductal 
narrowing was observed in 44/112 (39.2%) and complete stenosis in 61/112 
(54.5%); multiple stenoses were detected in 51/105 (48.6%). Dilation of side-
branch ducts was observed in 47/112 patients (42%). The median value of 
stricture length was 19 mm and of the caliber of upstream duct was 3 mm. 
Biliary involvement was observed in 32/112 (28.6%) patients and renal involve-
ment in 23/112 (20.5%).
Conclusion: Our data confirm the characteristic pattern of AIP described in 
literature, although the prevalence of some findings are quite different from 
some other published papers.
SS 14.2 
Focal and diffuse autoimmune pancreatitis: MRI-MRCP 
findings and comparison of focal-type of the head and 
of the body-tail
G. Avesani, R. Negrelli, E. Boninsegna, L. Frulloni, 
R. Manfredi, R.M. Pozzi Mucelli; Verona/IT 
Purpose: To evaluate the MRI-MRCP findings of focal-type and diffuse auto-
immune pancreatitis (AIP) and to compare, among focal-types, involvement of 
the head and the body-tail.
Material and methods: We retrospectively evaluated the MR-MRCP examina-
tions performed before therapy in 112 patients with diagnosis of AIP. Image 
analysis included signal intensity on T1- and T2-WI, DWI, enhancement pat-
tern, extra-pancreatic involvement and main pancreatic duct(MPD) character-
istics.
Results: 61/112 (54.5%) patients had diffuse enlargement of pancreas and 
51/112 (45.5%) focal involvement. The signal intensity of affected parenchyma 
on T1-WI, T2-WI and DWI was not significantly different. The lesions were hy-
pointense in arterial phase (93.4% vs 92.2%) with delayed enhancement 
(88.5% vs 80.4%) (p=NS). During venous phase, 39.2% of focal-type and 
14.7% of diffuse AIP showed hyperintensity (p=0.003). Prevalence of stenosis, 
side-branch involvement and extra-pancreatic disease did not differ signifi-
cantly. The caliber of the upstream MPD was higher in focal-type (3.1 mm vs 
2.4 mm, p=0.017). Among patients with focal AIP, 21/51 (41.2%) showed in-
volvement of the head and 30/51 (58.8%) of the body-tail. In 42.8% of head 
involvement and in 16.7% of body-tail there was a multifocal stenosis of MPD 
(p=0,03); 42.8% and 16.7% respectively demonstrated stenosis of main bile 
duct (p=0.03). Caliber of upstream duct was higher in AIP of the head (4 mm 
vs 2 mm, p=0.03).
Conclusion: Focal-type AIP showed an earlier delayed enhancement and a 
greater dilation of upstream MPD. Head involvement demonstrated a higher 
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SS 14.3 
Usefulness of three-dimensional magnetic resonance 
cholangiopancreatography with partial maximum 
intensity projection for diagnosing autoimmune 
pancreatitis
S. Yanagisawa, Y. Fujinaga, M. Maruyama, T. Muraki, 
M. Takahashi, A. Fujita, S. Fujita, M. Kurozumi, K. Ueda, 
H. Hamano, S. Kawa, M. Kadoya; Matsumoto/JP 
Purpose: To evaluate the usefulness of 3D magnetic resonance cholangiopan-
creatography (MRCP) with/without partial maximum intensity projection (MIP) 
in patients with autoimmune pancreatitis (AIP).
Material and methods: 3D MRCP and endoscopic retrograde cholangiopan-
creatography (ERCP) images were retrospectively analyzed in 24 patients with 
AIP. Three types of pancreatic duct findings, length of the main pancreatic duct 
narrowing (NR-MPD), multiple skipped MPD narrowing (SK-MPD) and side 
branches arising from the narrowed portion of the MPD (SB-MPD) were evalu-
ated on four sets of MRCP images, MIP with 5–7.5 mm (MIP5), 10–15 mm 
(MIP10), 72–90 mm thickness (full-MIP), and the three data sets combined (a-
MIP) were scored using a three- or five-point scale. The scores in the four 
MRCP data sets were statistically analyzed, and the positive rate of each find-
ing was compared in the MRCP data sets and ERCP.
Results: Scores on NR-MPD and SK-MPD did not differ significantly among 
the four MRCP data sets. However, full-MIP yielded a significantly lower score 
on SB-MPD than the other three data sets (P < 0.05). NR-MPD and SK-MPD 
positivity rates were higher in all MRCP data sets than in ERCP (P < 0.05), 
whereas the SB-MPD positivity rate was similar in three MRCP data sets, ex-
cluding full-MIP, and ERCP.
Conclusion: 3D MRCP shows NR-MPD and SK-MPD better than ERCP. Par-
tial-MIP MRCP allows good evaluation of SB-MPD, comparable to ERCP.
SS 14.4 
Type 1 and type 2 autoimmune pancreatitis: is there any 
difference in MRI?
R. Negrelli, G. Avesani, E. Boninsegna, L. Frulloni, 
R. Manfredi, R.M. Pozzi Mucelli; Verona/IT 
Purpose: To evaluate the MRI-MRCP findings of autoimmune pancreatitis 
(AIP) to find radiological patterns which could differentiate type 1 and type 2 
AIP. 
Material and methods: 84 patients with AIP were included in this retrospec-
tive study, who satisfied ICDC criteria for type 1 (n=66) and type 2 (n=18) AIP 
and performed MR-MRCP before treatment. Image analysis included: signal 
intensity abnormalities, pancreatic enhancement, biliary and extrapancreatic 
involvement, main pancreatic duct (MPD) stenosis, presence of upstream 
MPD dilation.
Results: Pancreatic parenchyma resulted hypointense on T1-WI in 65/66 
(98%) cases in type 1 and in 17/18 (94%) in type 2; hyperintense on T2-WI in 
41/66 (62%) cases in type 1 and in 15/18 (83%) in type 2 (p=NS). The lesions 
were hypovascular in 64/66 (97%) cases in type 1 and in 16/18(89%) in type 2 
with delayed contrast retention in 56/66 (85%) and in 17/18 (94%) respectively 
(p=NS). Autoimmune cholangitis was found in 29/66 (44%) patients with type 
1 AIP and in 3/18 (16%) with type 2 (p=0,02); renal involvement was found in 
20/66 (30%) and 1/18 (6%) respectively (p=0,02). The mean number of sten-
oses was 1,8 in type 1 AIP and 1,4 in type 2 (p=NS). Mild dilation of the up-
stream MPD was significantly more frequent in type 1 AIP than in type 2 
(p=0,01). 
Conclusion: MR-MRCP is useful to detect extra-pancreatic involvement, typi-
cally seen in type 1 AIP. The presence of a mild dilation of the upstream MPD 
suggests type 1 AIP.
SS 14.5 
Role of imaging for procedural risk factor assessment in 
post-ERCP iatrogenic pancreatitis
Z. Verdina, M. Radzina, L. Skrule; Riga/LV 
Purpose: To analyze post ERCP iatrogenic pancreatitis risk factors related to 
invasive procedure parameters by imaging.
Material and methods: We retrospectively studied 677 patients post ERCP 
from January 2014 to December 2015. Out of selected patients 143 were 
scanned by CT or MRI after the procedure due to alterations in clinical and 
laboratory data. Procedural ERCP parameters (manipulation time, ductus 
choledochus size, papillotomy, contrast and basket usage, balloon dilatation) 
were correlated to radiological criteria to assess their role in development of 
pancreatitis.
Results: After ERCP procedure 143 patients were scanned by CT or MRI 
(21.1%), 86 were female (60.1%) and 57 male (39,9%) with median age 63 
±13.85 years. Iatrogenic pancreatitis diagnosis was proved for 11 patients 
(7.7%): 8 patients with 3 times elevated serum alpha amylasis (p<0.001) and 
leucocytosis (p<0.003), 10 patients had specific radiological signs (edema, in-
filtration, ascites) and 2 patients had lethal outcome. We found no correlation 
between ductus choledochus enlargement, procedure time and iatrogenic 
pancreatitis (p=0.72). We found significant statistical difference between con-
trast use (p<0.001), cannulation (p<0.001), basket use (p<0.004) and papillot-
omy (p<0.001) in the development of pancreatitis, but there was no significant 
risk found with stent placement and balloon dilatation (p=0.41).
Conclusion: Imaging may provide additional value in detection of post ERCP 
iatrogenic pancreatitis. Main procedural risk factors for development of com-
plications are basket and contrast usage, cannulation and papillotomy.
SS 14.6 
Are PanIN pancreatic lesions detectable with imaging? 
A retrospective study upon 99 MRI
L. Menassa1, T. Ibrahim1, V. Vilgrain2, M.-P. Vullierme2; 
1Beyrouth/LB, 2Clichy/FR 
Purpose: To retrospectively find imaging signs of PanIN on abdominal CT 
scans and MRIs of patients being operated on.
Material and methods: 2 independent reviewers, blind to the diagnosis, re-
viewed retrospectively a series of 99 operated pancreas for NET (n=44, 14 of 
them having fatty pancreas), solid and pseudopapllary tumor (n=16), and IPMN 
(n=39), 77% having PanIN at pathology (only one patient having PanIN 3). All 
patient had an MRI including 2D MRCP, 74 having performed also a CT. Pa-
rameters included parenchymal abnormalities (Fibrous foci), and presence of 
microcyst (<5mm, without communication with pancreatic duct).
Results: Concordance Kappa between reviewers was 0.71. Among elemen-
tary findings, microcyst detection by MRI was the only factor found to have a 
significant discriminatory capacity for PanIN detection with specificity 92.16%, 
sensitivity 26.9 %, NPV 21.56% and PPV 94%. Furthermore in the head of the 
pancreas such pattern had an AUC of .651, and p = 0.04. The others signs 
studied at MRI had no statistical value and CT revealed no significant pattern. 
One weakness of our study was the very few patients with PanIN 3.
Conclusion: Presence of microcysts detected with MRI could be associated 
with PanIN 1 or PanIN 2 lesions. These results are to be used with caution, as 
the consequence of such diagnosis, including patients with family history of 
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SS 14.7 
Biliary strictures after orthotopic liver transplantation: 
can Gd-EOB-DTPA-enhanced 3T MR cholangiography 
provide additional information?
S. Salemi, P. Boraschi, F. Donati, R. Gigoni, M.C. Della Pina, 
F. Pacciardi, D. Caramella, F. Falaschi; Pisa/IT 
Purpose: To determine whether Gd-EOB-DTPA-enhanced 3T MR Cholangio-
graphy may provide additional information in the evaluation of biliary strictures 
after orthotopic liver transplantation.
Material and methods: Fifty-two liver transplant patients with clinical-echo-
graphical suspicion of biliary strictures underwent MR imaging at 3T device 
(GE-DISCOVERY MR750; GE Healthcare). After acquisition of T1w/T2w imag-
es and conventional T2-weighted MR Cholangiography (image set 1), a 3D 
T1-weighted fat-suppressed LAVA sequence was performed before and 20-
120 minutes after intravenous administration of 10 ml Gd-EOB-DTPA (Primov-
ist®, Bayer HealthCare) (image set 2). The diagnostic value of Gd-EOB-DTPA-
enhanced MR Cholangiography in the assessment of biliary strictures was 
tested by separate analysis results of image set 1 alone and image set 1 and 2 
together. MRI results were correlated with direct cholangiography, surgery 
and/or clinical-radiological follow-up.
Results: The level of confidence in the assessment of biliary anastomotic and 
non-anastomotic strictures was significantly increased by the administration of 
Gd-EOB-DTPA (p<0.05). Particularly, contrast-enhanced T1-weighted LAVA 
sequences tended to out-perform conventional T2-weighted MR Cholangio-
graphy in the visualization of the extra-hepatic biliary system and in the grad-
ing and extension of non-anastomotic strictures. Functional information pro-
vided by Gd-EOB-DTPA biliary excretion was especially helpful in patients 
previously undergoing biliary-enteric anastomosis with not or poorly dilated 
biliary system.
Conclusion: Gd-EOB-DTPA-enhanced MR Cholangiography may improve the 
level of diagnostic confidence provided by conventional T2-weighted MR 
Cholangiography at 3T device in the evaluation of biliary strictures in liver 
transplant recipients.
SS 14.8 
Biliary stricture: benign or malignant? Percutaneous 
transhepatic intraductal biopsy for differentiation
D. Frantsev, M.A. Shorikov, O. Sergeeva, E. Virshke, 
V. Panov, E. Moroz, O. Chistyakova, B. Dolgushin;  
Moscow/RU 
Purpose: The majority of biliary strictures are attributed to bile duct malig-
nancy. Surgical exploration is usually performed for exception of benign condi-
tions. Pictorial essay of percutaneous transhepatic intraductal biopsy (PTIB) 
assessment in biliary stricture differentiation is the point of the paper.
Material and methods: Since 2007 224 patients have undergone percutane-
ous transhepatic biliary drainage (PTBD) for obstructive jaundice causing by 
biliary strictures without evident periductal mass lesion. PTIB was performed 
in all cases. Biopsy devices (brush and forceps) were delivered to biliary stric-
ture through thin-walled tube (9-10 Fr) inserted in the biliary drainage channel. 
Histology and cytology studies of obtained material were performed. The PTIB 
was repeated at least three times in cases of non-neoplastic pathologist find-
ings.
Results: Ten out of 224 patients (4.5%) demonstrated absence of malignancy 
in the obtained by PTIB tissue. The following diagnostic work-up identified the 
nature of non-neoplastic biliary strictures: IgG4-related cholangiopathy in 4, 
dominant stricture in primary sclerosing cholangitis in 2, biliary papillomatosis 
in 1, penetrating to hepatoduodenal ligament duodenal ulcer causing biliary 
stricture in 1, cicatrical biliary strictures of unknown aetiology in 2 patients, 
respectively. Nobody required surgical exploration. In 8 cases specific treat-
ment was performed followed by patient status improvement. Biliary drainages 
were removed in 3 patients.
Conclusion: Biliary neoplastic–mimicking lesions still remain diagnostic di-
lemma frequently require unnecessary surgery. PTIB is easy and effective in-
tervention differentiating benign and malignant biliary strictures without sur-
gery.
SS 14.9 
Bile leaks after hepatic surgery and liver transplantation: 
usefulness of Gd-EOB-DTPA-enhanced MR 
cholangiography
S. Salemi, P. Boraschi, F. Donati, R. Gigoni, F. Pacciardi, 
D. Caramella, F. Falaschi; Pisa/IT 
Purpose: To determine the usefulness of Gd-EOB-DTPA-enhanced MR chol-
angiography in the diagnosis of bile leaks after hepatic surgery and liver trans-
plantation.
Material and methods: Twenty-six patients with previous hepatic resection 
(n=16) or liver transplantation (n=10) underwent MRI at 1.5T/3T-device due to 
strong suspicion of bile leak, based on a combination of clincal, laboratory and 
imaging findings. After acquisition of axial T1w/T2w images and conventional 
MRC (thin-slab 3D FRFSE and thick-slab SSFSE T2w sequences), a 3D fat-
suppressed LAVA sequence was performed before, 20 minutes and between 
25 and 120 minutes after intravenous administration of 10ml Gd-EOB-DTPA 
(Primovist®, Bayer HealthCare). Two radiologists in conference evaluated all 
the images for the presence or absence of bile leak, and its location when 
present. Imaging results were correlated with direct cholangiography, percuta-
neous drainage of fluid collection and/or imaging follow-up.
Results: A well-defined collection containing extravasated Gd-EOB-DTPA 
was detected in 11 out of 26 patients (one false negative case on MRI). Gd-
EOB-DTPA enhanced MRC yielded an overall sensitivity of 92%, specificity of 
100% and accuracy of 96% for the diagnosis of an active bile leak. The sensi-
tivity of 20 minutes delayed MR images was 42%.
Conclusion: Gd-EOB-DTPA-enhanced MR cholangiography utilizing delayed 
phase images is a highly reliable technique for the detection of active bile leaks 
after liver transplantation and hepatic surgery. The images acquired 25-120 
minutes after injection significantly increased the dentification of leakages.
SS 14.10 
CT and MR findings in xanthoganulomatous 
cholecystitis: retrospective analysis of pathologically 
proven 30 cases - tertiary care experience
B. Sureka, V.P. Singh, S. Rajesh, K. Bansal, C. Bihari, 
A. Rastogi, S.K. Sarin; New Delhi/IN
Purpose: To study the CT and MR findings in histopathologically confirmed 
cases of xanthoganulomatous cholecystitis - masquerader of gallbladder car-
cinoma. Approach to management of these two entities differ and so the out-
come. Preoperative imaging diagnosis can help the treating surgeons plan 
their treatment accordingly.
Material and methods: Retrospective analysis of histpathologically confirmed 
30 cases of xanthoganulomatous cholecystitis was done (17-CECT; 13-MR). 
The following features were analysed-wall thickness, intramural 
nodules,pericholecystic fat stranding, pattern of wall thickness, THAD,fat with-
in the gallbladder wall, cholelithiasis, infiltration into adjacent structures, biliary 
dilatation, lymph nodes, complications.
Results: Discontinuous mucosal lining was seen in 22 (73.3%) and continuous 
mucosal lining in 8 cases. Discontinuous mucosal lining was seen in 100% 
cases with wall thickness >10mm and this was statistically significant (p=0.03). 
Diffuse wall thickening was seen in 23, focal 3 and polyploidal in 2 cases. 
Cases which showed polyploidal thickening had coexisting carcinoma gall-
bladder. Intramural nodules were present in 87.5% cases with discontinuous 
mucosal lining. Pericholecystic fat stranding was seen in 19. Biliary dilatation 
was seen in 12, liver infiltration in 13 and intramural fat in 7 cases. 4 cases 
showed drop in signal in the intramural nodules on out-of-phase image.
Conclusion: Coexistence of five features - diffusely thickened wall, wall thick-
ness > 3mm, intramural hypodense nodule, discontinuous mucosal lining, 
cholelithiasis may suggest xanthoganulomatous cholecystitis. Correlating with 
the pathophysiology, we conclude that discontinuous mucosal lining is not so 
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11:00 - 12:30 Chamber Hall
Scientific Session SS 15
Colon: new imaging perspectives
SS 15.1 
Computer-aided detection for CT colonography: an 
evaluation of the optimal reader paradigm using 
evidence-based medicine methodology
C.E. Redmond, D. Malone, S.J. Skehan; Dublin/IE 
Purpose: Computer-aided detection (CAD) software for CT colonography 
(CTC) interpretation, which can be used in various reader paradigms, is widely 
available. The aim of this project was to establish the optimal reader paradigm 
in terms of per-polyp sensitivity (≥ 6mm) and reporting time, based on the cur-
rent best available evidence.
Material and methods: Evidence-based medicine (EBM) methods were used 
to retrieve and appraise studies published on the use of CAD for CTC. Ap-
praisal was performed using the Oxford Centre for Evidence Based Medicine 
(CEBM) tools for diagnostic studies.
Results: No studies were retrieved from the secondary literature. From the 
primary literature, 9 relevant studies were identified, analysed and ranked in a 
“hierarchy of evidence”. When compared to unassisted interpretation, using 
CAD as a second reader was associated with a higher per-polyp sensitivity 
(77.1% vs. 81.5%, respectively, p=0.001). Using CAD as a concurrent reader 
has a statistically significant shorter reporting time (p <0.001) and equivalent 
per-polyp sensitivity when compared to CAD as a second reader. The use of 
CAD as a first reader is controversial, however it appears to have similar per-
polyp sensitivity levels.
Conclusion: The best current evidence indicates that CAD for CTC as a sec-
ond reader results in higher per-polyp sensitivity when compared to unassisted 
interpretation (grade B recommendation). Using CAD as a concurrent reader is 
more time efficient and has a similar sensitivity (grade C recommendation).
SS 15.2 
Participation to sequential fecal immunochemical test of 
non-responders to CT colonography and colonoscopy in 
a randomized screening trial (SAVE)
L. Sali1, M. Mascalchi1, L. Ventura1, M. Falchini1, 
S. Delsanto2, A. Borgheresi1, G. Gabbani1, G. Grazzini1, 
G. Scarpini1, M. Zappa1; 1Florence/IT, 2Turin/IT 
Purpose: To evaluate if sequential invitation to fecal immunochemical test (FIT) 
might improve participation in colorectal cancer screening in subjects refusing 
CT colonography (CTC) or colonoscopy as primary tests.
Material and methods: Citizens of a district of Florence, Italy, aged 54-65, 
were allocated (8:2.5:2.5:1) with simple randomization to be invited by mail to 
one of four screening interventions: 1) biennial FIT for 3 rounds; 2) reduced 
preparation CTC (r-CTC); 3) full preparation CTC (f-CTC); 4) optical colonos-
copy (OC). Non-responders to r-CTC, f-CTC and OC were invited to FIT, real-
izing a combined strategy (r-CTC+FIT, f-CTC+FIT, OC+FIT). Outcome was 
participation rate.
Results: 16087 randomized subjects were invited to the assigned screening 
test. Participation rates were 50.4% (4677/9288) for first-round FIT, 28.1% 
(674/2395) for r-CTC, 25.2% (612/2430) for f-CTC, and 14.8% (153/1036) for 
OC. Participation rates to sequential FIT were 20.2% (347/1721) in non-re-
sponders to r-CTC, 21.4% (389/1818) in non-responders to f-CTC, and 25.8% 
(228/883) in non-responders to OC. Overall participation rates to combined 
screening strategy were 42.6% (1021/2395) for r-CTC+FIT, 41.2% (1001/2430) 
for f-CTC+FIT and 36.8% (381/1036) for OC+FIT, compared to 50.4% 
(4677/9288) for first-round FIT alone. All differences between groups were sig-
nificant (p<0.01), but not between r-CTC+FIT vs. f-CTC+FIT (p=0.32).
Conclusion: Sequential invitation to FIT catches up at least one-fifth of non-
responders to screening CT colonography or colonoscopy.
SS 15.3 
Colorectal cancer outcomes in a large negative CT 
colonography screening cohort
D.A. Mccomiskey, K. Mckay, E. Sala; St. John’s, NL/CA 
Purpose: Computed tomography colonography (CTC) is an efficient method 
for detecting overt colorectal cancer, serving as a viable alternative to colonos-
copy. This study conducts an average 6.63 year follow-up of patients undergo-
ing CTC. Those receiving negative results were followed for the occurrence of 
incidental colorectal cancers, allowing for the determination of CTC screening 
efficacy and providing valuable and practical data for the assessment of cur-
rent colorectal cancer screening guidelines.
Material and methods: Negative CTC screening patients (n=509) in the New-
foundland & Labrador Eastern Health system over a 15-month period were 
included. A comprehensive electronic medical record review was undertaken, 
encompassing provider, colonoscopy, imaging, and histopathology reports. 
Subjects were also cross-validated through the Newfoundland Cancer Clinic 
Registry Database. Incident colorectal cancers were recorded.
Results: The study population (n=509) was followed for an average of 6.63 
years. One incident colorectal adenocarcinoma represented a crude cancer 
incidence of 0.31 cancers per 1000 patient years, and a rate of 0.2% following 
a normal CTC.
Conclusion: Colorectal cancer presenting clinically is rare in the 6.63 years 
following a negative CTC screen, suggesting CTC is an equally effective meth-
od for colorectal screening compared to OC. These results also indicate that 
the 6 mm threshold for clinically significant polyps in CTC is appropriate. Fur-
thermore, current guidelines recommending interval CTC screening every 5 
years is conservative, and interval screening can be recommended over a 
longer time period.
SS 15.4 
Bowel preparation in CT colonography: is diet 
necessary? (DIETSAN) A randomized trial
D. Bellini, D. De Santis, T. Biondi, R. Ferrari, M. Rengo, 
A. Laghi; Latina/IT 
Purpose: To investigate whether diet restriction affects the quality of colon 
cleansing during reduced bowel preparation for CT colonography.
Material and methods: This pragmatic single-centre randomized trial recruit-
ed asymptomatic and symptomatic patients aged 45 years or older and re-
ferred by clinicians for CT colonography. Patients were randomly assigned in a 
1:1 ratio, in block of ten, to receive a reduced bowel preparation with diet re-
striction or the same reduced bowel preparation without diet restriction. All 
investigators were masked to treatment allocation. The primary endpoint, ana-
lyzed by ITT, was a composite of indices describing the quality of large bowel 
cleansing.
Results: 100 patients were randomly allocated to treatments (50 with diet re-
striction; 50 without diet restriction) and were included in intention-to-treat 
analysis. Six patients withdrew consent, leaving for analysis 46 assigned to 
reduced bowel preparation with diet restriction and 48 assigned to reduced 
bowel preparation without diet restriction. The mean residual stool (0.22 of 
three, 95%CI 0.00-0.44) and fluid burden (0.39 of three, 95%CI 0.25-0.53) 
scores for patients underwent diet restriction were similar to those for patients 
did not follow any diet restriction (0.25, 95%CI 0.03-0.47 [P = .82] and 0.49, 
95%CI 0.30-0.67 [P = .38], respectively). Both bowel preparations resulted in 
optimal colon cleansing. Serious adverse events were absent.
Conclusion: A reduced bowel preparation in association with faecal tagging 
and without any diet restriction demonstrated optimal colon cleansing effec-
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SS 15.5 
Straight to test CT colonography in the English two-
week wait cancer referral system for investigation of 
symptomatic patients
J.A. Stephenson, J. Mullineux, B. Billimoria, S.L. Jepson, 
V. Shah, R. Verma, K. Mulcahy, M. Elabassy; Leicester/GB 
Purpose: Due to the over-whelming burden on local colonoscopy services for 
bowel cancer exclusion we developed a straight to test pathway for patients 
with iron deficiency anaemia (IDA) and change in bowel habit (CIBH). Referrals 
from both primary and secondary care with a local population of one million 
attend directly for CTC with subsequent triage to cancer services or return to 
referrer dependent on findings.
Material and methods: We aim to present information on the referral pathway, 
inclusion and exclusion criteria, in built quality assurance mechanisms, report-
ing proformas, report outcome codes and initial results from prospective audit 
– to include pathway times, cancer detection, polyp detection and incidental 
findings.
Results: The first 2 months have seen >400 referrals, 31% for IDA and 66% for 
CIBH, with 58% females and a mean age of 72. 78% of referrals are from pri-
mary care. Referral to scan has a mean time of 12 days, with scan to report 
taking 2 days. There has been a 9% patient non-attendance rate. Colon can-
cer diagnosis rate is 5%, with 10% polyp, 4% non-colon cancer and 5% sig-
nificant incidental finding detection rate. 3% rate of diverticulitis and 43% rate 
of diverticulosis.
Conclusion: We believe this is the first straight to test CTC service in the UK 
for symptomatic patients and initial results of this streamlined pathway are 
promising.
SS 15.6 
Conspicuity of important extracolonic pathology at CT 
colonography without intravenous contrast 
enhancement
M. Thorley1, A. Bandara2, S. Fernando1, J. Nanayakkara2, 
H. Stunell2, D. Boone2; 1Norwich/GB, 2Colchester/GB 
Purpose: To evaluate conspicuity of important extracolonic pathology at low 
dose, unenhanced CT colonography.
Material and methods: Two experienced GI radiologists retrospectively re-
viewed 808 contrast-enhanced CT colonography (CTC) studies carried out on 
symptomatic patients between 20/10/2011-19/10/2014. Both observers cate-
gorised extracolonic findings according to C-RADS criteria and discrepancies 
were resolved by consensus. For all patients with likely important extracolonic 
findings (C-RADS E4), histopathological and clinicoradiological outcomes 
were established by querying relevant databases and examining case-notes. 
For all patients with confirmed important pathology identified at contrast-en-
hanced CTC, the low-dose, pre-contrast, prone acquisitions were re-read by a 
resident, blind to the contrast-enhanced imaging, reports, outcomes and 
study purpose. Results were compared to the reference standard and descrip-
tive statistics produced.
Results: In total, 94 (12%) studies were classified C-RADS E4, for which fol-
low-up data were available for 87 (median 24 months; range 14-48). One pa-
tient refused investigation and 6 had died. 24 were ultimately considered incor-
rectly classified (12 metastatic disease from colorectal primary; 12 pre-existing 
pathology). Of 46 potential new extracolonic cancers, 29 were benign; of the 
17 confirmed malignancies, 100% were identified at unenhanced CT. Of 7 aor-
tic aneurysms and 10 further important, non-neoplastic findings, all were con-
spicuous on the pre-contrast acquisition.
Conclusion: All important extracolonic pathology was demonstrated at review 
of the low-dose, unenhanced CTC studies. The clinical benefit, cost efficacy 
and safety of routine iodinated contrast enhancement at CTC requires further 
evaluation.
SS 15.7 
CT colonography: a tool to determine favorability for 
complete optical colonoscopy?
L. Sammut, N. Bonanno, P. Ellul, K. Micallef; Msida/MT 
Purpose: CT colonography (CTC) is extremely valuable in patients who had an 
incomplete colonoscopy. Our aim was to assess the anatomical factors pre-
dictive of an incomplete/failed conventional colonoscopy based on CTC find-
ings.
Material and methods: Patients who had undergone a CTC between January 
2015 and December 2015, in which the indication was an incomplete colonos-
copy, were evaluated retrospectively. The examinations were reviewed by a 
gastrointestinal radiologist and the parameters assessed were age, gender, 
total colon length, tortuosity of the colon (that is the number of acute angle 
flexures), extensive diverticular disease, previous surgery, presence of stric-
tures, adhesions and hernias.
Results: 60 patients (mean age 62.6 years) were recruited. The majority, 
68.3%, were females. Mean colon length was 176.6cm; mean number of acute 
angle flexures was 10.4. Extensive diverticular disease was present in 55% of 
patients. This was found mainly in the descending and sigmoid colon. 10% of 
the patients had previous abdominal or pelvic surgery. Colonic strictures were 
present in 8.3% of patients. 1.67% had adhesions secondary to endometrio-
sis, 1.67% had a spigelian hernia containing a loop of sigmoid colon and 
1.67% had large bowel malrotation.
Conclusion: By assessing certain anatomical features, CTC can be used as a 
tool to determine favorability for performing a complete colonoscopy. This fac-
tor is especially important when optical colonoscopy is required as to provide 
a histological diagnosis.
SS 15.8 
Polyp detection rates at CT colonography progressively 
reduce during the day and over the course of a reporting 
session
M. Almarashi, A. Plumb, G. Bhatnagar, S.A. Taylor, 
S. Halligan; London/GB 
Purpose: To determine if (a) time of day and (b) number of cases reported each 
day affects the detection rate of 6mm+ polyps and cancers at CT colonogra-
phy (CTC).
Material and methods: Single centre retrospective study (January 2013-Au-
gust 2015) of 1766 CTC examinations reported by one of four radiologists. 
Each report was categorised as positive or negative for 6mm+ polyps/cancer. 
The time of day at which the report was issued was extracted from the hospital 
Radiology Information System (RIS), as was the number of CTC reported by 
each radiologist on that particular day. Logistic regression models were con-
structed to assess the statistical significance of (a) time of day and (b) number 
of prior cases reported that day by a given radiologist on 6mm+ polyp/cancer 
detection.
Results: The detection rate of 6mm+ polyps/cancer dropped from 20.6% (for 
scans reported between 08:00am and 09:00am) to only 15.3% (for the 
17:00pm to 18:00pm period), p=0.048. The detection rate also progressively 
declined over the course of a reporting session (from 22.2% to 15.3%, 
p=0.0123). Radiologists reporting their first CTC study on a given day had a 
detection rate of 22.5% whereas later scans had progressively lower detec-
tion, falling to 10.8% by their 5th scan of the day (p=0.0013).
Conclusion: Detection rates at CTC progressively decline during the day (mir-
roring previous findings for colonoscopy), raising the possibility of clinically 
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SS 15.9 
Diagnostic performance of MR imaging in local staging 
of primary colon cancer patients
E. Nerad1, M.J. Lahaye2, D.M.J. Lambregts3, E.L.J. Kersten1, 
H.C.M. Van Den Bosch1, F.C.H. Bakers3, G.L. Beets2, 
H. Grabsch3, R.G.H. Beets-Tan2; 1Eindhoven/NL, 
2Amsterdam/NL, 3Maastricht/NL 
Purpose: Currently the FOXTROT trial is investigating the benefits of neo-ad-
juvant treatment for colon cancer. Imaging plays a crucial role, selecting pa-
tients for neo-adjuvant treatment. CT shows a questionable performance. Al-
though MRI is standard in rectal cancer staging, only one small study is 
published concerning colon cancer staging with MRI. Therefore the aim of this 
study was to evaluate the diagnostic performance of MRI for staging of colon 
cancer.
Material and methods: 55 colon cancer patients underwent MRI(1.5T; T2TSE/
DWI) of the abdomen and were retrospectively analysed by two blinded, inde-
pendent readers and compared with histopathology after resection, evaluat-
ing; invasion through bowel wall (T3/T4 tumours), invasion beyond bowel wall 
of ≥5mm and/or invasion of surrounding organs(T3cd/T4), serosal involve-
ment, extramural vascular invasion(EMVI) and malignant lymph nodes(N+). 
Inter-observer agreement was compared using Kappa(κ) statistics.
Results: The sensitivity/specificity detecting T3/T4 tumours (35/55), T3cd/T4 
tumours (15/55), fascia involvement (8/55), EMVI (17/55) and nodal involve-
ment (19/55) for reader 1 were; 91%/84%, 40%/88%, 88%/74%, 100%/62% 
and 47%/86% and for reader 2: 72%/89%, 60%/75%, 75%/72% 88%/70% 
and 68%/64% respectively. Interobserver agreement between both readers 
were good to moderate: 0.72, 0.55, 0.62, 0.60 and 0.60 respectively.
Conclusion: MRI seems to be able to select high-risk colon cancer patients 
with a good sensitivity for tumour invasion through the bowel wall, EMVI and 
serosal involvement. Together with its well-known superiority in detecting/
characterizing liver lesions, MRI might become the most optimal primary stag-
ing modality for colon cancer.
SS 15.10 
Clinical impact of MRI vs computed tomography in the 
diagnostic work-up of colon cancer patients
M.J. Lahaye1, D.M.J. Lambregts1, E. Nerad2, G.L. Beets1, 
F.C.H. Bakers3, R.G.H. Beets-Tan1; 1Amsterdam/NL, 
2Eindhoven/NL, 3Maastricht/NL 
Purpose: Traditionally, colon cancer patients are mainly staged with CT. How-
ever, MRI is superior to CT for detecting hepatic disease. Preliminairy reports 
indicate that MRI is able to stage colon tumors and as such may replace CT for 
integrated local and liver staging. Aim of this study was to evaluate the clinical 
impact of replacing CT for MRI in abdominal staging of colon cancer patients.
Material and methods: Sixty colon cancer patients were included: 30 under-
went abdominal CT (including 4-phase liver scan) and 30 patients underwent 
abdominal MRI (including 4-phase liver sequences and DWI). Both groups 
were retrospectively assessed regarding: primary tumour stage, presence of 
liver metastases and the need for additional imaging in inconclusive results. 
Histology/clinical/imaging follow-up was the reference standard.
Results: All colon tumors (100%) were detected and staged in both groups. 
4/30 patients in the CT-group and 3/30 in the MRI-group presented with liver 
metastases at primary staging; 2 additional patients from the CT-group devel-
oped metastases within 1 year (versus none in the MRI group). In the CT-group 
8/30(27%) had inconclusive results concerning hepatic disease; in 5/8 patients 
additional imaging was performed in the MRI group no inconclusive results 
occurred and no additional imaging was needed.
Conclusion: Simultaneous staging of hepatic disease and the colon tumor 
with MRI is feasible and has a clear clinical impact. As such MRI could become 
a valuable integrated staging tool for colon cancer.
11:00 - 12:30 Meeting Hall IV
Scientific Session SS 16
Abdominal imaging: new post processing 
techniques
SS 16.1 
Optimization of the window/level settings for virtual 
monoenergetic imaging in dual-energy CT of the liver: a 
multi-reader evaluation of standard monoenergetic and 
advanced imaged-based monoenergetic data-sets
C.N.N. De Cecco1, D. Caruso2, A. Laghi3, D. Sheafor1, 
A. Schaefer1, A.D. Hardie1; 1Charleston/US, 2Rome/IT, 
3Latina/IT
Purpose: To evaluate the optimal window settings for displaying and reading 
virtual monoenergetic reconstructions in third-generation dual-source, dual-
energy computed tomography (DECT) of the liver.
Material and methods: Twenty-nine subjects with liver lesions were prospec-
tively evaluated with DECT in the arterial (AP) and portal venous (PVP) phases. 
Three reconstructed datasets were calculated: standard linearly-blended 
(LB120), 70-keV standard monoenergetic (M70), and 50-keV advanced image-
based virtual monoenergetic (M50+). Two readers determined the optimal win-
dow (width and length, W/L) settings and the mean of their assessment was 
defined as the optimal W/L setting. The optimal settings for each reconstruc-
tion were then used for a blinded assessment of liver lesions.
Results: The optimal W/L settings for M50+ were significantly higher for both 
the AP (W=429.3±44.6HU, L=129.4±9.7HU) and the PVP (W=376.1±14.2HU, 
L=146.6±7.0HU) than for LB120 (AP, W=215.9±16.9HU, L=82.3±9.4HU; 
p<0.001) (PVP, W=173.4±8.9HU, L=69.3±6.0HU; p<0.001) and M70 (AP, 
W=247.1±22.2HU, L=72.9±6.8HU; p<0.001) (PVP, W=232.0±27.9HU, 
L=91.6±14.4HU; p<0.001). Use of the optimal window settings for M50+ vs. 
LB120 resulted in higher sensitivity for liver lesion detection (AP, 100% vs. 
86%; PVP, 96% vs. 63%).
Conclusion: Application of optimized window settings results in improved 
liver lesion detection rates in advanced image-based virtual monoenergetic 
DECT when customized for arterial and portal venous phases.
SS 16.2 
CT Perfusion for early response assessment after 
radiofrequency ablation of focal liver lesions
H.P. Marquez Masquiaran, G.D. Puippe, T. Pfammatter, 
R.P. Mathew, H. Alkadhi, M.A. Fischer; Zurich/CH 
Purpose: To evaluate the feasibility and diagnostic performance of perfusion-
CT (P-CT) for early assessment of treatment response in patients undergoing 
radiofrequency ablation (RFA) of focal liver lesions.
Material and methods: 20 patients (14men; mean age 64±14) undergoing 
RFA due liver metastases (N=10) or HCC (N=10), were prospectively included. 
P-CT was performed within 24 hours after RFA. Two readers determined arte-
rial-liver-perfusion (ALP,mL/min/100mL), portal-venous-perfusion (PLP,mL/
min/100mL) and hepatic-perfusion-index (HPI,%) in all 20 lesions by placing a 
freehand volume-of-interest (VOI) in the necrotic central (CZ), transition (TZ) 
and surrounding parenchymal (PZ) zones. Patients were classified in respond-
ers (no residual-tumor) and non-responders (residual/progressive-tumor) using 
imaging follow-up with contrast-enhanced CT or MRI after a mean of 139±70 
days. Prediction of treatment response was evaluated using receiver-operat-
ing-characteristics.
Results: Mean ALP/PLP/HPI of both readers was 4.89/15.44/61.25 for the CZ, 
9.98/16.88/66.35 for the TZ and 20.70/29.09/61.87 for the PZ. Interreader 
agreement of HPI was good for the CZ (ICC=0.875) and the TZ (ICC=0.857) 
zone, and high for the PZ (ICC=0.920). For both readers there was significant 
difference in PVP/HPI of the CZ and HPI of the TZ (all, P<0.03) between re-
sponders and non-responders. HPI of the TZ showed the highest area under 
the curve (0.90) for prediction of residual tumor, suggesting a cut-off value of 
73%.
Conclusion: Increased arterial perfusion of the transition zone assessed di-
rectly after RFA might be an early biomarker for residual tumor/tumor recur-
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SS 16.3 
CT with 3D reconstruction for planning of staged “in situ 
split” hepatectomy (ALPPS)
A. Kaprin, N. Rubtsova, D. Sidorov, L. Petrov, M. Lozhkin, 
A. Isaeva, K. Puzakov; Moscow/RU 
Purpose: To evaluate the role of CT volumetry with 3D liver reconstruction in 
planning of ALPPS for liver malignancies.
Material and methods: Volumetric measurements of FLR using CT with 3D 
liver reconstruction were obtained in pre- and post-first stage of ALPPS. CT 
scans were performed with a 80-section Aquilion PRIME Toshiba MS scanner, 
with 1 mm slice thickness, reconstruction interval 0,5mm, pitch factor 1.8, volt-
age 120 kV, 100 mA, tube rotation time 0.35 s. As a CT-contrast agent we used 
omnipack 350 (Iohexol) 200 ml, injection speed 5 ml/s. We used standard liver 
multiphase bolus contrast enhancement program. The circumscribed areas 
were then automatically multiplied by the CT section thickness, yielding an 
approximate volume for each liver section, and the volumes of all sections 
were summed to give the selected liver volume. The critical minimum FLR has 
been estimated to be approximately 25-30% in normal liver, and 35-40% in 
liver after chemotherapy.
Results: Between January 2013 and September 2015 in 15 patients FLR ratio 
were < 26%, determining the indication for ALPPS. CT scans were performed 
on postoperative day 8, after liver transection and portal vein ligation. All pa-
tients have had significantly increases in FLR (195,1%) and extended right 
hepatectomies were successfully performed in all cases.
Conclusion: CT-volumetry with 3D reconstructions allows to increase the 
safety of major liver resections for primary and metastatic liver cancer.
SS 16.4 
Is a CT unique portal phase enough for causal diagnosis 
of non traumatic abdominopelvic emergencies?
G. Herpe, M. Verdier, G. Vesselle, J.P. Tasu; Poitiers/FR 
Purpose: Computed tomography (CT) is widely used in the management of 
acute non traumatic abdominal emergencies (ANTAE). The aim of this study is 
to evaluate if a reduced CT protocol including a unique portal phase (Pp) is as 
accurate than a protocol including pre-contrast and post-contrast phases (Pc).
Material and methods: A retrospective study included adults undergone pre-
contrast and post-contrast abdominopelvic CT for ANTAE was conducted. 
Suspected haemorrhagic and/or ischemic disease were excluded. Two blind 
CT readings were carried out, one using only Pp, the second all phases of the 
Pc. In case of reading discrepancy, a third reading was performed, by an ab-
dominal imaging expert. The final diagnosis obtained by consulting the clinical 
report of the patient was considered as the gold standard for the diagnosis. 
Total radiation dose was compared for each CT protocol.
Results: 196 patients were included. There was no statistically significant dif-
ference in term of diagnosis between Pp and Pc (concordance ratio 98.5%; 
CI95% = 95.6% - 99.7%). Three errors due to an inappropriated protocol were 
observed (1.5%), Two of them were related to biliary tract obstruction causes. 
The use of single portal phase led to a 61% decrease of the global radiation 
dose.
Conclusion: Using a single portal phase in cases of ANTAE, CT accuracy re-
mains the same and radiation dose decreases by 61%. Precontrast phase 
should be nevertheless added in suspicious biliary tract pathologies.
SS 16.5 
Prognostic significance of PET texture analysis in 
oesophageal cancer staging
K.G. Foley, B. Berthon, C. Parkinson, C. Marshall, 
W.G. Lewis, E. Spezi, S.A. Roberts; Cardiff/GB 
Purpose: Texture analysis is a rapidly evolving field, in which potentially sig-
nificant additional prognostic data are extracted from radiological staging in-
vestigations. This study aims to determine the prognostic significance of PET 
texture variables when incorporated into a model predicting overall survival in 
patients with oesophageal cancer (OC).
Material and methods: Consecutive OC patients were staged with PET/CT 
between October 2010 and December 2014. PET-defined tumour variables 
were obtained using PET-STAT, software developed and written in the Matlab-
based open source software CERR (Computational Environment for Radio-
therapy Research). The tumour was outlined with ATLAAS, a learning algorithm 
for optimised automatic segmentation developed at Cardiff University. A Cox 
regression model, stratified by treatment and including age, TNM stage, tu-
mour length (TL) and 12 novel texture variables, including Entropy (a measure 
of the uniformity of grey-levels derived from a histogram) was developed. Pri-
mary outcome measure was overall survival (OS).
Results: 264 patients [median age 67 (range 38-83), 196 adenocarcinoma, 
198 male] were included. Multivariate analysis demonstrated three variables 
that were significantly and independently associated with OS; Age (HR 1.028, 
95% CI 1.010 - 1.046, p=0.002), SUVmax (HR 1.000, 95% CI 1.000 - 1.000, 
p=0.011) and Entropy (HR 0.157, 95% CI 0.042 – 0.585, p=0.006).
Conclusion: Age, SUVmax and Entropy are important prognostic indicators in 
OC. This study demonstrates the additional benefit of texture analysis in OC 
staging compared to the current TNM system.
SS 16.6 
Can CT histogram texture analysis help in the 
differential diagnosis between pancreatic 
neuroendocrine tumours and pancreatic metastasis of 
kidney clear cell carcinoma?
N. Cardobi, G.A. Zamboni, F. Lombardo, M.C. Ambrosetti, 
R.M. Pozzi Mucelli; Verona/IT 
Purpose: To evaluate the differences at CT histogram texture analysis be-
tween pancreatic neuroendocrine tumours (PNETs) and pancreatic metastasis 
of renal clear cell carcinoma (PMRCCCs).
Material and methods: We selected 28 patients (15 PNETs and 13 PMRCC-
Cs) with a CT with baseline and arterial phase scans, and histologically proven 
lesions. The DICOM files of each patient were loaded in a texture analysis 
freeware software (MaZda 4.6), then lesions were selected by manually draw-
ing a Region of Interest (ROI). Since lesions were not always clear on unen-
hanced CT, ROIs were drawn on the arterial CT scan and then copied to the 
unenhanced CT. Mean, variance, skewness and kurtosis histogram values 
were extracted for each ROI in both unenhanced and enhanced CT images. 
Mean and standard deviation were calculated for each parameter and an un-
paired t-test was used to compare PNETs and PMKCCCs.
Results: No significant difference was observed between PNETs and PMRC-
CCs for all the analyzed parameters, both for the unenhanced and arterial 
phases. Kurtosis and skewness extracted from the unenhanced CT phase 
showed a trend to significance (respectively p = 0.056 and p = 0.072).
Conclusion: From our preliminary results, a differentiation between PNETs and 
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SS 16.7 
Multi-slice accelerated EPI diffusion-weighted imaging 
versus conventional diffusion-weighted imaging in the 
upper abdomen: influence of acceleration factor on 
image quality
C.S. Reiner, B.K. Barth, L. Filli, D. Kenkel, M. Piccirelli, 
A. Boss; Zurich/CH 
Purpose: To optimize a diffusion-weighted (DWI) echo-planar-imaging (EPI) 
sequence capable of simultaneous multi-slice (SMS) excitation in liver and 
pancreas regarding acquisition time (TA), signal-to-noise ratio (SNR), and im-
age quality (IQ).
Material and methods: Ten volunteers underwent DWI of the upper abdomen 
in a 3T MR-scanner with an 18-channel body-coil. A SMS-DWI sequence us-
ing blipped CAIPIRINHA technique (b-values 0/50/400/800 s/mm2, accelera-
tion factors (AF) 2 and 3) was compared to a standard EPI (AF1). Three 
schemes were evaluated: (i) reducing TA, (ii) keeping TA identical with increas-
ing averages, (iii) increasing number of slices with identical TA. All acquisition 
schemes were evaluated qualitatively (IQ) and quantitatively (SNR).
Results: In scheme (i), no differences in SNR were observed (p=0.321-0.038) 
with reduction in TA from 5:23min to 2:55min (AF2, increase in SNR/time 
75.6%) and 2:14min (AF3, increase SNR/time 102.4%). Comparable image 
quality was obtained for AF1 and AF2, whereas AF3 resulted in image degra-
dation. No improvement in SNR was obtained in scheme (ii). Increased SNR/
time could be invested in acquisition of more and thinner slices (30 slices, 
5mm; 40 slices, 4mm; 50 slices 3mm) without significant reduction in SNR 
(p=0.083-0.702). Image quality scores were stable for AF2 but decreased for 
AF3.
Conclusion: SMS-DWI of the liver and pancreas provides substantially higher 
SNR/time, which may be used for shorter scan time or higher slice resolution. 
Optimum acceleration factor is AF2 as higher acceleration results in increased 
artifacts.
SS 16.8 
The 3D Bag of Visual Words (3D-BoVW) algorithm for 
classification of liver lesions
E. Klang1, I. Diamant2, A. Ben-Cohen2, E. Konen1, 
H. Greenspan2, M.-M. Amitai1; 1Ramat Gan/IL, 2Tel Aviv/IL 
Purpose: To evaluate the improved performance of 3D-BoVW over the typical-
BoVW algorithm for automatic classification of liver lesions in multi-phase CT 
images.
Material and methods: This study included multi-phase CT images of 134 
liver lesions: 22 cysts, 35 metastases, 32 hemangiomas, 16 FNH and 29 HCC 
(2011-2013). Radiologist circumscribed the lesions margins in one slice per CT 
phase (2D). The typical-BoVW algorithm classifies images by treating image-
features as “words in a dictionary”. Images are divided to small patches 
(“words”), and “dictionaries” are created, that are used to classify new lesions. 
In multiphase CT studies, dictionaries are built from each phase. Our 3D-
BoVW algorithm is a refinement of the typical-BoVW. Instead of using data 
from only one slice in each phase, as was done before, the 3D-BoVW auto-
matically propagates the 2D segmentation of each lesion in the z-direction to 
several neighboring slices, thus, extending data to 3D. Sensitivity and specific-
ity of the 3D-BOVW and the typical-BoVW were compared.
Results: The 3D-BoVW showed an overall improvement of sensitivity from 
71.6% to 76.1% and specificity from 91.9% to 93.4%, compared to the typi-
cal-BoVW. Best performances were shown for hemangioma (sensitivity from 
62.5% to 81.3%) and FNH (sensitivity from 56.3% to 68.8%).
Conclusion: Extending BoVW classifier from 2D to 3D showed promising re-
sults in the multi-phase CT liver lesions classification task. Implementation of 
this algorithm in other medical imaging problems should be considered.
SS 16.9 
Fusion of real-time ultrasonography with CECT by 
navigation system for CECT indeterminate focal liver 
lesions
H. Petrasova, J. Foukal; Brno/CZ 
Purpose: Aim was to find out, if fusion of US and CECT,in patients with inde-
terminate focal liver lesion by navigation system, is a feasible method and to 
calculate statistic analysis of fused US/CECT in determination of lesions’ etiol-
ogy.
Material and methods: Prospective study has covered 30 indeterminate hy-
poattenuating liver nodule found on CECT. Fused real-time US/CECT was per-
formed within the same day by navigation system Percunav. Reconstructed 
images of CECT- porto-venous phase, slice thickness 2mm, were used as a 
data source for the fusion. Registration process for seeing fused images was 
done manually (3 points match). US was performed with 1-5MHz probe. All US 
modes were used in area of interest (B-mode, color Doppler, power Doppler, 
CEUS- application of 2.4 ml of sulfur hexafluoride intravenously). The biologi-
cal nature of all lesions was proved in time by follow up (for period at least 1 
year).
Results: The fusion of US with CECT was possible in all our patient with high 
spatial accuracy. All lesions were detectable in fused US, determination of 
nature was based on features in all US modes. Statistic analysis of our data 
brings following results: sensitivity of fused US/CECT on regard of the evalua-
tion of malignant etiology was 83%, specificity 100%, PPV 100%, NPV 96%, 
AAC 96,67%.
Conclusion: The navigation systems for ultrasound represent News in radiol-
ogy. We have found fusion of US/CECT very helpful, feasible, just slightly op-
erator depended and highly accurate.
SS 16.10 
Metal implants on CT: comparison of iterative 
reconstructions algorithms for reduction of metal 
artifacts with single energy versus spectral CT scanning 
in a phantom model
J. Fang, D. Zhang, B. Heidinger, V. Raptopoulos, A. Brook, 
O.R. Brook; Boston, MA/US 
Purpose: To assess single energy metal artifact reduction (SEMAR) and spec-
tral energy metal artifact reduction (MARS) algorithms in reducing artifact gen-
erated by different metals.
Material and methods: Phantom was scanned with and without SEMAR (Aq-
uilion One, Toshiba) and MARS (Discovery CT750 HD, GE), with various metal 
implants. Images were evaluated objectively by measuring standard deviation 
and subjectively by two independent reviewers grading on a scale of 0 (no ar-
tifact) to 4 (severe artifact). Reviewers graded new artifacts introduced by 
metal artifact reduction algorithms.
Results: SEMAR and MARS significantly decreased variability of the density 
measurement adjacent to the metal implant, with median SD (standard devia-
tion) of 52.1HU without SEMAR, vs. 12.3HU with SEMAR, p<0.001. Median SD 
without MARS of 63.1HU decreased to 25.9HU with MARS, p<0.001. Median 
SD with SEMAR is significantly lower than with MARS (p=0.0011). SEMAR 
improved subjective image quality with reduction in overall artifacts grading 
from 3.2±0.7 to 1.4±0.9, p<0.001. Improvement of overall image quality by 
MARS has not reached statistical significance (3.2±0.6 to 2.6±0.8, p=0.088). 
There was introduction of artifacts introduced by metal artifacts reduction al-
gorithm for MARS with 2.4±1.0, but minimal with SEMAR 0.4±0.7, p<0.001.
Conclusion: CT iterative reconstruction algorithms with single and spectral 
energy are effective in reduction of metal artifacts. Single energy algorithm 
provides better image quality than spectral CT algorithm. Spectral metal arti-
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Contrast media: optimising abdominal 
protocols
SS 17.1 
High concentration (400 mgI/mL) versus low 
concentration (320 mgI/mL) iodinated contrast media in 
multi detector computed tomography of the liver: 
comparison between 100 kV and 120 kV acquisition 
protocol
S. Picchia, M. Rengo, D. De Santis, D. Bellini, D. Caruso, 
A. Laghi; Latina/IT 
Purpose: To compare Iodixanol 320mgI/mL and Iomeprol 400mgI/mL in terms 
of liver enhancement in MDCT at 100kV and 120kV.
Material and methods: 110 patients were prospectively randomized into 
three groups. Group A received 637.5mgI/kg LBW of Iodixanol 320 and images 
were acquired at 120kV. Group B received 637.5mgI/kg LBW of Iodixanol 320 
and images were acquired at 100kV. Group C received 750mgI/kg LBW of 
Iomeprol 400 and images were acquired at 120kV. Attenuation values were 
measured on pre-contrast and portal-venous phase. Contrast Enhancement 
Indexes (CEI) were calculated subtracting basal densities from post-contrast 
acquisitions. Means were compared with paired T-test. A blinded independent 
reader evaluated image quality.
Results: Mean CEIs for groups A, B and C were respectively 49.37, 58.04 and 
54.55 HU. Liver enhancement achieved injecting Iodixanol320 was significant-
ly higher at 100kV compared to 120kV (P=0.0369). Liver enhancement 
achieved injecting Iodixanol320 at 100 and 120kV was not significantly differ-
ent from that achieved injecting Iomeprol400 at 100 and 120kV, respectively 
(P=0.4183 and P=0.0526). No significant differences were observed in terms of 
image quality among the three groups.
Conclusion: Similar liver enhancement values were observed injecting a lower 
amount of Iodixanol 320 compared to the ones achieved injecting Iomeprol 
400. Values were even more similar when images obtained at 100kV with Iodix-
anol 320 were compared to the ones obtained at 120kV with Iomeprol 400 with 
no significant differences in terms of image quality.
SS 17.2 
Iodine quantification in an ex-vivo calf liver model with 
simulated lesions using a single source dual energy CT 
(ssDECT) and three segmentation methods: inter-reader 
agreement and reproducibility.
A. Agostini, U. Mahmood, D. Ryan, P. Sawan, L. Mannelli; 
New York, NY/US 
Purpose: To evaluate inter-reader agreement and reproducibility of iodine 
quantification using a single source dual energy CT (ssDECT) and three seg-
mentation methods on an ex-vivo animal model.
Material and methods: A radiologist manually injected different volumes of 
Iohexol 300 mgI/ml in ten chicken sausages and inserted them in two calf liv-
ers, recording injected volumes and positions. Livers were scanned 7 times 
with a GE Discovery CT750HD (80/140kVp, 260 mA, 0.984 pitch, 0.7s rotation 
time, and 2.5mm slice thickness). Three other radiologists, blinded to iodine 
injected and sausage positions, segmented the sausages with three methods 
(manual, semi-automatic segmentation, and fixed threshold) by using a GE AW 
VolumeShare 5; iodine concentrations were calculated on iodine (-water) im-
ages. The estimated and injected iodine quantities were compared with Bland-
Altman plots. Inter-reader agreement and reproducibility were calculated with 
intra-class correlation coefficients.
Results: 8 sausages were injected with a total of 1590mg of iodine; two sau-
sages were excluded because of macroscopic iodine leakage. Mean errors of 
estimated iodine quantities were -2.76mg (-2.73%), -3.73mg (-3.27%), and 
-2.62mg (-2.67%) for manual, semi-automatic segmentation, and fixed thresh-
old. Inter-reader agreements were respectively 0.9998, 0.9951, and 0.9883, 
while intraclass correlation coefficients among 7 scans were 0.9993, 0.9977, 
and 0.9999 respectively for the three segmentation methods.
Conclusion: ssDECT has high inter-reader agreement and reproducibility in 
iodine quantification.
SS 17.3 
Contrast media protocol optimization in MDCT of the 
liver: advantages of using a bioimpedance device
S. Picchia, M. Rengo, D. Caruso, D. Bellini, D. De Santis, 
A. Laghi; Latina/IT 
Purpose: To compare two different approaches to the quantification of CM 
volume for MDCT of the liver, in a population of patients with high (>30) BMI, 
one using nomograms and the second using a bioimpedance device.
Material and methods: 9 patients were prospectively randomized into two 
groups. In Group A LBW was calculated using nomograms while in Group B 
using a bioimpedance devices. In both groups patients received 750mgI per 
Kg of LBW of iodinated contrast medium. Attenuation values were measured 
on pre-contrast and portal-venous phase. Contrast Enhancement Indexes 
(CEI) were calculated sottracting basal densities from post-contrast acquisi-
tions. Means were compared with Paired T-test. Image quality was evaluated 
by a blinded independent reader.
Results: The average amount of iodine administered in group A (41,9g) was 
significantly higher (p=0,04) than in group B (35,91g). Mean CEIs of the liver in 
portal-phase for groups A and B were respectively 66,09HU and 58,6HU. A 
significant greater portal-enhancement of the liver was observed in group A 
(p=0,03). No significant differences were observed in terms of image quality 
among the three groups.
Conclusion: In patients with high BMI (>30) a significant higher liver enhance-
ment was achieved using a bioimpedance device for the quantification of CM 
volume. The use of nomograms for the calculation of LBW in high BMI patients 
determine an underestimation of the adequate amount of iodine needed to 
obtain a proper liver enhancement.
SS 17.4 
Incidence of acute transient dyspnea (ATD) after 
administration of gadoxetic acid (EOB) in liver magnetic 
resonance imaging
L. Grazioli1, R. Faletti2, G. Battisti3, B. Frittoli1, P. Fonio2; 
1Brescia/IT, 2Turin/IT, 3Spoleto/IT 
Purpose: The aim of the study was the evaluation of the incidence of ATD after 
administration of EOB and its correlation with motion artifacts during arterial 
phase.
Material and methods: Two hundred fifty consecutives patients who under-
went liver MRI with EOB were prospectively analyzed with multi-arterial CAIP-
IRINHA algorithm. The incidence of ATD and the breath impairment were 
evaluated either after the saline flush and the MR scan procedure using a spe-
cific questionnaire and a breath hold registration (PACE system). Quality of the 
images was evaluated with a semiquantitative five-point scale by three differ-
ent radiologists.
Results: PACE system alterations were recognized in 16/250 patients (6%). 
Incomplete breath-hold at the end of arterial phase was reported on specific 
questionnaire in 11/16 patients. Acute transient dyspnea, in agreement with 
PACE system and questionnaire, was identified in 2/250 patients (0,8%). Mo-
tion artifacts are present in 51/250 (20%) and increase from first and second 
phase to the third in both different administration (saline flush and EOB) using 
CAIPIRINHA multi-arterial phase technique. Inter-observer concordance by 
three radiologists was good (k=0.78 with Choen test).
Conclusion: Incidence of ATD after EOB administration was significantly lower 
than previously reported by literature. Motion-related artifacts incidence in-
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SS 17.5 
Gadoxetic acid-enhanced MRI for visual assessment of 
graft dysfunction in liver transplant recipients
D. Tamandl, N. Bastati-Huber, A. Wibmer, H. Einspieler, 
S. Poetter-Lang, A. Ba-Ssalamah; Vienna/AT 
Purpose: To evaluate whether a qualitative visual scoring system, using spe-
cific features of gadoxetic acid-enhanced MRI, could be applied to estimate 
graft function and survival probability after orthotopic liver transplantation 
(OLT).
Material and methods: 85 patients, 31 females (36.5%) and 54 males (63.5%) 
with a median age of 54.6 years were examined on a 3 Tesla MR. Gadoxetic 
acid was administered using a bolus injection of 0.025 mmol/kg at 1 mL/sec. 
Dynamic imaging, including a 20 minute hepatobiliary phase (HBP), was sub-
sequently performed. Two readers independently analyzed the unenhanced 
and HBP-enhanced MR images qualitatively. The degree of parenchymal con-
trast enhancement (enhancement quality score [EnQS]), biliary excretion (ex-
cretion quality score [ExQS]) as well as the persistence of signal intensity (SI) 
in the portal vein on the HPB (portal vein sign quality score [PVsQS]) was as-
sessed. A quantitative measurement on the unenhanced and HBP-enhanced 
images was performed as well, to measure the relative liver parenchymal en-
hancement (RLE) at 20 minutes. Kaplan-Meier survival estimates and Cox pro-
portional hazard regression models was used to calculate the probability of 
graft survival.
Results: The inter-reader agreement for the qualitative assessment of EnQS, 
ExQS, PVsQS was very good (k: 0.81). Univariate and multivariate survival 
analysis showed that the EnQS, ExQS, and PVsQS were independently asso-
ciated with the probability of graft survival, respectively.
Conclusion: Qualitative assessment using gadoxetic acid enhanced-MRI al-
lows us to estimate graft survival probability after OLT.
SS 17.6 
The liver-to-spleen enhancement difference normalized 
by phantoms (LSED_NP20): a new signal intensity-based 
index for hepatocellular uptake function of the liver 
easily available in clinical practice using Gd-EOB-DTPA-
enhanced MR imaging
A. Yamada1, Y. Fujinaga1, Y. Kitou1, A. Nozaki2,  
Y. Iwadate2, T. Suzuki1, D. Komatsu1, K. Ueda1, M. Kadoya1; 
1Matsumoto/JP, 2Hino/JP 
Purpose: To clarify an optimal signal intensity-based index for hepatocellular 
uptake function of the liver using Gd-EOB-DTPA-enhanced MR imaging (EOB-
MRI).
Material and methods: Consecutive 34 patients with chronic liver diseases 
who underwent EOB-MRI using Differential Sub-sampling with Cartesian Or-
dering (DISCO) pulse sequence were enrolled in this prospective study. Plastic 
bottle phantoms containing several concentrations of contrast media diluted 
by normal saline were scanned together in order to evaluate contrast enhance-
ment quantitatively. The estimated concentration of Gd-EOB-DTPA in hepato-
cytes at heaptobiliary phase (eCi20) was determined from compartment mod-
el analysis of normalized signal intensities of abdominal aorta, portal vein, and 
the liver on dynamic EOB-MRI. Previously reported signal intensity-based 
clinical indices for hepatocellular uptake function, such as the liver-to-spleen 
contrast ratios (LSC_20) and the normalized liver-to-spleen contrast ratios 
(LSC_N20), and newly proposed index, the liver-to-spleen enhancement differ-
ence normalized by phantoms (LSED_NP20) were obtained from signal inten-
sities of the liver and spleen on hepatobiliary phase of EOB-MRI. The correla-
tion between eCi20 and these indices were statistically evaluated.
Results: Correlation coefficients and its 95% CIs between eCi20 and signal 
intensity-based clinical indices for hepatocellular uptake function were as fol-
lows: LSC_20, r = -0.19 (-0.44, 0.13); LSC_N20, r = 0.23 (-0.25, 0.59); and 
LSED_NP20, r = 0.90 (0.80, 0.95).
Conclusion: LSED_NP20 is an optimal signal intensity-based index for the 
hepatocellular uptake function of the liver easily available in clinical practice 
using EOB-MRI.
SS 17.7 
Gadoxetic acid enhanced MR imaging of transient 
hepatic perfusion disorder: another cause of 
hypointense observation on hepatobiliary phase
C. Torrisi, D. Picone, M. Midiri, G. Brancatelli; Palermo/IT 
Purpose: To describe MR imaging features of transient hepatic perfusion dis-
orders (THPD) in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced 
MR imaging.
Material and methods: Gadoxetic acid-enhanced MR imaging of 125 patients 
(91 males; mean age: 68 years; range 26-82 years) with THPD were retrospec-
tively reviewed. 105/125 patients had chronic liver disease. Three readers 
evaluated in consensus intensity of THPD on HAP and HBP and evolution at 
follow up. In cases of patients with multiple THPD, largest lesion was selected 
as being representative for each patient. Fisher’s exact test was used for sta-
tistical analysis.
Results: THPD were hypervascular on HAP (125 of 125;100%) and hypoin-
tense on HBP (17 of 125;14%). Hypointense THPD were observed in patients 
with previous loco-regional treatment of adjacent tumors (either RFTA, PEI or 
TACE: n=13), peripheral portal venous branch thrombosis (n=1), biliary ob-
struction (n=1), previous surgery (n=1), cryptogenic (n=1). Of 108 patients with 
isointense THPD,63 were cryptogenic, 40 had previous locoregional treatment 
or were adjacent to hemangioma (n=4) or metastasis (n=1). At Fisher’s exact 
test, hypointense THPD on HBP was associated with previous locoregional 
treatment (p<0,05). Of seven patients with hypointense THPD who had follow-
up MR (range: 3-15 months; mean 7 months), six showed reduction in size.
Conclusion: A hypointense THPD on HBP was observed in 14% of patients, 
and it was associated with previous locoregional treatment of adjacent tumor.
SS 17.8 
Gadolinium-based contrast agent (GBCA) in rectal MRI: 
could patient care be enhanced?
M. Corines1, S. Nougaret2, M. Weiser1, J.L. Fuqua Iii1, 
M.J. Gollub1; 1New York, NY/US, 2Montpellier/FR 
Purpose: To assess if GBCA, including dynamic contrast enhancement (DCE-
MRI) changes (1) radiologic stage at baseline (BL) or post neoadjuvant treat-
ment (PNT) MRI and (2) treatment plan
Material and methods: This IRB approved, retrospective study analyzed 100 
rectal MRIs from Dec. 2011 to Jan. 2015. Subjects operated by the surgical 
co-author or with distant metastases were excluded. Two radiologists inde-
pendently re-interpreted MRI unfamiliar to them. Cases were assessed without 
(C-) then with GBCA (C+) for tumor stage and location. Differences were ana-
lyzed using Student’s T-test. Interpretations were presented with clinical histo-
ries to 1 experienced surgeon blinded to GBCA use for treatment assess-
ments. Management differences were analyzed descriptively.
Results: With GBCA, T-down-staging occurred in 16% and 4% and T-upstag-
ing in 8% and 4% of BL and PNT, respectively. Mean distances (cm) from tu-
mor to the anorectal junction, anal verge and mesorectal fascia C- and C+ at 
BL were not statistically different, but were statistically smaller at PNT. Seven-
teen baseline discordant treatment assessments, included 5 appropriate to 
changed T-stage and 12 unexplained by radiologic differences. Three PNT 
cases recommended a different operation despite unchanged radiologic as-
sessment.
Conclusion: In this unique evaluation of GBCA including DCE-MRI in rectal 
cancer, tumor stage infrequently changed, and did so more often at baseline; 
resulting in down-staging. Most discrepancies in recommended treatment 
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SS 17.9 
Contrast-enhaced ultrasonography in the evaluation of 
incidental focal liver lesions: a cost-effective study for 
three years
M. Šmajerová, T. Andrasina, H. Petrasova; Brno/CZ 
Purpose: The purpose was to find out whether contrast-enhanced ultrasonog-
raphy (CEUS) is a cost-effective method for the first line evaluation of focal 
liver lesions (FLL) compared to CT and MRI.
Material and methods: The retrospective study included 1058 patients with 
incidental FLL, examined using CEUS in three years. Where CEUS results were 
not conclusive, CT or MRI was performed. Some patients with malignant find-
ings on CEUS had additional CT for staging. The costs of this strategy were 
calculated. Other calculations show potential savings compared to costs if all 
the patients had been examined by CT or MRI after initial native ultrasound.
Results: The costs for evaluation of these lesions by CEUS (+ additional ex-
aminations) were CZK 1,624,314 (approx. €63,600) for three years. If CT or 
MRI had been used instead it would have been CZK 1,888,255 (€74,000) and 
CZK 5,141,971 (€200,000), respectively. CEUS was CZK 263,941 (€10,300) 
(13.98 %) cheaper compared to CT and CZK 3,517,657 (€138,000) (68.41 %) 
cheaper compared to MRI for all three years together. The average difference 
in price between CEUS and CT or MR for a year was CZK 87,980 (€3,500) and 
CZK 1,172,552 (€46,000), respectively.
Conclusion: Costs for evaluation of FLL by CEUS were slightly lower than CT. 
CEUS is a much more cost-effective method compared to MRI.
SS 17.10 
Early clinical experience in the management of post-
operative lymphatic leakage using lipiodol 
lymphangiography and two additional glue embolization 
techniques
S. Hur; Seoul/KR 
Purpose: To evaluate the safety and efficacy of lipiodol lymphangiography and 
two additional embolization techniques using glue (N-butyl cyanoacrylate) for 
the management of postoperative lymphatic leakage.
Material and methods: This study included patients with post-operative lym-
phatic leakage who were referred to the interventional radiology department of 
two tertiary referral centers for Lipiodol lymphangiography from August 2010 
to December 2015. Lipiodol lymphangiography was performed for both diag-
nostic and therapeutic purposes. Additional embolization using glue was per-
formed as needed using two different techniques: 1) lympho-pseudoaneurysm 
embolization and 2) lymph node embolization. The safety and efficacy of these 
techniques were determined.
Results: All 18 patients underwent successful lymphangiography. Fifteen pa-
tients were observed for the therapeutic effect of lymphangiography and 7 
(47%) recovered without further embolization. Nine patients, including 3 pa-
tients who underwent embolization immediately after lymphangiography and 6 
patients whose conditions did not respond to lymphangiography, underwent 7 
lympho-pseudoaneurysm and 4 lymph node embolizations. The clinical suc-
cess rate of additional embolization was 89% (8/9) and the overall clinical suc-
cess rate was 83% (15/18). The median time from initial lymphangiography to 
recovery was 5.5 days. No major complication related to these procedures 
were reported other than transient leg edema in 3 patients, all of which could 
be managed conservatively.
Conclusion: Lipiodol lymphangiography and the two additional embolization 
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